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 Deleted in liver cancer 1 (DLC1) is a ubiquitously expressed Rho GTPase-
activating protein (RhoGAP) that has been shown to enhance the intrinsic GTPase 
activity of RhoA and to a much lesser extent, Cdc42. Through mechanisms such as 
loss of heterozygosity and promoter hypermethlyation, the inactivation of DLC1 
and subsequent enhancement of RhoA activity has contributed to rapid tumor 
expansion and metastasis. The re-introduction of DLC1 into various cancer cell 
lines has been shown to result in drastic cytoskeletal remodeling and inhibition of 
tumor cell growth via inhibiting cell proliferation, inducing apoptosis and 
reducing cell migration. This tumor suppressor activity of DLC1 has been 
attributed to the ability of the GAP domain to negatively regulate Rho GTPases as 
well as through other GAP-independent mechanisms. The multi-modular 
architecture of DLC1 suggest that other domains such as the sterile alpha motif 
(SAM) and STAR-related lipid transfer (START) domains may be important for 
interaction with proteins other than Rho that may contribute to its function.  
 To address this possibility, pulldown experiments using DLC1 as a bait 
protein was conducted to identify potential interacting partners in 293T cells. 
Adenine nucleotide translocase 2 (ANT2), a resident of the inner mitochondrial 
membrane, was identified by mass spectrometry and validated by co-
immunoprecipitation studies to associate with DLC1. The regions on both DLC1 
and ANT2 that are required for their interaction have been mapped to unique sites 
not known to bind other known DLC1 interacting partners. While the co-
expression of DLC1 with ANT2 did not reduce levels of apoptotic markers pro-
caspase 3 or 9 in 293T cells, confocal microscopic studies in HeLa cells indicate 
that wild-type or a GAP-inactive DLC1 mutant could reduce mitochondria 
membrane potential via interaction with ANT2, as measured by a reduction in the 
fluorescence of MitoTracker Red.  
 This study has established a GAP-independent function of DLC1 to bring 
about a reduction in mitochondrial membrane potential through its interaction 
with ANT2. The significance of the findings presented here is also discussed.    
(325 words) 
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1 INTRODUCTION 
1.1 The Ras superfamily of small GTPases 
The Ras (Ras sarcoma) superfamily of guanosine triphosphatases (GTPases) 
are small monomeric guanosine diphosphate/guanosine triphosphate 
(GDP/GTP)-regulated proteins that control a diverse spectrum of cellular 
processes. In humans, 150 members have been identified with evolutionarily 
conserved orthologues also found in other mammalian species, invertebrates 
(Drosophila), nematodes (Caenorhabditis elegans), fungi (Saccharomyces 
cerevisiae), plants, and even amoebas (Dictyostelium) (Wennerberg et al., 2005). 
Although definitive classification of all the small GTPases is still not possible due 
to the lack of functional information (Wennerberg et al., 2005), they have been 
classically divided into five subfamilies, Ras, Rho (Ras homologous), Rab (Ras-like 
proteins in brain), Ran (Ras-like nuclear proteins) and Arf (ADP-ribosylation 
factor), based on sequence, structure and for some, functional similarities (Figure 
1.1). Recently, the Miro proteins have been described as a separate subgroup of 
atypical GTPases localized to the mitochondria (Wennerberg et al., 2005).  
The small GTPases share basic biochemical activity – GTP binding and 
hydrolysis – mediated by a conserved ~ 20 – 25 kDa catalytic G domain that 
contains the following five G box GDP/GTP-binding motifs at the N terminus: G1 
(GXXXXGKS/T), G2 (T), G3, (DXXGQ/H/T), G4 (T/NKXD) and G5 (C/SAK/L/T) (X = 
any amino acid) (Bourne et al., 1991; Wennerberg et al., 2005). While the G 
domain is a conserved module with similar structure and biochemistry across all 
members in the superfamily, each GTPase also contains additional sequences and 
are subject to post-translational modifications that can dictate their subcellular 
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localization and confer versatility in their interaction with different regulators and 
effectors. This enables them to modulate complex signaling networks responsible 
for controlling cellular activities such as proliferation (Ras), survival (Ras), 
cytoskeletal organization (Rho), intracellular vesicular transport and protein 
trafficking (Rab and Arf), nucleocytoplasmic transport (Ran), gene expression 





Figure 1.1 The human Ras superfamily of small GTPases. The members are 
divided classically into five branches, the Ras (pink), Rho (yellow), Ran (blue), Rab 
(blue) and Arf (green), and have different cellular roles as indicated in text. The 
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1.2 The Rho GTPase signaling network  
In humans, the Rho GTPases comprises of at least 25 members encoded by 
22 genes and are traditionally categorized into five groups, namely the RhoA-
related, Ras-related C3 botulinum toxin substrate 1 (Rac1)-related, Cell division 
cycle 42 (Cdc42)-related, Rnd and RhoBTB subfamilies based on primary amino 
acid sequence identity, structural motifs and biological functions (Wennerberg 
and Der, 2004). The representative RhoA, Rac1 and Cdc42 GTPases are the most 
characterized to date while the Rnd and RhoBTB subfamily members do not 
possess GTP hydrolysis capabilities and remain the least studied members in the 
family (Wennerberg and Der, 2004).  
 
1.2.1 Rho GTPases function as binary molecular switches 
Rho GTPases are distinguished from other Ras superfamily members by a 
Rho-type GTPase domain that is defined by an additional 13 amino acid helical 
Rho motif inserted into the canonical catalytic G domain (Wennerberg and Der, 
2004). Rho GTPases also contain two switch regions and a phosphate-binding loop 
(P-loop) that cooperatively interacts with the ,-phosphates of the nucleotide and 
its associated magnesium ion (Vetter and Wittinghofer, 2001).  
The Rho GTPases share a common modus operandi that is associated with 
nucleotide-regulated conformational shifts. They cycle between two states, the 
inactive GDP bound state and the active GTP bound state and are thus termed 
binary switches. The switch “ON” transition involves the exchange of GDP for GTP 
such that the GTPase presents a binding surface in the switch regions that is 
favorable for directly binding effector proteins (Vetter and Wittinghofer, 2001). 
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The switch to the “OFF” state involves GTP hydrolysis to release the γ-phosphate 
that results in the reorientation of effector binding residues and subsequent 
release of the effector proteins due to reduced affinity (Vetter and Wittinghofer, 
2001).  
Although the Rho GTPases exhibit high-affinity binding for GDP and GTP, 
they possess low intrinsic GTP hydrolysis and GDP/GTP exchange capabilities. As 
such, in order to achieve high signaling efficiency, the GTPase cycle of Rho family 
members is regulated by three classes of molecules known as the guanine 
nucleotide dissociation inhibitors (GDIs), guanine nucleotide exchange factors 
(GEFs) and GTPase-activating proteins (GAPs). In the absence of intracellular or 
extracellular signals, the Rho GTPase is sequestered in the cytosol by its GDI in an 
inactive GDP-bound state (Tcherkezian and Lamarche-Vane, 2007). Upon the 
arrival of a stimulus, the Rho GTPase is released from the inhibitory complex and 
can then associate with its GEF that catalyzes the dissociation of GDP from the 
GTPase. GTP is spontaneously incorporated into the GTPase, due to the higher 
intracellular concentration of GTP over GDP, resulting in the formation of the 
active Rho GTPase that can now interact with effector proteins to elicit the 
appropriate biological response to the stimulus. To attenuate this signal, a GAP is 
recruited to accelerate the intrinsic GTP hydrolysis of the Rho GTPase, thereby 
promoting the formation of the GDP-bound form that has reduced affinity for 
effector proteins. Following GAP activity, the GDI once again stabilizes the inactive 
GDP-bound Rho GTPase until further directions are received (Tcherkezian and 
Lamarche-Vane, 2007). This GTPase cycle is summarized in Figure 1.2  
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Figure 1.2 The GTPase cycle. The Rho GTPase exists in equilibrium between the 
GDP- and GTP-bound forms, regulated by three key classes of molecules, the GDIs, 
GEFs and GAPS, which are responsive to intracellular and/or extracellular cues. 
The GDIs maintain the GTPase in the inactive form while the GEFs and GAPs 
promote the formation of the active GTP-bound and the return to the inactive 
GDP-bound form respectively.  
 
 
1.2.2 Rho GTPases are involved in cell dynamics control  
Cell-type specific expression and distinct subcellular localization of effector 
molecules such as scaffold proteins, kinases and actin nucleation-promoting 
molecules (Karlsson et al., 2009) define the cellular roles of the Rho GTPases and 
thus contribute to pronounced functional differences across members of the Rho 
family.  
All members of the Rho GTPase family are key regulators of actin 
cytoskeletal remodeling in response to extracellular signals but manifest 
profoundly distinct effects on cell shape and movement. For instance, RhoA 
promotes actin-myosin contractility to regulate the formation of stress fibers and 
assembly of focal adhesions that modulate cell shape, attachment and motility 
while Rac1 induces actin polymerization that results in the formation of sheet-like 
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lamellipodia and membrane ruffles at the leading edge of migrating cells 
(Wennerberg and Der, 2004). Cdc42 initiates the assembly of actin into tight 
bundles known as filopodia or shorter protrusions termed as microspikes at the 
cell periphery that may be involved in the recognition of cues from the 
extracellular environment (Wennerberg and Der, 2004). In addition, Rho GTPases 
have growth-promoting and anti-apoptotic roles and are regulators of gene 
expression by activating specific signaling molecules (Wennerberg and Der, 
2004). 
 
1.2.3 Biochemical regulation of Rho GTPase activity 
The large number of Rho GTPases necessitates the presence of multiple 
regulators to avoid unnecessary GTP turnover and to enforce signaling specificity. 
Besides the C-terminal modifications displayed by the Rho GTPases that 
determine their subcellular localization, there are three GDIs, 82 GEFs and 67 
GAPs that are known to control the activity of the 25 human members of the Rho 
family (Lahoz and Hall, 2008). Interestingly, while each GEF and GAP has a 
particular specificity profile for Rho GTPases, a specific Rho GTPase can be 
regulated by several GEFs and GAPs and thus integrate signals from multiple 
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1.2.3.1 Lipid modifications facilitate Rho GTPases membrane association 
Rho GTPases possess a C-terminal polybasic domain that functions as a 
membrane compartment-localizing signal. The CAAX (A = aliphatic, X = any amino 
acid) motif at the C-terminal is recognized by farnesyltransferases and 
geranylgeranyltransferases that catalyze the covalent addition of prenyl groups to 
the cysteine residue that serves as a lipid anchor for Rho GTPases to associate 
with certain membranes (Wennerberg et al., 2005). Some members of the Rho 
family are also palmitoylated at the C-terminal, which may affect their interaction 
with Rho GDIs (Michaelson et al., 2001). These variations in post-translational 
lipid modifications at the C-terminal by isoprenoid lipids facilitates their 
differential subcellular localization and thus their interaction with upstream 
activators and downstream effectors, thereby allowing the highly similar Rho 
GTPases to perform divergent functions (Wennerberg and Der, 2004).  
 
1.2.3.2 Rho GDIs are inhibitors of the GTPase activity 
There are three GDIs in humans that display Rho-binding specificity. 
RhoGDI-1 is ubiquitously expressed while RhoGDI-2 and RhoGDI-3 are specifically 
expressed in the brain, lung and testis (Grise et al., 2009). The GDIs bind to the 
prenylated form of the Rho GTPase at the switch region to mask the C-terminal 
lipid modifications, resulting in the sequestration of the Rho GTPase in the cytosol 
(Seabra and Wasmeier, 2004).  This prevents the GEFs from activating the Rho 
GTPase while simultaneously inhibiting the GAPs and effectors from interacting 
with the GTPase (Grise et al., 2005). Rho GDIs thus play a role in the trafficking of 
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the Rho GTPases between the cytosol and membrane where Rho GTPases are 
activated.  
It has been shown that the amount of RhoGDI-1 within the cell is matched 
stoichiometrically with the amount of its target Rho GTPase (Michaelson et al., 
2001). This indicates that a large proportion of the Rho GTPase exists as the 
inactive Rho GTPase-GDI complex and suggests that the interaction of the Rho 
GTPase with the GDI is a potent mechanism to regulate GTPase activity and 
protects against aberrant signaling.  
 
1.2.3.3 Rho GEFs mediate the activation of the GTPase machinery 
Rho GEFs are activated downstream of cell receptor stimulation and are 
components of signaling complexes organized by scaffold proteins to increase the 
efficiency and enhance the specificity of Rho signaling (Bos et al., 2007). Rho GEFs 
act as a catalyst to accelerate the rate at which equilibrium between the GDP- and 
GTP-bound forms is attained by deforming the nucleotide-binding site to reduce 
affinity of the Rho GTPase for GDP. The interaction of the Rho GEFs with the 
switch regions of the Rho GTPase sterically occludes the P-loop and magnesium-
binding site such that the magnesium is no longer able to mediate tight binding of 
nucleotides to the Rho GTPase (Bos et al., 2007; Vetter and Wittinghofer, 2001). 
Additionally, the binding surface for the phosphates is perturbed to allow the 
release of the phosphate groups (Bos et al., 2007; Vetter and Wittinghofer, 2001). 
GTP, which is present in approximately ten times higher concentration over GDP 
in the cell, then spontaneously binds to the Rho GTPase resulting in the 
displacement of the Rho GEFs (Bos et al., 2007).  
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As potent activators of Rho GTPases, Rho GEFs are also subject to tight 
regulatory control by mechanisms such as protein-protein or protein-lipid 
interactions, association with second messengers and even post-translational 
modifications that may facilitate their translocation to specific compartments or 
exposure of GTPase binding sites (Bos et al., 2007).  
 
1.2.3.4 Rho GAPs prevent prolonged signal transduction 
The GTP hydrolytic activity of the Rho GTPases is inherently slow and thus 
requires Rho GAPs as a catalyst to completely terminate further signal 
propagation within minutes from the onset. Rho GAPs promote effective catalysis 
by stabilization and proper orientation of the intrinsically mobile catalytic 
machinery of the Rho GTPase. This is achieved by the contribution of a conserved 
catalytic arginine residue (known as the arginine finger) by the Rho GAP in trans 
to stabilize the glutamate residue on the switch region of the Rho GTPase which is 
responsible for optimally orienting the hydrolytic water molecule for nucleophilic 
attack to the –phosphate (Scheffzek et al., 1997). Stabilization of the glutamate 
residue on the Rho GTPase restricts the freedom of movement of the water 
molecule that may reduce the energy barrier for GTP hydrolysis (Nassar et al., 
1998). In addition, structural studies of Cdc42 as a complex with the GAP domain 
of p50RhoGAP in the presence of aluminum fluoride to mimic the transition state 
reveal that conformational changes are induced such that the arginine finger is 
positioned into the active site of the GTPase to stabilize the transition state by 
neutralizing the negative charges at the –phosphate (Rittinger et al., 1997). The 
Rho GAP also provides an invariant secondary positively charged residue to 
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stabilize the arginine finger coordinating catalysis (Rittinger et al., 1997). Given 
the importance of the conserved arginine finger residue in Rho GAPs, it is not 
surprising that mutation of the arginine finger severely diminishes GAP activity 
without altering its affinity for the Rho GTPase (Scheffzek et al., 1997).  
 
1.2.4 Rho GAP-containing proteins are critical regulators of diverse cellular 
activities 
Rho GAPs are defined by the presence of a Rho GAP-like domain that 
displays activity towards the Rho GTPases. They contain multiple well-
characterized protein interaction domains such as src homology 2 (SH2) and src 
homology 3 (SH3) domains as well as lipid interaction domains such as the 
pleckstrin homology (PH) and bin–amphiphysin–rvs (BAR) domains that facilitate 
localization of the Rho GAPs to sites of activity (Bos et al., 2007). These domains 
may also serve as scaffolds for the assembly of higher order transient signaling 
complexes (Bernards and Settleman, 2005). In addition, some Rho GAP-containing 
proteins also possess catalytic domains such as kinase domains and GEFs (Moon 
and Zheng, 2003). The presence of these motifs thus allows the Rho GAP to 
combine the downregulation of Rho GTPase activity with other functions. As such, 
Rho GAPs are often viewed as critical signal convergent or divergent nodes in Rho 
signaling that incorporates diverse cellular stimuli to coordinately modulate 
cytoskeletal network changes involved in multiple cellular processes such as cell 
migration, proliferation, apoptosis and differentiation (Moon and Zheng, 2003).  
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1.2.5 Mechanisms of Rho GAP regulation 
Rho GAP activity is subject to precise spatial-temporal control and is under 
stringent regulation. This premise is made more complex by the fact that the 
number of Rho GAPs far exceeds the number of Rho GTPases they regulate and 
that the modular architecture of the Rho GAPs presents the opportunity for 
cooperative interplay of these multi-functional domains. To further appreciate 
how signal integration occurs, there is a need to understand how Rho GAPs are 
regulated.  
Firstly, proteins may interact with Rho GAPs at various characterized 
domains to regulate GAP activity, mediate translocation or expose Rho GTPase-
binding sites. For example, the proline-rich motif on CdGAP mediates interaction 
with the SH3 domains of intersectin, an endocytic scaffolding protein, resulting in 
the inhibition of GAP catalytic activity (Moon and Zheng, 2003). The interaction 
between p120RasGAP and p190RhoGAP, on the other hand, can trigger the 
translocation of p190RhoGAP to the plasma membrane without affecting GAP 
activity (Bradley et al., 2006). Interaction of the Ras/Rap1-associating (RA) 
domain in RA-RhoGAP with Rap1 was also found to release the Rho GAP from 
auto-inhibition, thereby inducing GAP activity (Yamada et al., 2005).  
Next, Rho GAPs could associate with phospholipids to affect subcellular 
localization or catalytic activity. For example, ARP3, a Rho GAP, was found to 
interact with phosphatidylinositol (3, 4, 5)-triphosphate (PIP3) that initiated the 
translocation of the Rho GAP to the plasma membrane where it will be in close 
proximity to its target Rho GTPase (Krugmann et al., 2004). Second messenger 
signaling lipids generated by activation of growth factor receptors may also 
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interact with Rho GAPs, thus linking the action of Rho GAPs to growth factor 
stimulation (Bernards and Settleman, 2005).  
Separately, phosphorylation of the Rho GAPs may not only activate or inhibit 
the GAP activity on target GTPases but may also alter the substrate specificity of 
the Rho GAP. MgcRacGAP, a Rac1- and Cdc42-specific GAP, was shown to undergo 
serine phosphorylation during cytokinesis and was functionally converted into a 
GAP specific for RhoA (Minoshima et al., 2003). In addition, phosphorylation of 
p190BRhoGAP by insulin growth factor receptors induces the redistribution of the 
Rho GAP from the cytoplasm to the plasma membrane where active Rho GTPases 
are localized, thereby facilitating efficient signaling (Sordella et al., 2003).  
Finally, Rho GAPs can be regulated temporally by controlling the protein 
turnover rates through proteolytic degradation. It was demonstrated that cell 
cycle-regulated ubiquitin-mediated degradation was responsible for determining 
the levels of p190RhoGAP and was intricately linked to the completion of 
cytokinesis (Su et al., 2003). The continual discovery of novel Rho GAPs not only 
increases our current knowledge of their cellular functions but also presents 
exciting opportunities to understand and appreciate their complex modes of 
regulation. One such novel Rho GAP, the protein of interest in this study, is further 
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1.3 The Deleted in Liver Cancer (DLC) family of Rho GAPs  
Deleted in Liver Cancer 1 (DLC1) was originally identified by subtractive 
hybridization as a gene homozygously deleted in primary human hepatocellular 
carcinomas (HCC) (Yuan et al., 1998) and is the founding member of a family of 
three proteins with similar domain architecture that includes a Rho GAP domain. 
DLC1 encodes a 1091 amino acid protein of molecular weight 123 kDa and is 
ubiquitously expressed in many human tissues including the brain, heart, lung, 
colon, kidney and placenta (Yuan et al., 1998; Wilson et al., 2000). DLC1 was 
mapped in humans to chromosome 8p21.3 – 22, a region that frequently exhibits 
loss of heterozygosity (LOH) in many human cancers and thus was assigned as a 
candidate tumor suppressor gene (Yuan et al., 1998; Lahoz and Hall, 2008). It has 
been well established that DLC1 is localized to focal adhesions and is a negative 
regulator for RhoA as overexpression of DLC1 induced characteristic cell rounding 
due to the disassembly of the actin cytoskeleton and integrin-mediated adhesions 
(Yuan et al., 2004; Kim et al., 2007; Guan et al., 2008; Liao et al., 2008). 
 
1.3.1 DLC1 and its paralogs 
The other two members of the DLC family of Rho GAPs are similarly mapped 
to regions (DLC2: 13q13; DLC3L: Xq13) (Durkin et al., 2007a) that manifest LOH 
in multiple human cancers such as lung, breast, gastric, colon, renal and ovarian 
cancers and are also thought to be candidate tumor suppressor genes 
(Ullmannova et al., 2006). Further evidence of DLC2 and DLC3 as tumor 
suppressors came from studies showing that overexpression of the proteins 
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inhibited cell proliferation and anchorage-independent growth of tumor cells and 
reduced tumor cell migration (Leung et al., 2005; Durkin et al., 2007a).  
DLC2 is 58 % identical to DLC1 and has a tissue distribution similar to that of 
DLC1 with transcripts detected in heart, skeletal muscle, kidney and pancreas 
(Ching et al., 2003) while DLC3 shares 44 % identity with DLC1 in humans and is 
similarly ubiquitously expressed (Durkin et al., 2007a). Both DLC2 and DLC3 are 
localized to vinculin-associated focal adhesions possibly through binding to 
members of the tensin family (Kawai et al., 2009; Kawai et al., 2007) and can 
stimulate the intrinsic GTPase activity of RhoA and Cdc42 with less activity for 
Rac1 (Nagaraja and Kandpal, 2004; Kawai et al., 2007). In addition, like DLC1, 
DLC2 and DLC3 were able to inhibit actin stress fiber formation and induce cell 
rounding in a Rho GAP-dependent manner (Leung et al., 2005; Kawai et al., 2007).  
Later investigations revealed that the focal adhesion-targeting region on 
DLC2 competed with endogenous DLC1 and displaced it from focal adhesions, 
which suggests that targeting of DLC1 and DLC2 to the focal adhesions rely on 
common mechanisms (Kawai et al., 2009). DLC2 knockout mice also exhibited 
increased tumor-induced angiogenesis, implicating DLC2 in endothelial cell 
attachment and migration via a RhoA-dependent pathway (Lin et al., 2010). This 
suggests that DLC2 is functionally redundant in attenuating RhoA signaling. 
Interestingly, DLC2 has been found to localize to the mitochondria, possibly by the 
interaction of the START domain with mitochondrial membranes, although the 
functional relevance of DLC2 mitochondria localization was not conclusively 
addressed (Ng et al., 2006).  
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1.3.2 DLC1 and its orthologues 
DLC1, also known by their gene names as ARHGAP7 or STARD12 (STAR-
related lipid transfer domain-containing protein 12) in mouse (Mus musculus) and 
p122RhoGAP in rat (Rattus norvegicus), has also been identified in other 
vertebrates such as dog (Canis lupus), chicken (Gallus gallus), chimpanzee (Pan 
troglodytes), frog (Xenopus tropicalis), puffer fish (Lagocephalus lagocephalus) 
(Durkin et al., 2007b), and in urochordates (Ciona intestinalis) and invertebrates 
such as Drosophila and C. elegans (Durkin et al., 2007b), suggesting the 
evolutionary conservation of an important gene.  
Interestingly, the Drosophila and rat orthologues of human DLC1 are also 
functionally similar to the human orthologue, with the ability to affect actin 
cytoskeletal reorganization through its negative regulation on RhoA (Sato et al., 
2010 ; Kawai et al., 2004). In Drosophila, the DLC1 homologue encoded by the 
gene crossveinless-c (cv-c), was found to be essential for viability by localizing Rho 
GTPase activity to areas of cytoskeletal remodelling during morphogenesis 
(Denholm et al., 2005). It also regulates tubulogenesis (Durkin et al., 2007b) and 
was required for sprouting and anterior-posterior oriented growth of dendrites 
by GAP activity on Rho1 and Cd42 (Sato et al., 2010). 
Rat p122RhoGAP was initially discovered as a binding partner for 
phospholipase C-1 (PLC-1) and it has 93 % amino acid identity to human DLC1, 
with an expression profile that mirrors that of humans (Durkin et al., 2007b). 
Unlike human DLC1, it was found to stimulate hydrolysis of phosphatidylinositol 
(4, 5)-bisphosphate (PIP2) to the second messengers inositol triphosphate and 
diacylglycerol that releases intracellular calcium and activates protein kinase C 
respectively (Homma and Emori, 1995; Healy et al., 2008). The GAP domain in 
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p122RhoGAP could also function synergistically with PLC-1 to inhibit RhoA 
activation and induce morphological cell rounding via the loss of actin stress 
fibers and vinculin-loaded focal adhesion complexes (Sekimata et al., 1999). It was 
thus suggested that PLC-1, p122RhoGAP and RhoA collectively form a functional 
unit to regulate phosphoinositide/calcium signaling and actin cytoskeletal 
dynamics at specified plasma membrane domains (Yamaga et al., 2007).  
 
1.3.3 DLC1 not DLC2 is essential for embryonic development 
The DLC1 knockout phenotype is embryonic lethal in flies (Sato et al., 2010) 
and also in mice (Durkin et al., 2005; Sabbir et al., 2010). DLC1-null mice 
generated either by homologous recombination (Durkin et al., 2005) or by gene 
trap mutations (Sabbir et al., 2010) do not survive beyond 10.5 days post-coitus 
although heterozygotes display no gross physical, histological or behavioral 
abnormalities. The inability to survive to adulthood was attributed to 
abnormalities in the formation of the heart, neural tube, bronchial arches, and 
brain neuroepithelium as well as vasculature defects in the placenta. Interestingly, 
while Durkin and colleagues (2005) observed less long stress fibers and vinculin-
loaded focal adhesions in fibroblasts isolated from DLC1-null embryos, loss of 
DLC1 in the gene-trapped mice was associated with increased stress fibers and 
focal adhesions in fibroblasts possibly as a result of Rho activation triggered by 
culturing cells on a fibronectin substrate (Sabbir et al., 2010).  
Nonetheless, both studies consistently demonstrated that although DLC1 
haploinsufficiency was compatible with embryonic development, the complete 
loss of DLC1 could not be compensated by DLC2 or DLC3, suggesting some 
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functional divergence of these genes in mouse embryonic development. This is 
further supported by studies showing that DLC2-null mice could survive to 
adulthood with no histological abnormalities (Yau et al., 2009; Lin et al., 2010), 
possibly due to compensation by DLC1, although they were smaller with less 
adipose tissue.  
 
1.3.4 DLC1 is absent or silenced in many human cancers  
DLC1 was first implicated in liver tumorigenesis in 1998 when it was 
observed that genomic deletion of DLC1 occurred in 50 % of primary HCC and     
28 % of liver cancer cell lines (Yuan et al., 1998). Such heterozygous deletions 
(more than 60 % of liver cancers screened) were found to occur almost as 
commonly as deletions of the archetype tumor suppressor p53 in common 
cancers like lung, breast and colon (Xue et al., 2008). In addition to genomic 
deletions, epigenetic transcriptional silencing of DLC1 by promoter 
hypermethylation was also reported in other studies using primary liver tumor 
samples and HCC cell lines (Ng et al., 2000; Wong et al., 2003) and correlated with 
poorer liver tumor cell differentiation (Ko et al., 2009).  
Although the name suggests that DLC1 is a gene specifically deleted in liver 
cancer, DLC1 has also been found to be downregulated in many other human 
cancers either by LOH or epigenetic silencing involving promoter 
hypermethylation or histone hypoacetylation, and has thus been termed “Deleted 
in Lots of Cancers” by Lahoz and Hall (2008). DLC1 LOH has been reported in      
50 % of lung and 70 % of colon cancers (Xue et al., 2008) and transcript 
downregulation was also verified in several solid tumors including renal, 
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(Ullmannova et al., 2006; Zhang et al., 2007) rectal (Ullmannova et al., 2006) and 
gastric cancers (Kim et al., 2003; Ullmannova et al., 2006; Kim et al., 2008).   
In addition, loss of DLC1 was well documented in several hormone-
dependent cancers. Genomic deletion was found in 40 % of primary human breast 
cancer tissues (Yuan et al., 1998; Yuan et al., 2003) and 33 % of breast carcinoma 
cells lines (Seng et al., 2007). Aberrant promoter methylation was also responsible 
for low DLC1 expression in primary breast cancers and breast cancer cell lines 
(Plaumann et al., 2003) and expression could be restored by treatment with 
demethylating agent (Seng et al., 2007; Yuan et al., 2003). Silencing of DLC1 was 
also observed in ovarian cancer cell lines (Syed et al., 2005) and 87 % of cervical 
cell lines tested (Seng et al., 2007) as a result of epigenetic mechanisms. In 
addition, 37 % of prostate carcinomas, 60 % of prostate carcinoma cell lines and 
24 % of benign prostatic hyperplasias also displayed loss of DLC1 mRNA 
expression largely attributed to promoter hypermethylation (Guan et al., 2006).  
Loss of DLC1 expression was also implicated in the tumorigenesis of other 
less common cancers such as in 89 % of nasopharyngeal carcinomas and 51 % of 
esophageal carcinomas through promoter hypermethylation (Seng et al., 2007). 
Downregulation of DLC1 was also observed in meningiomas (Hankins et al., 2008) 
and supratentorial primitive neuroectodermal tumors (Pang et al., 2005). 
Additionally, absence or low expression levels of DLC1 was validated in 95 % of 
primary non-small cell lung carcinomas (NSCLC) and in 58 % of NSCLC cell lines 
that was associated either with allelic loss or DNA methylation (Yuan et al., 2004).  
Loss of DLC1 expression is not solely confined to solid tumors but is also 
manifested in several hematological malignancies as demonstrated in over 80 % 
of patients suffering from acute lymphoblastic leukemia (Ying et al., 2007) and in 
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87 % of non-Hodgkin’s lymphoma patients. Several studies have also revealed 
promoter hypermethylation-mediated loss of DLC1 in over 70 % of primary 
multiple myeloma and multiple myeloma cell lines (Song et al., 2006; Ullmannova-
Benson et al., 2009).  
 
1.3.5 DLC1 is a bona fide tumor suppressor 
DLC1 has biological functions that is characteristic of classical tumor 
suppressors, the most critical being the ability to inhibit tumor cell growth when 
overexpressed in many cancer cell lines such as liver and breast carcinomas in 
which DLC1 expression is absent or low (Ng et al., 2000; Plaumann et al., 2003; 
Yuan et al., 2003). Further support of DLC1 as a tumor suppressor came from 
studies establishing that the transfer of tumor cells overexpressing DLC1 into 
nude mice could abolish in vivo tumorigenicity. Restoration of DLC1 expression in 
HCC cell lines that were subsequently transferred to nude mice not only 
suppressed the tumor growth and size (Wong et al., 2005) but also suppressed 
metastasis or the dissemination of liver tumor cells to distant sites such as lung 
(Zhou et al., 2004; Zhou et al., 2008). In separate studies, mice that received DLC1-
transfected breast or NSCLC tumor cell lines remained essentially tumor-free for 
three months while control-transfected transplanted mice developed tumors in 
three to four weeks (Yuan et al., 2003; Yuan et al., 2004).  
However, direct evidence of DLC1 as a bona fide tumor suppressor came 
from the landmark study by Xue and colleagues (2008) that exploited the use of 
retroviruses to introduce micro-RNA based short hairpin RNAs (shRNAs) targeted 
against DLC1 into embryonic mouse liver progenitor cells that were p53-deficient 
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and overexpressed the c-Myc oncogene followed by transplantation into livers of 
recipient mice to assess the ability of the cells to form tumors in situ. The authors 
found that the loss of DLC1 cooperated with the oncogenic potential of c-Myc to 
significantly accelerate tumor onset, resulting in the formation of liver tumors 
with a pathology that mimicked human HCC. They were also able to prove that the 
restoration of DLC1, when combined with the presence of other oncogenes such as 
Ras, could greatly reduce liver tumor burden. Thus, loss of DLC1 is a potent 
driving force in liver carcinogenesis in a background where other oncogenic 
aberrations are present. Of note, disregulation of RhoA signaling was also 
implicated in liver tumorigenesis since ectopic expression of constitutively active 
RhoA in liver progenitor cells transplanted into nude mice was able to recapitulate 
the tumor growth-enhancing phenotype manifested by the loss of DLC1 
expression (Xue et al., 2008).  
 
1.3.6 Mechanisms of DLC1 tumor suppression 
In order to understand how DLC1 mediates tumor suppression, many 
studies have relied on the re-introduction of the DLC1 gene into various tumor cell 
lines for subsequent in vitro cell-based assays designed to mirror key steps in 
tumor progression.  
In soft agar colony formation assays, the overexpression of DLC1 was found 
to inhibit anchorage-independent growth of HCC (Ng et al., 2000; Wong et al., 
2005), colon (Jin et al., 2008), NSCLC (Yuan et al., 2004; Healy et al., 2008), ovarian 
(Syed et al., 2005), prostate (Guan et al., 2008), nasopharyngeal and esophageal 
cancer cell lines (Seng et al., 2007). Similarly, DLC1 overexpression could inhibit 
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cell proliferation in mitogen-dependent or –independent cultures as measured 
either by cell counting or MTS assay in DLC1-negative HCC (Ng et al., 2000; Wong 
et al., 2005), NSCL (Yuan et al., 2004), ovarian (Syed et al., 2005), breast 
carcinoma (Plaumann et al., 2003; Yuan et al., 2003) and meningioma cell lines 
(Hankins et al., 2008). Moreover, stable ectopic expression of DLC1 in HCC cells 
was associated with cell cycle arrest and an increase in the proportion of cells in 
the subG1 phase, which is indicative of apoptosis (Zhou et al., 2004; Wong et al., 
2005). 
Additional studies then revealed that DLC1-mediated tumor suppression 
could also be ascribed to its pro-apoptotic function that induces the cleavage of 
pro-caspase-3 in liver, ovarian, prostate and NSCLC cell lines (Zhou et al., 2004; 
Syed et al., 2005; Guan et al., 2008; Yuan et al., 2007).  Interestingly, a fraction of 
NSCLC cells ectopically expressing DLC1, which translocated to the nucleus, 
subsequently underwent caspase-3-dependent apoptosis and displayed 
characteristic apoptotic morphologies such as cytoplasmic extensions, membrane 
blebbing, progressive cell shrinkage and final cell decomposition (Yuan et al., 
2007). It was further demonstrated that the nuclear translocation that occurred 
prior to apoptosis was necessary for DLC1 to exert its pro-apoptotic activity (Yuan 
et al., 2007). 
Overexpression of DLC1 also suppresses tumorigenesis by reducing the 
migration and invasiveness of HCC cells (Zhou et al., 2004; Wong et al., 2005; Kim 
et al., 2007) and various tumor cell lines such as breast, ovarian, prostate, colon, 
NSCLC, and myeloma cell lines (Goodison et al., 2005; Syed et al., 2005; Guan et al., 
2008; Jin et al., 2008; Healy et al., 2008; Ullmannova-Benson et al., 2009). The 
reduction in migration and invasive capabilities of DLC1 was associated with the 
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dephosphorylation of focal adhesion proteins such as focal adhesion kinase, 
paxillin and Cas that decreased focal adhesion turnover (Kim et al., 2007). The 
negative regulation of DLC1 on RhoA signaling via the Rho effectors Dia1 and Rho 
kinase and subsequent suppression of actin stress fiber formation was also 
implicated in the loss of migrative ability in tumor cells (Ullmannova-Benson et al., 
2009; Holeiter et al., 2008; Wong et al., 2008). The role of DLC1 in cell migration 
has also been examined using a knockdown approach, revealing that the loss of 
DLC1’s ability to control Rho activity and hence actin cytoskeletal dynamics in a 
spatial manner during differentiation programs could inadvertently promote 
inappropriate and unwanted cell proliferation (Holeiter et al., 2008; Wong et al., 
2008; Sabbir et al., 2010).  
Finally, the observation that DLC1 was consistently downregulated in highly 
invasive and metastatic HCC cell lines compared to non-metastatic ones supports 
the role of DLC1 as a metastasis suppressor. DLC1 expression was also found to be 
reduced in human breast cancer cells that had been selected for increased 
metastasis to the bone (Kang et al., 2003).  In addition, DLC1 re-expression 
significantly inhibited the ability of metastatic breast cancer cells to develop lung 
metastases in nude mice (Goodison et al., 2005) and was associated with a 
downregulation of genes involved in metastasis such as osteopontin and matrix 
metalloproteinase-9 (Zhou et al., 2008). These tumor suppressor functions of 
DLC1 are summarized below (Figure 2.3). 
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Figure 1.3 Cellular effects of DLC1. DLC1 re-expression had an inhibitory effect 
on cell proliferation, migration and metastasis (red lines) while simultaneously 
promoting apoptosis (green arrow).  
 
 
1.3.7 DLC1 domain architecture-function relationship 
DLC1 is multi-modular protein comprising of a sterile-alpha motif (SAM) 
domain at the extreme N-terminal, a serine-rich region, an intervening Rho GAP 
domain and a steroidogenic acute regulatory protein (STAR)-related lipid transfer 
(START) domain at the C-terminal. This presents an interesting possibility that 
these domains may serve to regulate the subcellular localization of DLC1 and/or 
its Rho GAP activity. It is also equally possible that these domains may dictate 
GAP-independent functions of DLC1. The contribution of these domains to the 
cellular functions and regulation of DLC1 is individually analyzed in the sections 
below.   
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1.3.7.1 The Rho GAP domain attenuates RhoA signaling  
The Rho GAP domain is the most highly conserved module across the DLC 
family of proteins (Durkin et al., 2007b) and includes two conserved arginine 
residues (a. a. 677 and 718 in humans) that are critical for DLC1 to exert its 
negative regulation on Rho GTPases. In vitro, DLC1 enhanced the intrinsic GTP 
hydrolytic activity of RhoA, RhoB, RhoC and Cdc42 but only minimally for Rac1 
(Wong et al., 2003; Durkin et al., 2007b; Healy et al., 2008). Although the in vitro 
substrate specificity of GAPs may differ from their substrate preferences in vivo 
(Moon and Zheng et al., 2003), DLC1 Rho GAP activity was nonetheless implicated 
in the negative regulation of Rho signaling since overexpression of DLC1 resulted 
in the Rho GAP-mediated loss of actin stress fibers (Wong et al., 2005). 
Additionally, Holeiter and colleagues (2008) found that DLC1, but not the GAP-
inactive mutant, decreased the emission ratio of the Raichu-RhoA fluorescence 
resonance energy transfer biosensor, which was indicative of increased GTP 
hydrolysis and was also able to suppress serum response factor-dependent 
transcription, a process that involves functional Rho activity, in a GAP-dependent 
manner. Moreover, the hyperactivation of Rho associated with the loss of DLC1 
Rho GAP activity was found to be a key event in tumorigenesis as the knockdown 
of RhoA in two independent murine hematomas that have lost DLC1 expression 
suppressed tumor growth (Xue et al., 2008).   
DLC1 GAP activity on RhoA has been well recognized to be responsible for 
the extensive rounding, cortical retraction and membrane protrusions observed in 
cells expressing DLC1 as a result of the collapse of the actin cytoskeleton as a GAP-
inactive mutant of DLC1 could not reproduce these effects (Wong et al., 2005; 
Yuan et al., 2007). Later studies revealed that the disruption of actin filament and 
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focal adhesion assembly mediated by the Rho effector, Rho kinase, was a result of 
downregulation of cortical phosphorylation of myosin light chain 2 by DLC1 in a 
GAP-dependent fashion, thus affecting actomyosin contractility (Wong et al., 
2008). DLC1 GAP-dependent negative regulation on the Rho/Rho kinase/myosin 
light chain 2 pathway was also validated by the observation that displacement of 
DLC1 from focal adhesions resulted in local activation of Rho that led to increased 
strength of focal adhesions and actomyosin contractility while simultaneously 
enhancing the backward retraction of actin (Kim et al., 2008). DLC1 
overexpression, however, had minimal effects on the formation of the actin-
related protein 2/3 actin nucleation complex driven by Rac1 activity, which 
directs the formation of actin protrusions (Kim et al., 2008). Consequently, the 
failure to properly execute actomyosin contractility greatly impaired migration 
and metastasis of HCC cells (Wong et al., 2008). In addition, Rho GAP-dependent 
cytoskeletal remodeling was also required for HCC cell proliferation (Wong et al., 
2005) and nuclear-translocation that preceded apoptosis (Yuan et al., 2007).  
The interaction of p120RasGAP with the Rho GAP domain at focal adhesions 
was recently discovered to elicit potent inhibitory activity on DLC1 Rho GAP 
catalytic activity (Yang et al., 2009). Ectopic overexpression of p120RasGAP in 
colon carcinoma cells obliterated the anti-proliferative action of DLC1 while 
simultaneously increasing levels of active RhoA, pointing to a novel mechanism of 
cross-talk between Ras and Rho GTPases (Yang et al., 2009).  
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1.3.7.2 The SAM domain as a protein interaction module 
There are over 200 SAM domain-containing proteins in humans and include 
transcription factors and signaling proteins (Qiao and Bowie, 2005). While SAM 
domains may also bind RNA and lipids (Qiao and Bowie, 2005), their ability to 
form oligomers or multi-protein complexes by interacting with SAM domains in 
other proteins or other non-SAM domain-containing proteins in a homo- or 
heterotypic manner is better characterized. As such, SAM domains have classically 
been considered as protein-protein interaction modules.  
To this end, the eukaryotic elongation factor 1A1 (EF1A1) was recently 
identified as a protein partner of the SAM domain in DLC1 and found to be 
targeted to the membrane periphery and ruffles by interacting with DLC1 upon 
growth factor stimulation to modulate cell migration (Zhong et al., 2009). The 
SAM domain was also found to be required for interaction with the phosphatase 
and tensin homolog (PTEN) tumor suppressor in breast cancer cells to regulate 
cell migration (Heering et al., 2009).  
It was further shown that the SAM domain alone did not localize to focal 
adhesions (Kim et al., 2008; Zhong et al., 2009) and could not induce 
morphological cell rounding, affect actin stress fiber formation or inhibit colony 
formation of HCC cells (Wong et al., 2005). In addition, overexpression of a DLC1 
mutant that did not contain the SAM domain produced the same cellular effects as 
wild-type DLC1, indicating that the SAM domain was not necessary for GAP-
mediated cell shrinkage, actin cytoskeletal collapse as well as the tumor 
suppressor activity of DLC1 (Wong et al., 2005). Additional studies then revealed 
that the SAM domain might act as a negative intramolecular regulator of DLC1’s 
Rho GAP activity (Kim et al., 2008). Consistently, introduction of the DLC1 SAM-
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deletion mutant, that is thought to possess constitutively active Rho GAP activity 
due to its release from auto-inhibition, was found to induce more drastic cell 
morphological changes (Kim et al., 2008; Wong et al., 2008) and also reduced the 
directionality of cell movements during migration compared to wild-type DLC1 
(Kim et al., 2008).  
The solution structure of the SAM domain in human DLC1 was recently 
solved by NMR spectroscopy and found to adopt a different fold from other SAM 
domain-containing proteins (Yang et al., 2009). Instead of folding into five 
canonical -helices, DLC1 SAM domain exhibited a monomeric fold with four -
helical bundles and has a similar structure to that of the SAM domain in DLC2 
(Yang et al., 2009). This suggests that the SAM domain in DLC1 may interact with a 
novel set of biomolecular ligands and thus possibly dictate the subcellular 
localization of DLC1 by enabling association with certain membranes. 
 
1.3.7.3 The serine-rich region regulates the localization and GAP activity of 
DLC1 
The serine-rich region in DLC1 is relatively unstructured with no known 
tertiary globular structure and is the region that shows the least overall amino 
acid sequence conservation with DLC2 and DLC3 (Durkin et al., 2007b).  While it 
shares very little sequence similarity with known protein domains, it contains 
several conserved sequence elements such as the consensus LD motif (LDXLLXXL) 
found in paxillin and other signaling protein binding partners of paxillin (Brown et 
al., 1998) as well as proline-rich segments that could mediate binding to SH3 and 
WW motifs present in other signaling proteins (Durkin et al., 2007b). In addition, 
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bioinformatics analysis has revealed several potential phosphorylation sites by 
serine-threonine protein kinases (Durkin et al., 2007b) with a recent study 
establishing that phosphorylation of DLC1 at S567 by Akt was functionally 
important in DLC1-mediated tumorigenesis and metastasis (Ko et al., 2010). The 
open and extended flexible conformation of this region affords DLC1 the ability to 
interact with other molecules which could serve to regulate the spatial 
distribution and GAP activity of DLC1 while possibly regulating protein turnover 
by increasing the susceptibility of DLC1 to proteolysis (Durkin et al., 2007b).  
The best-characterized interaction of DLC1 with tensin proteins has 
provided insights into the regulation of DLC1’s localization and activity at a 
protein level. Tensin2 was the first identified novel interacting partner of DLC1 
from a human liver cDNA library using yeast-two-hybrid screening (Yam et al., 
2006) and was found to co-localize with DLC1 at vinculin-associated focal 
adhesions in HCC cells. The interaction was mediated through region a. a. 375 – 
385 on DLC1 binding in a phosphorylation-independent manner to the 
phosphotyrosine-binding (PTB) domain on tensin2 (Chan et al., 2009; Kawai et al., 
2010), while targeting of DLC1 to focal adhesions was mapped to residues S440 
and Y442 (Chan et al., 2009). Similarly, the phosphorylation-independent 
interaction between DLC1 and C-terminal tensin-like (cten) required residues 
S440 and Y442 on DLC, although the SH2 instead of the PTB domain of cten was 
responsible for this binding (Liao et al., 2007). Interestingly, Y442 and S440 on 
DLC1 were also identified as phosphorylation-independent motifs indispensable 
for mediating the interaction with both the PTB and SH2 domains on tensin1 
respectively (Qian et al., 2007). These motifs on DLC1 were validated to be crucial 
for the recruitment of tensin proteins that facilitated the localization of the DLC1-
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tensin complex to focal adhesions where it executes its tumor suppressor 
functions such as inhibition of colony formation (Chan et al., 2009; Liao et al., 
2007; Qian et al., 2007). Hence, the serine-rich region has also been designated as 
the focal adhesion-targeting region. In addition, tensin2 was identified in a 
complex with DLC1 and caveolin-1 in hepatocytes and found to be involved in the 
inhibition of Ras signaling at the caveolae where signaling molecules are 
concentrated (Yam et al., 2006).  
The serine-rich region also contains a bipartite nuclear localizing sequence 
(a. a. 415 – 430) as well as a regulatory region (a. a. 209 – 291) that was described 
to negatively regulate the translocation of DLC1 into the nucleus and may function 
to control the duration and/or stability of DLC1 nuclear residency (Yuan et al., 
2007). To add another layer of complexity, the interaction of DLC1 with its 
negative regulator 14-3-3 was found to mask the nuclear localizing sequence of 
DLC1, thereby sequestering DLC1 in the cytosol as an inhibitory complex that has 
no Rho GAP activity (Scholz et al., 2009).  
Many studies have reported the inability of the isolated Rho GAP domain in 
DLC1 to mediate cell rounding, inhibit cell growth and the formation of stress 
fibers cells (Wong et al., 2005), suggesting the presence of additional sequences 
that regulates its Rho GAP activity. Recently, a polybasic region in DLC1 (a. a 623 – 
631) that is conserved in the DLC family as well as in DLC1 orthologues, was 
discovered to be essential for binding to membrane-resident PIP2 to stimulate the 
GAP activity of DLC1 on RhoA (Erlmann et al., 2009). While deletion of this 
polybasic region was not found to affect localization of DLC1 to focal adhesions, 
the mutant DLC1 was markedly less potent in inducing morphological changes, 
inhibiting motility and proliferation that are Rho GAP-driven events (Erlmann et 
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al., 2009). This suggests for the first time that lipids can regulate the Rho GAP 
activity of DLC1. Moreover, T301 and S308 were verified to be possible allosteric 
regulatory sites for the Rho GAP activity of DLC1 though they were dispensable 
for determining the localization of DLC1 in cells (Liao et al., 2008). 
Besides regulating the subcellular localization of DLC1, tensin2 and cten 
have also been implicated in the regulation of DLC1 activity. Tensin2 was 
proposed to be a negative regulator of DLC1 Rho GAP-dependent actomyosin 
contractility and extracellular matrix remodeling either by stabilizing the auto-
inhibited conformation of DLC1 by the SAM domain or by promoting the 
association of DLC1 with p120RasGAP (Clark et al., 2010).  
 
1.3.7.4 The START domain as a lipid binding module 
The START domain was first discovered in proteins that participate in 
several lipid-related cellular processes such as lipid metabolism, lipid transport, 
transcriptional regulation and lipid-modulated signal transduction and have been 
identified in 15 human proteins to date (Alpy and Tomasetto, 2005). The START 
domain in several proteins has been found to fold into a hydrophobic tunnel that 
is likely to be a binding cavity for various lipid ligands such as cholesterol or 
phosphatidylcholine (Soccio and Breslow, 2003). As each START domain displays 
a certain specificity profile for lipid ligands, they are able to exert very diverse 
lipid-related cellular functions. In other Rho GAP domain-containing proteins, 
different lipid-binding modules exist such as Sec14 domain in Cdc42GAP that is 
thought to modulate its subcellular localization and/or its Rho GAP activity (Moon 
and Zheng, 2003.).  
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Although the role of the START domain in DLC1 is still not well 
characterized, the importance of this domain in supporting DLC1 function is 
beginning to unravel with studies showing that it is necessary but not sufficient 
for mediating the tumor suppressor activity of DLC1 (Liao et al., 2007; Kim et al., 
2008). While the START domain was not required for focal adhesion targeting 
(Kim et al., 2008), it was shown to be integral for the Rho GAP-dependent ability 
of DLC1 to inhibit the formation of stress fibers and colony formation in HCC cells 
(Wong et al., 2005). Further studies may benefit from the identification of its 
target lipid ligands in order to further elucidate the function of the START domain 
in DLC1.  
 
1.3.7.5 Rho GAP-independent functions of DLC1  
Several studies have shown that DLC1 demonstrates residual tumor 
suppressor activity in the absence of functional Rho GAP activity. Firstly, it was 
observed that a Rho GAP-dead DLC1 mutant with tensin-binding capabilities could 
mediate inhibition of cell migration and anchorage-independent growth to a 
similar extent as a mutant that has Rho GAP activity but lost focal adhesion 
targeting, albeit not to levels as seen in with wild-type DLC1 (Qian et al., 2007). 
This suggests that DLC1-tensin1 binding is independent from its Rho GAP activity 
but that both events may cooperatively contribute to tumor suppression. Next, 
exogenous expression of a Rho GAP-deficient DLC1 could still significantly inhibit 
anchorage-independent growth and invasion of NSCLC cells in vitro, thus 
indicating that the Rho GAP activity was not totally responsible for DLC1-
mediated tumor suppression (Healy et al., 2008). It was also postulated the 
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translocation of DLC1 into the nucleus could facilitate its association with other 
non-GTPase substrates to exert functions that extend beyond modulation of Rho 
GTPases (Scholz et al., 2009). Interestingly, the overexpression of the SAM domain 
alone was found to greatly promote cell migration, advocating the possibility that 
there exists a Rho GAP-independent mechanism driving DLC1-regulated cell 
migration (Zhong et al., 2009). Given the presence of other domains in DLC1, Rho 
GAP-independent tumor suppression or even Rho GAP-independent regulation of 
other cellular activities by DLC1 appears to be a probable phenomenon and 
warrants further investigation. 
 
1.3.7.6 A unifying model for DLC1 structure-function relationship 
In summary, the Rho GAP activity of DLC1 has been extensively studied and 
recognized to be primarily responsible for eliciting the many cellular effects of 
DLC1 such as the inhibition of proliferation and migration and promotion of 
apoptosis, all of which drive tumor suppression. However, the isolated Rho GAP 
domain does not display any catalytic activity and requires the adjacent N-
terminal sequences on the serine-rich region and START domain to exert its GTP 
hydrolysis-enhancing function. In addition, the Rho GAP activity can also be 
controlled temporally as different signals received by the cell at different point in 
time may serve to facilitate the release of DLC1 from inhibition by the SAM 
domain or p120RasGAP. To direct the spatial activation of its Rho GAP activity, the 
subcellular localization of DLC1 is also modulated by sequences on the serine-rich 
region or START domain that targets DLC1 to where its GTPase substrates are 
located by interaction with other protein partners. Finally, the SAM domain, 
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serine-rich region and START domain may themselves autonomously educe a 
similar or different set of biological effects from DLC1 Rho GAP-dependent 









Figure 1.4 A unifying model for the effects of DLC1 domain architecture on 
its function. DLC1 may exist in an inactive form by interaction with p120RasGAP 
or its SAM domain. Upon the arrival of a stimulus, DLC1 is released from the 
inhibitory complex and allowed to interact with various partners by virtue of the 
N- and C-terminal sequences flanking the Rho GAP domain that regulate DLC1 Rho 
GAP activity and localization. In turn, these sequences may also confer DLC1 with 
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1.4 The Adenine Nucleotide Translocase (ANT) family of ADP/ATP carriers 
The next protein of interest in this study belongs to the adenine nucleotide 
translocase (ANT) family of adenosine monophosphate/ adenosine triphosphate 
(ADP/ATP) carriers. The members of the ANT family are part of the superfamily of 
mitochondrial carriers and are the most abundant residents of the inner 
membrane of the mitochondria (Riccio et al., 1975).  Each ANT gene encodes a 
protein of approximately 300 amino acids comprising of three internal homology 
regions of about 100 amino acids each and are highly conserved in mammals and 
other eukaryotic species including yeast and plants (O’Malley et al., 1982; Lawson 
and Douglas, 1988). As the name suggests, ANT members are involved in the 
transport of adenine nucleotides, thus rendering them a functionally integral 
component of the eukaryotic cell (Klingenberg, 2008).  
 
1.4.1 Structure of the mitochondrial ADP/ATP carrier 
Although the ADP/ATP carrier proteins were discovered decades ago with 
studies continuing to elucidate their transport kinetics and mechanisms, how ANT 
functions in ADP/ATP transport was only better appreciated after the crystal 
structure of the carrier isoform in the bovine heart as a complex with its inhibitor 
was solved (Pebay-Peyroula et al., 2003).  
The ADP/ATP carrier exists as a dimer of two identical 33 kDa subunits, each 
consisting of three repeats (less than 15 % amino acid sequence identity) of a pair 
of transmembrane –helices linked by short –helical stretches and hydrophilic 
mitochondria matrix-facing loops with the N- and C-termini oriented towards the 
mitochondria intermembrane space (Figure 1.5). Together, the six 
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transmembrane -helices form a tight barrel structure with a deep cone-shaped 
depression lined with internal hydrophilic surfaces for substrate binding. The 
basic hexapeptide motif (RRRMMM) that is characteristic of ADP/ATP carriers but 
not other mitochondrial carriers, is located at the bottom of this cavity and 
thought to be responsible for binding negatively-charged magnesium-free 
nucleotides since individual mutation of any of the arginines abolished the ability 
to transport substrates. The carrier protein also has a conserved sequence motif 
found in other mitochondrial carriers (PX (D/E) XX (K/R) (X = any amino acid). 
Charged residues in this motif tightly link the helices together via salt bridges that 
must be broken to facilitate substrate translocation. As each odd-numbered 
transmembrane helix un-tilts with respect to the membrane via the proline 
hinges, the carrier undergoes a transient transition from a ‘pit’ to ‘channel’ 
conformation for substrate transport across the mitochondrial membranes. 
 
 
Figure 1.5 A schematic representation of the secondary structure of one 
monomeric unit of the bovine ADP/ATP carrier in the mitochondria as 
solved by X-ray crystallography. H1 – H6 indicate the six transmembrane 
helices spanning the mitochondria inner membrane while h1 – h3 indicate the 
surface helices parallel to the membrane on the matrix side of the mitochondria. 
The mitochondria matrix-facing loops are labeled M1 – M3. The odd-numbered 
helices are displayed with a kink due to the presence of proline residues. Adapted 
from Pebay-Peyroula et al., 2003. 
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The structure suggests that each monomer has two favorable conformations 
in which the single binding site for either ADP or ATP alternately faces the 
intermembrane side of the membrane (c-conformation) or mitochondria matrix 
(m-conformation). The carrier protein thus functions as an anti-porter where 
binding of one nucleotide from either side cooperatively enhances the binding of a 
second nucleotide from the opposite side such that mitochondrial ATP is 
exchanged for cytosolic ADP at a 1 : 1 ratio (Klingenberg, 2008).  
252 out of the 297 amino acids (84.6 %) of ADP/ATP carrier proteins are 
completely identical across different species and isoforms (Yamazaki et al., 2002), 
suggesting that they are likely to fold in a similar fashion. Of interest, residues 45, 
147 and 154, all located in the first two matrix-facing loops, were found to exhibit 
strict isoform specificity across all mammalian ANTs and could possibly 
determine differences in functions (Yamazaki et al., 2002).  
 
1.4.2 ANT family members have dual functions  
The members of the ANT family are bi-functional proteins with a primary 
role under normal physiological conditions in ADP/ATP transport and a 
secondary role in apoptosis as one of the components of a non-specific pore, more 
commonly referred to as the mitochondrial permeability transition pore complex 
(PTPC).  
In eukaryotic cells, adenine nucleotides are critical for many cellular 
functions and are hence widely considered the universal energy currency of the 
cell.  Under aerobic conditions, the rate of ATP production in the mitochondria by 
oxidative phosphorylation is dependent on the intramitochondrial ADP 
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concentration. This links the synthesis of ATP, required for driving energy-
dependent processes, to the kinetics of ADP uptake (Stepien et al., 1992). 
However, the large and hydrophilic nature of these nucleotides precludes efficient 
transport across biomembranes without the presence of a highly efficient carrier. 
As such, the role of ANTs in catalyzing the exchange of mitochondrially produced 
ATP for ADP in the cytosol during the last step of mitochondrial oxidative 
phosphorylation, is critical in ensuring energy homeostasis by regulating the 
ADP/ATP ratio in the mitochondria (Stepien et al., 1992). This functional role of 
ANTs is even more crucial given that they are the only mitochondrial translocases 
for nucleotides and thus serve as an essential link between energy-producing and 
energy-consuming processes. The export of ATP from the mitochondria does not 
require energy and occurs at a nearly equal rate as the import of cytosolic ADP as 
long as the mitochondria inner membrane maintains its high membrane potential, 
generated as a result of unequal distribution of protons across the inner 
mitochondrial membrane (Macho et al., 1996) by the action of the enzymes 
involved in oxidative phosphorylation (Klingenberg, 2008).  
ANT family members are also integral constituents required for the 
formation of the mitochondrial PTPC that interacts with the B-cell lymphoma 2 
(Bcl-2) family of apoptosis-associated proteins and are thus implicated in 
mitochondria-mediated apoptosis (Belzacq et al., 2003). The mitochondrial PTPC, 
comprising of ANTs, voltage-dependent anion channels and cyclophilin D, 
regulates the permeability of the outer and inner mitochondrial membranes for 
the unidirectional efflux of metabolites (Vieira et al., 2000) when the cell is under 
stress or receives external insults that trigger apoptosis, necrosis or autophagy 
(Crompton, 2000). It has been proposed that the opening of the PTPC leads to the 
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collapse of mitochondrial membrane potential and is associated with swelling of 
the mitochondrion, both of which will result in an increase in inner and outer 
mitochondrial membrane permeability to initiate the release of pro-apoptotic 
factors like cytochrome c and apoptosis-inducing factor (Bernardi et al., 1998). As 
such, ANT family members are thought to be critical in the maintenance of 
mitochondrial membrane potential and thus cell viability (Crompton, 2000).  
 
1.4.3 The four mammalian ANT isoforms  
The existence of ANT isoforms was only revealed when it was observed that 
antibodies against the ANT protein isolated from heart muscles only partially 
cross-reacted with the ANT protein found in the kidneys and livers (Schultheiss 
and Klingenberg, 1984). Since then, three isoforms of ANT have been identified 
and a fourth one recently characterized in mammals. The ANT nuclear genes have 
similar structural features comprising of four exons with exactly the same length 
and homologies of between 77 – 79 % (Cozens et al., 1989; Chung et al., 1992). In 
addition, all four isoforms share significant amino acid sequence similarity (88 - 
91 % identity) (Doerner et al., 2006), suggesting that they originate from a 
common ancestral gene. However, their expression profiles are distinct in various 
tissues and cell types as the relative expression of the isoforms depends on the 
developmental stage and proliferation state of the cell (Stepien et al., 1992). This 
suggests that the various isoforms may exhibit different kinetics in ADP/ATP 
transport that may be attributed to amino acid differences in regions a. a. 105 – 
107 and a. a 148 – 151 that are located in the first two matrix-facing loops of the 
carrier protein as well as sites involved in ADP/ATP binding (Stepien et al., 1992). 
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Despite the high conservation of these isoforms, little is known about their 
functional roles.  
The first isoform discovered from a muscle library, ANT1, is encoded in 
humans by a gene located on chromosome 4 (4q34-45) and is widely expressed in 
tissues with restricted mitotic regenerative capabilities like the heart and skeletal 
muscle (Neckelmann et al., 1987). While ANT1 is not found in proliferating 
myoblasts, its expression was detected after the myoblasts ceased growth and 
started to differentiate and fuse to form myotubes (Stepien et al., 1992). This is 
consistent with tissue expression data showing that this isoform is selectively 
expressed in terminally differentiated tissues. ANT1-null mice did not manifest 
any brain pathology but were observed to develop abnormal ragged-red muscle 
fibers and exhibited cardiac hypertrophy that was in both tissues accompanied by 
significant proliferation of the mitochondria, extensive mitochondrial DNA 
damage and increased levels of reactive oxygen species (Graham et al., 1997; Lee 
et al., 2009). Although the ANT1-null mice were viable to adulthood, possibly due 
to compensation by the other isoforms, the adult mutants displayed 
characteristics of metabolic acidosis, cardiomyopathies and mitochondrial 
myopathies. In addition, exogenous expression of ANT1 was found to induce 
apoptosis in human embryonic cells and breast cancer cells (Bauer et al., 1999; Le 
Bras et al., 2006;Jang et al., 2008) which was linked to the dissipation of 
mitochondrial membrane potential, the release of cytochrome c and subsequent 
activation of caspase-9 and caspase-3. The role of ANT1 in apoptosis was further 
substantiated by the observation of increased resistance against permeability 
transition in ANT1-null mice (Lee et al., 2009). As such, it was proposed that ANT1 
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critically links energy metabolism, anti-oxidant defenses and apoptosis in an 
integrated metabolic network (Subramaniam et al., 2008).  
ANT3 was isolated from an adult liver library (Houldsworth and Attardi, 
1988) and was mapped to a pseudoautosomal region of the human X-chromosome 
that escaped X-inactivation (Xp22.3) (Schiebel et al., 1993). It is ubiquitously 
expressed and exhibits properties of a housekeeping gene, as it is relatively 
insensitive to changes in the proliferative state of the cell (Stepien et al., 1992; 
Lunardi and Attardi, 1992). ANT3 expression however, did correlate with levels of 
oxidative metabolism and overexpression of this isoform was found to induce 
apoptosis in cells (Zamora et al., 2004; Yang et al., 2007). Moreover, ANT3-
deficient mice were resistant to tumor necrosis factor (TNF)--induced apoptosis 
linked to the disregulation of mitochondrial membrane potential and cytochrome 
c release (Yang et al., 2007).  
The ANT4 gene is located on chromosome 4 (4q28.1) in humans and is 
exclusively expressed in the brain, liver and testis. It was found to be a pluripotent 
stem- and germ cell-specific isoform in mouse that was transcriptionally silenced 
by methylation in somatic cells (Rodic et al., 2005). The observation that ANT4 
was conserved in mammals and totally absent in non-mammal species indicates 
that this isoform plays an indispensable role in mammalian development that 
cannot be compensated by the other isoforms (Brower et al., 2007). This is 
corroborated by the infertile phenotype of ANT4-null mice that was ascribed to a 
significant reduction in testicular size and defects in spermatogenesis (Brower et 
al., 2007). Interestingly, unlike the pro-apoptotic ANT1 and ANT3 isoforms, 
ectopic expression of ANT4 did not affect the mitochondrial network and even 
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enhanced cell growth, suggesting that ANT4 confers some protective activity 
against cell death (Gallerne et al., 2010).  
 
1.4.4 ANT2 is a growth- and glycolysis-regulated ADP/ATP carrier  
The ANT2 isoform was first isolated as a growth-regulated ADP/ATP carrier 
from fibroblasts (Battini et al., 1987) and subsequently mapped to a region on X-
chromosome (Xq24-25) in humans that was susceptible to X-inactivation 
(Schiebel et al., 1994). ANT2 physically interacts with the Pi carrier and ATP 
synthase and is exclusively present in the cristae of the mitochondria (Zamora et 
al., 2004; Vyssokikh et al., 2001).  
ANT2 has an expression profile that is exclusive to undifferentiated cells or 
tissues that are capable of regeneration such as lymphocytes, myoblasts, liver, 
spleen and kidney (Stepien et al., 1992). Additionally, its expression could be 
induced in quiescent human fibroblasts (Battini et al., 1987), leukemia cells 
(Battini et al., 1987) and T-lymphocytes (Kaczmarek et al., 1985) that are 
stimulated with serum or growth factors to induce entry into the G1 phase of the 
cell cycle. Conversely, the expression of ANT2 was repressed in cells induced to 
differentiate (Battini et al., 1987; Lunardi et al., 1992), in growth-arrested cells or 
in cells grown to confluence (Barath et al., 1999; Luciakova et al., 2003). As such, 
the levels of ANT2 can serve as an informative readout of the proliferative status 
of the cell (Barath et al., 1999). It was later shown that the expression of ANT2 
coincided with that of immediate-early genes that drive cell cycle progression and 
was maintained throughout the cell cycle (Barath et al., 1999). However, it is 
presently still unclear if the increase in ANT2 expression is simply a reflection of 
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proliferation or is a cell cycle-specific event (Barath et al., 1999). Moreover, there 
is a line of evidence that suggests that ANT2 may also regulate proliferation (Alder 
et al., 1989).  
ANT2 transcripts are also highly expressed in cells that rely on ATP 
produced during the anaerobic breakdown of glucose in glycolysis such as those 
that lack mitochondrial DNA, proliferating cells under hypoxia or transformed 
cells (Lunardi et al., 1991; Chevrollier et al., 2005; Kaczmarek et al., 1985). The 
expression of ANT2 in transformed and mitochondrial DNA deficient cell lines was 
found to be induced following a switch from an exclusive oxidative to glycolytic 
metabolism (Giraud et al., 1998).  
The confinement of ANT2 expression to cells that generally have a high 
energy demand suggests that this particular isoform might possess kinetic 
properties different from the other isoforms. Indeed, functional complementation 
studies revealed that ANT2 was able to catalyze an inverse transport of ATP 
synthesized in the cytosol by glycolysis to the mitochondrial matrix (Giraud et al., 
1998). Here, energy in the form of ATP is utilized for the maintenance of 
mitochondrial membrane potential to preserve mitochondrial structural integrity 
for supporting intra-mitochondrial metabolic activities such as mitochondrial 
DNA expression, gluconeogenesis and urea production (Giraud et al., 1998). 
Although the ADP/ATP exchange kinetics has not been directly measured for 
ANT2, indirect evidence suggests that ANT2 has a higher transport capacity than 
ANT1 that could confer cells pro-survival properties when it is expressed 
(Klingenberg, 1980). 
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1.4.5 ANT2 transcriptional control 
The ANT genes share common genomic organization with highly 
homologous coding sequences (Ku et al., 1990). Contrary to these structural 
similarities, the expression patterns of these genes are spatially and temporally 
different and can be attributed to distinct promoter elements that place these 
genes under divergent regulatory controls (Ku et al., 1990). In particular, levels of 
ANT2 were shown to be controlled transcriptionally as the stability of the ANT2 
protein was not affected by changes in serum levels (Barath et al., 1999).  
The ANT2 promoter contains canonical TATA motifs that are typically found 
in developmentally regulated genes (Ku et al., 1990). Expression of ANT2 was 
found to be under the control of three promoter-specific transcription factor (Sp1) 
elements in the promoter region, two of which act synergistically to activate 
growth-stimulated transcription and one of which lowers the transcription 
initiation efficiency (Li et al., 1996). Growth-arrest mediated repression of ANT2 
expression involves the binding of nuclear factor 1, Smad and Sp family of 
transcription factors to these repressor elements (Luciakova et al., 2008). In 
addition, the promoter sequence of ANT2 contains a glycolysis-regulated box 
motif that is negatively regulated by transcription factors that participate in 
pathways selecting for the import of glycolytic ATP into the mitochondria (Giraud 
et al., 1998). These glycolytic-responsive elements may serve as the final 
molecular sensor of cellular metabolism that ultimately dictates how ADP and ATP 
are transported (Giraud et al., 1998).  
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1.4.6 ANT2 is involved in normal development and disease pathogenesis 
Aside from its purported ADP/ATP carrier function, little else is known 
about the cellular functions of ANT2. It has been previously reported that both 
ANT1 and ANT2 are present in every mitochondrion in the cell, which suggests 
that the isoforms have distinct physiological roles (Vyssokikh et al., 2001). 
Accordingly, while ANT1-null mice could survive to adulthood, the small 
percentage of ANT2-null mice that survived gestation all succumbed to death by 
16 days post-natal (Wallace et al., 2005). The failure to produce fully viable ANT2-
null progeny was ascribed to defects in cardiac and vasculature development 
associated with mitochondrial abnormalities that could not be rescued by the 
presence of ANT1 (Wallace et al., 2005). 
Besides the critical role of ANT2 in development, ANT2 has also been 
implicated in the progression of several disease states. For example, ANT2 was 
found to be upregulated in the rat brain during hypertonicity that may be an 
adaptive response to environmental osmotic stress (Yamashita et al., 1999). The 
importance of the ANT2 isoform has also been described in the development of 
dilated cardiomyopathy as a downregulation of ANT2 resulted in a decrease in 
maximum ADP/ATP transport activity (Dorner et al., 2006). Additionally, ANT2 
gene expression was induced in the livers of patients suffering from liver 
mitochondrial DNA depletion syndrome as a result of the necessity to rely on 
glycolysis for ATP generation (Bonod-Bidaud et al., 2001). Furthermore, ANT2 
was recently identified by mass spectrometry as one of the cellular targets for the 
herpes simplex virus I UL7 gene involved in viral replication, thus implicating 
ANT2 in viral pathogenesis (Tanaka et al., 2008).   
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1.4.7 ANT2 and its links with cancer  
More importantly, several studies have established the relevance of the 
ANT2 isoform in carcinogenesis. ANT2 expression was found to be significantly 
upregulated in various hormone-dependent cancers such as those of the thyroid, 
breast, ovary, uterus, cervix, bladder and testis (Le Bras et al., 2006) as well as in 
several cancer cell lines including those derived from the lung, stomach and liver 
(Jang et al., 2008). Moreover, ANT2 expression levels appeared to be correlated 
with the growth rate of cells (Battini et al., 1987) and repression of ANT2 
expression was able to arrest cell growth in chemosensitized cancer cells 
(Luciakova et al., 2003; Le Bras et al., 2006).  
One of the key hallmarks of cancer cells is their ability to sustain an 
increased rate of glucose utilization by glycolysis even under aerobic conditions 
(Nakashima et al., 1984). This confers them the capability to convert glucose into 
fatty acids and nucleotides for continued cell division by preferentially selecting 
for an energy-producing pathway that is responsive to pro-proliferative signals. In 
line with this, ANT2 expression was shown to be upregulated during the G1/S 
transition in transformed cells that was associated with the simultaneous 
expression of glycolytic genes such as hexokinase II (Chevrollier et al., 2005). This 
highlights the exploitation of ANT2 in glycolysis-dependent cancer cells to shuttle 
cytoplasmic ATP into the mitochondria for maintenance of mitochondrial 
membrane potential (Chevrollier et al., 2005). In addition, hypoxia-induced 
glycolysis also triggered the expression of ANT2 in tumor cells (Chevrollier et al., 
2005). This could possibly afford cancer cells resistance to changes in the levels of 
proteins involved in oxidative metabolism, thus liberating them from growth 
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inhibition due to environmental constraints. As such, the switch to a glycolytic 
metabolism in cancer cells drives the development of more aggressive cancers.  
Previous studies have validated that ANT2, in contrast to ANT1 and ANT3, 
was not pro-apoptotic when overexpressed (Bauer et al., 1999; Zamora et al., 
2004; Le Bras et al., 2006) and in fact functions as an anti-apoptotic oncoprotein 
that inhibits mitochondrial membrane permeability (Jang et al., 2008). Prolonged 
transcriptional silencing of ANT2 by the introduction of shRNAs into human 
breast cancer cells induced caspase-3-dependent apoptosis by upregulation of 
pro-apoptotic Bax and downregulation of anti-apoptotic Bcl-xL (Jang et al., 2008). 
ANT2 deficiency also led to a reduction in intracellular ATP levels and the 
disruption of mitochondrial membrane potential that was accompanied by 
necrosis in neighboring cells due to the release of cytotoxins from ANT2-deficient 
cells (Jang et al., 2008). ANT2 depletion also inhibited proliferation by cell cycle 
arrest at the G1 phase and could suppress tumor growth in vivo (Jang et al., 2008). 
Moreover, knockdown of ANT2 was also found to sensitize cancer cells treated 
with an anti-tumor agent to apoptosis by relieving the inhibition on mitochondrial 
membrane permeability (Le Bras et al., 2006), thus reaffirming the role of ANT2 as 
an anti-apoptotic protein.  
Finally, ANT2 was recently verified to interact with the pro-invasive 
membrane type-1 matrix metalloproteinase, produced by fibrosarcoma cells, in a 
manner that was independent of the catalytic activity of the metalloproteinase 
(Radichev et al., 2009). This suggests a role for ANT2 in coupling energy 
metabolism to extracellular matrix proteolysis in migrating cancer cells. 
Consequently, the autonomy from oxidative metabolism, resistance to 
chemotherapy and pro-migratory abilities in cancer cells afforded by ANT2 makes 
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it a very attractive anti-tumor target whose molecular mechanisms must be 
elucidated for effective cancer management therapies.   
 
1.5 Rationale and objectives of this study  
The identification of interacting partners for DLC1 has led to a better 
understanding of how DLC1 functions, both in normal physiology and in 
pathology. It has also facilitated the elucidation of both Rho GAP-dependent and 
Rho GAP-independent functions of DLC1. To date, known partners for DLC1 
include the three members of the tensin family, PTEN, EF1A1, 14-3-33 and 
p120RasGAP (Table 1.1). Given the multiple domain architecture of DLC1, it is 
entirely possible that the interaction repertoire extends far beyond these few 
partners; hence the main aim of this study is to identify novel interacting partners 
for DLC1 and to understand the way in which the interaction allows DLC1 to 






PTEN SAM Control cell migration 
Heering et 
al., 2009 
EF1A1 SAM Modulate cell migration 





Focal adhesion localization and 
Rho GAP-independent tumor 
suppression 





Focal adhesion localization and 
regulation of Rho GAP activity 
Yam et al., 
2006 
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Focal adhesion localization and 
regulation of DLC1 activity 
Liao et al., 
2007 
14-3-3 (all isoforms 




shuttling and Rho GAP activity  
Scholz et al., 
2009 
p120RasGAP GAP Inhibition of Rho GAP activity 
Yang et al., 
2009 
Table 1.1 Known interacting protein partners of DLC1 to date that are 
involved in the regulation of DLC1’s cellular functions. The regions on DLC1 
that mediate the interaction and the functional outcome of the interaction are 
stated in the table alongside the corresponding references.  
 
Briefly, there are two approaches that can be undertaken to identify 
candidate proteins associated with DLC1. In the hypothesis-driven approach, 
candidate proteins are singled out and then validated whereas in the discovery-
based approach, there is no target pre-selection that is constrained by the need for 
prior knowledge. To facilitate the identification of multiple novel binding partners, 
the latter approach would be adopted in a proteomics pull-down where the bait 
DLC1 protein would be overexpressed and associated proteins complexed with 
DLC1 identified by mass spectrometry. The binding motifs required for the 
interaction will be established to better appreciate the functional significance of 
the interaction. The general workflow of this study is summarized in Figure 1.6.   
 
Figure 1.6 General workflow of the proposed study to identify novel 
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2 Materials and Methods 
2.1 Cloning of DLC1 constructs 
The cloning of full-length DLC1, its domain truncation mutants and GAP 
inactive mutant used in this study was jointly performed with Zhong Dandan (Ph.D) 
and Zhou Yi Ting (Ph.D) and is briefly described in this section. Total RNA was 
isolated from human embryonic kidney 293T epithelial cells and subject to first 
strand cDNA synthesis with reverse transcriptase (Roche) using oligo-dT primers 
(Operon). The full-length cDNA of human DLC1 was then obtained through 
polymerase chain reaction (PCR) using the primers DLC1-F and DLC1-R that are 
specific to the cDNA sequence for human DLC1 (GenBank accession number: 
NM_006094) (Table 2.1). Subsequently, the full-length PCR product was gel-purified 
and sub-cloned into Flag-tagged and HA-tagged pXJ40 vectors (courtesy of E. Manser 
(Ph.D), Institute of Molecular and Cell Biology, Singapore) after restriction 
digestion, ligation and transformation into E.coli DH5α cells. Similarly, the domain 
truncation mutants were obtained by sub-cloning the PCR products of the various 
reactions using specific primers (Table 2.1) and the full-length DLC1 cDNA as a 
template in the respective Flag-tagged and HA-tagged pXJ40 vectors.  
The DLC1-R677E point mutant was obtained by PCR using specific primers 
R677E-F and R677E-R (Table 2.1) under the following cycling parameters: (1) initial 
denaturation at 95 °C for 30 seconds, (2) amplification (16 cycles) at 95 °C for 30 
seconds, (3) annealing at 55 °C for 1 minute and (4) extension at 68 °C for 7 
minutes and 40 seconds. The PCR products were digested with the Dpn I enzyme for 
2 hours at 37 °C before immediate transformation into E.coli DH5α cells. Selected 
clones were selected for DNA sequencing to verify the sequence. 
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DLC1-F 5' – CGGGGATCCATGTGCAGAAAGAAGCCGG – 3’ 
DLC1-R 5' – CCGGCCCGGGTCACCTAGATTTGGTGTCTTGG – 3’ 
DLC1-PGR-F 5' – CGCGGGATCCAAGCTAGAAATTAGTCCTCATCGG – 3’ 
DLC1-PGR-R 5' – CGGCCCGGGTCAAGCTGAGTCATCATTACCC – 3’ 
DLC1-C-F 5' – CGGGGATCCATGACCCTGAAGAGAGAGAATTCC – 3’ 
R677E-F 5' – GGATCAGGTTGGGCTCTTCGAAAAATCGGGGGTCAAGTCC – 3’ 
R677E-R 5' – GGACTTGACCCCCGATTTTTCGAAGAGCCCAACCTGATCC – 3’ 
Table 2.1 Primer sequences used for the cloning of full-length human DLC1 
and its GAP-inactive mutant. The restriction sites used for cloning are 
underlined in bold. The mutations sites are bolded and italicized.  
 
2.2 Cell culture 
2.2.1 293T  
Human embryonic kidney 293T epithelial cells (referred from here on as 
293T) (American Type Cell Culture) were cultured as a monolayer without any 
coating on tissue culture dishes (Nunc) in Roswell Park Memorial Institute (RPMI) 
1640 medium (10.4 g of HyQ RPMI - 1640 powder in 1 L of autoclaved deionized 
water) supplemented with 2 g/L sodium bicarbonate, 10 mM HEPES free acid, 2 
mM L-Glutamine, 100 U/ml penicillin, 100 U/ml streptomycin solution (all from 
Hyclone Laboratories) and 10 % (v/v) defined fetal bovine serum (FBS) (PAA Cell 
Culture) and maintained in a humidified incubator at 37 °C with 5 % carbon 
dioxide. To sub-culture the cells, 0.25 % trypsin-EDTA (Hyclone Laboratories) was 
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applied to the cell monolayer. The cells were then harvested in serum-containing 
medium and seeded for subsequent experiments.  
 
2.2.2 HeLa 
HeLa cells (cervical cancer cell line) (American Type Cell Culture) were 
grown in Dulbecco’s Modified Eagle’s Medium (10.4 g of HyQ DME/High Glucose 
powder in 1 L of autoclaved deionized water) supplemented with 5 g/L sodium 
bicarbonate, 2 mM L-Glutamine, 100 U/ml penicillin, 100 U/ml streptomycin 
solution (all from Hyclone Laboratories) and 10 % (v/v) defined fetal bovine 
serum (FBS) (PAA Cell Culture) as a monolayer on uncoated tissue culture dishes 
(Nunc) and maintained at 37 °C with 5 % carbon dioxide in a humidified 
incubator. 0.25 % trypsin-EDTA (Hyclone Laboratories) was used to trypsinize the 
cells for sub-culturing. The cells were then harvested in antibiotic-free medium 
and seeded for subsequent experiments.  
 
2.3 Transient transfection 
2.3.1 293T 
The plasmid DNA used for transfection were all eluted in deionized water 
and had an optical density (OD) 260 nm/OD280 nm ratio of between 1.8 and 2.0. 
293T cells were cultured as described in section 2.2.1 and plated 24 hours before 
transfection in serum-containing RPMI - 1640 to achieve 70 - 80 % confluence in 
cell culture dishes (Nunc). Just prior to transfection, the cells were given a change 
of fresh serum-containing medium. Transfection was performed according to 
manufacturer’s recommendations by incubating 3 µl of Mirus TransIT®-LT1 
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Transfection reagent (Mirus Bio Corporation) per 1 µg of plasmid DNA with 250 µl 
of serum-free RPMI - 1640 for 20 minutes at room temperature. The plasmid DNA 
was then added and incubated for 20 minutes at room temperature before drop-
wise application of the complexes to the cells. The culture plates were swirled to 
ensure proper distribution of the complexes and before returning the cells to 
culture at 37 °C for 24 hours in a humidified incubator with 5 % carbon dioxide.  
 
2.3.2 HeLa 
The plasmid DNA used for transfection were all eluted in deionized water 
and had an OD260 nm/OD280 nm ratio of between 1.8 and 2.0. HeLa cells were 
cultured as described in section 2.2.2 and plated 24 hours before transfection in 
antibiotics-free RPMI - 1640 to achieve 50 % confluence on 13 mm microscope 
cover glasses (EINST) placed in 6-well cell culture dishes (Nunc). Just prior to 
transfection, the cells were transferred to 12-well cell culture dishes (Nunc) and 
given a change of fresh antibiotics-free medium. Transfection was performed 
according to manufacturer’s instructions by incubating 2.5 µl of Lipofectamine™ 
2000 transfection reagent (Invitrogen Life Technologies) per 1 µg of plasmid DNA 
with 50 µl of OPTI-MEM® reduced serum medium (Gibco) for 5 minutes at room 
temperature. The plasmid DNA was similarly diluted in 50 µl of OPTI-MEM® 
reduced serum medium and added to the transfection reagent complex and 
incubated for 20 minutes at room temperature before addition to the cells in a 
drop-wise manner with swirling to ensure proper distribution of the complexes. 
The cells were then maintained in culture at 37 °C for 24 hours in a humidified 
incubator containing 5 % carbon dioxide.  
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2.4 Identification of DLC1 interacting partners 
The plasmid DNA encoding the FLAG-PGR and -C DLC1 constructs (cloned by 
Zhong Dandan (Ph.D)) used as bait proteins were all eluted in deionized water and 
were of good quality as indicated by the absorbance at 260 nm/280 nm ratio. 
293T cells were cultured as described in section 2.2.1 and seeded 24 hours prior 
to transfection on 6 cm cell culture plates (Nunc). To increase the amount of 
endogenous proteins captured by the bait DLC1 proteins, five 6 cm plates of cells 
were transfected per construct. The cells were transfected as outlined in section 
2.3.1 using 2 µg of plasmid DNA. After 24 hours, the cells from one plate was lysed 
with 500 µl of radio-immuno precipitation assay (RIPA) lysis buffer (50 mM Tris-
HCl, 150 mM sodium chloride (Merck), 0.25 mM ethylenediaminetetraacetic acid 
(EDTA) (Biological Industries), 1 % (w/v) sodium deoxycholate (Sigma), 1 % (v/v) 
Triton X-100 (USBiologicals), 0.2 % (w/v) sodium fluoride (Sigma); adjusted to a 
final pH of 7.3) freshly supplemented with Complete Protease Inhibitor Cocktail 
(Roche) and 5 mM sodium orthovanadate (Sigma).  The cells were scraped off the 
surface of the plate and the lysate was collected and transferred to lyse the second 
plate of cells. This was repeated for the remaining plates of cells to obtain the 
lysates from the combined pool of cells. To facilitate complete lysis, the lysates 
were place on a nutator for 15 minutes and vortexed briefly before centrifugation 
at maximum speed (14,000 rpm) at 4C for 15 minutes. 20 µl of each of the 
supernatant (whole cell lysate) was then aliquoted and boiled in Laemmli buffer 
(0.1 M Tris-HCl (pH 6.8), 3 % (v/v) sodium dodecyl sulfate (SDS) (1st Base), 15 % 
glycerol (Merck), 7.5 % (v/v) -mercaptoethanol, 0.005 % (w/v) bromophenol 
blue (BioRad)) at 85C for 5 minutes. To assess the transfection efficiency, the 
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whole cell lysates were separated by SDS-PAGE and immunoblotted using the 
anti-FLAG antibody as described in section 2.7.   
The remaining lysates were then incubated with 15 µl of anti-FLAG M2 
beads (Sigma) for immunoprecipitation at 4C on a nutator for 3 hours. The beads 
were spun down and the supernatant was transferred to a fresh tube before 
adding 15 µl of anti-FLAG M2 beads and incubating at 4C on a nutator overnight. 
The beads were then spun down briefly and subject to stringent washing (1 ml of 
chilled RIPA lysis buffer for 6 times) to remove non-specifically bound proteins. 
The beads were boiled in Laemmli buffer at 85C for 5 minutes before separation 
on a 10 % SDS-polyacrylamide gel by electrophoresis (as described in section 
2.7.1). The gel was then fixed in a solution containing 10 % acetic acid and 25 % 
isopropanol, washed with deionized water and stained with PageBlue™ solution 
(Fermentas) overnight.  
Following de-staining of the gel, bands of interest were excised and subject 
to in-gel reduction/alkylation and digestion with trypsin. After cleanup and 
peptide concentration, mass spectrometry analysis was carried out with a matrix-
assisted laser desorption ionization-time of flight (MALDI-TOF/TOF) Voyager-
DE™ STR Biospectrometry™ workstation (Applied Biosystems). To ascertain the 
identity of the proteins in the excised bands, peptide mass fingerprints of the 
tryptic peptides from the mass spectrometric data were subject to a MASCOT 
(Matrix Sciences) search against a human database. All the mass spectrometry 
analysis was performed at the Proteins and Proteomics Center at the Department 
of Biological Sciences, National University of Singapore. Only proteins with a 
probability score of p < 0.05, correct molecular weight as determined by SDS-
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PAGE and peptide sequence coverage of the protein of at least 20 % were 
considered as potential candidate partners.  
  
2.5 Cloning of ANT2 constructs 
2.5.1 Polymerase chain reaction to amplify ANT2-FL cDNA 
DNAMAN sequence analysis software (Version 4.15) (Lynnon Biosoft) was 
employed to search for restriction enzymes that do not possess restriction sites 
along the published human ANT2 complementary DNA (cDNA) sequence 
(GenBank Accession Number: NM_001152).   Primers were then designed to include 
restriction sites for Xho I and Xma I to facilitate cloning into the pXJ40-Flag and 
pXJ40-HA epitope-tagged expression vector (Table 2.2). The full-length human 
ANT2 cDNA (hereon referred to as hANT2-FL) was amplified from total cDNA 
isolated from 293T cells (courtesy of Chew Li Li (Ph.D)) with the high-fidelity 
long-template DyNAzyme EXT DNA polymerase (Finnzymes) using 10 pmol of 
primers hANT2FL-F and hANT2FL-R (1st Base) in a magnesium-containing buffer 
by temperature-gradient PCR. 
 
Primer name Primer sequence 
hANT2FL-F 5' – CGCGCTCGAGATGACAGATGCCGCTGTGTCC – 3’ 
hANT2FL-R 5' – CGCGCCCGGGTCATGTGTACTTCTTGATTTC – 3’ 
Table 2.2 Primer sequences used for the cloning of full-length human ANT2. 




M.Sc Thesis  Chapter 2 Materials and Methods 
WONG Ming Zhi Denise (HT 080931 B) 
 56 
Each 25 µl reaction was conducted in 0.2 ml thin-walled PCR tubes using a 
thermal cycler (BioRad iCycler) under the following cycling parameters: (1) initial 
denaturation at 94 °C for 2 minutes, (2) denaturation at 94 °C for 30 seconds, 
annealing at either 50 °C, 54 °C, 56 °C, 60 °C or 65 °C for 30 seconds and extension 
at 72 °C for 1 minute for a total of 25 cycles followed by (3) final extension at 72 °C 
for 10 minutes to generate the ‘A’ overhangs at the 3’ end of the PCR products.   
 
2.5.2 Agarose gel electrophoresis 
The amplified hANT2-FL cDNA was separated on a 1 % agarose gel (1st Base) 
containing SYBR®Safe (Invitrogen Life Technologies) DNA gel stain at a 50,000 
times dilution in 1 × TAE buffer (40 mM Tris-base (pH 8.0) with glacial acetic acid, 
10 mM EDTA). The GeneRuler 1kb DNA ladder (Fermentas) was run alongside as a 
reference to aid in size determination.  
 
2.5.3 Gel extraction 
The gel was visualized under 50 % ultraviolet radiation (UVR) with the 
Molecular Imager Gel Doc XR system (BioRad) and a sterile blade was used to 
excise the desired bands quickly to minimize exposure to the UVR. Images were 
captured using the Quantity One 1-D analysis software (BioRad). The hANT2-FL 
cDNA was then extracted from the gel slices using the QIAquick gel extraction kit 
(Qiagen) according to manufacturer’s instructions and eluted with 30 µl of 
deionized water to obtain a higher concentration of DNA.  
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2.5.4 TA cloning into pGEM®-T Easy vector 
The hANT2-FL cDNA was subsequently ligated into the 3 kb pGEM®-T Easy 
vector using the pGEM®-T Easy Vector System I kit (Promega) using 50 ng of the 
pGEM®-T Easy vector with a 3 : 1 molar ratio of insert DNA to vector DNA in the 
presence of the supplied T4 DNA ligase and the 2 × Rapid Ligation Buffer at 4 °C 
overnight. The following formula was used to calculate the amount of insert (in 
ng) to include in the ligation reaction: [(ng of vector × size of insert in kb)/ size of 
vector in kb] × insert : vector molar ratio. 
 
2.5.5 Preparation of competent cells (Escherichia coli strain DH5) 
This strain of E. coli is commonly used for cloning as it allows for the 
production of plasmid DNA that is of high purity and yield due to a mutation in the 
endA gene that reduces the levels of endonuclease activity. To prepare chemically 
competent E. coli DH5, bacteria cells were first streaked onto an antibiotics-free 
Luria Bertani (LB) agar plate (BD Difco) and incubated overnight at 37 C. A 
starter culture was then prepared by inoculating a single colony into 5 ml of 
antibiotics-free LB broth and allowed to grow overnight at 37 C with agitation at 
250 rpm. 50 ml of antibiotics-free LB broth was then inoculated with a 200 times 
dilution of the starter culture and grown at 37 C with shaking at 250 rpm until 
the OD measured at 600 nm reached 0.6. The culture was then chilled on ice for 10 
minutes before being centrifuged at 2,500 rpm for 15 minutes at 4 C to pellet the 
bacteria cells. The pelleted cells were completely resuspended by gentle vortexing 
in 1/3 volume of the original culture (17 ml) of ice-cold calcium/manganese based 
buffer (CCMB) (80 mM CaCl22H20, 20 mM MnCl24H20, 10 mM MgCl26H20, 10 mM 
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KOAc (pH 7.0), 10 % (v/v) glycerol; adjusted to a final pH of 6.4) and incubated on 
ice for 20 minutes. After centrifuging at 3,000 rpm for 10 minutes at 4 C, the 
pelleted bacteria cells were then resuspended in 1/12 volume of the original 
culture (4 ml) of ice-cold CCMB. The competent cells were then snap-frozen in   
100 l aliquots and stored at - 80 C until use.  
 
2.5.6 Heat shock transformation of ligated products into competent E. coli 
DH5 
To introduce ligated products into competent E. coli DH5α cells, 4 µl of the 
ligation mixture was mixed with 100 µl of cells and incubated on ice for 30 
minutes before applying a heat-shock at 42 °C for 45 seconds. After 5 minutes of 
incubation on ice, 900 µl of LB broth was added before incubating at 37 °C for an 
hour with shaking at 250 rpm to allow recovery of the cells. The resultant 
transformation mixture was concentrated to 200 µl before spreading onto LB agar 
plates containing 100 µg/ml ampicillin (Sigma), 0.5 mM isopropyl-1-thio-β-D-
galactopyranoside (IPTG) (Sigma) and 80 µg/ml 5-bromo-4-chloro-3-indolyl-β-D-
galactopyranoside (X-gal) (BioRad) to screen for successful transformants. Only 
white colonies, indicative of transformants containing the hANT2-FL cDNA insert, 
were selected for subsequent plasmid DNA isolation. The plates were then 
incubated at 37 °C overnight.   
 
2.5.7 Plasmid purification from transformed E. coli DH5 
Single white colonies were each separately inoculated into 5 ml of LB broth 
containing 100 µg/ml of ampicillin for overnight culturing at 37 °C with shaking at 
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250 rpm. The putative recombinant pGEM®-T Easy plasmids containing the 
hANT2-FL insert (pGEMT-ANT2FL), were then purified using the AxyPrep plasmid 
miniprep kit (Axygen Biosciences) as per manufacturer’s directions and eluted in 
deionized water to a final volume of 50 µl.   
 
2.5.8 Spectrophotometric quantitation of plasmid DNA 
The quantity and purity of the isolated plasmid DNA was assessed by 
spectrophotometry. Briefly, the plasmid DNA was diluted 200 times with 
deionized water before measuring the absorbance at wavelengths 260 nm and 
280 nm. The yield was determined by the following equation: DNA concentration 
(g/ml) = OD260 nm × dilution factor × 50 g/ml. A ratio of absorptions at 260 nm : 
280 nm (260/280 ratio) between 1.8 – 2.0 is indicative of high purity of the 
plasmid that is free from contaminants such as proteins.  
 
2.5.9 Subcloning of cDNA fragments into pXJ40 expression vectors  
The pXJ40 expression vectors (courtesy of E. Manser (Ph.D), Institute of 
Molecular and Cell Biology, Singapore) are 4.3 kb expression plasmids that either 
encodes the FLAG epitope sequence (DYKDDDDK) (pXJ40-FLAG) or the 
hemagglutinin epitope sequence (YPYDVPDYA) (pXJ40-HA) at the 5’ end. The 
cytomegalovirus promoter and enhancer flanking the multiple cloning site and 
ampicillin-resistance gene drive the expression of cloned genes as either FLAG- or 
HA-tagged proteins. The vector also contains a –globin intron to improve gene 
expression in mammalian hosts. 
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2.5.9.1 Restriction enzyme digestion 
2 µg of each recombinant pGEM®-T Easy plasmid was digested in 20 µl for 3 
hours at 37 °C using 6 units of Xho I (New England Biolabs) and 6 units of Xma I 
(New England Biolabs) in the presence of 1 × bovine serum albumin (BSA) (New 
England Biolabs) in Buffer 4 (New England Biolabs) to release the insert of 
interest. Similarly, 4 µg of the pXJ40-FLAG or pXJ40-HA vector was digested. The 
resultant fragments were resolved on a 1 % agarose gel and the DNA was 
extracted as outlined in sections 2.5.2 and 2.5.3.  
 
2.5.9.2 Ligation 
The hANT2-FL cDNA insert containing the restriction enzyme overhangs was 
subsequently cloned into the digested pXJ40-FLAG vector (50 ng) by an overnight 
ligation at 14 °C using a 3 : 1 molar ratio of insert to vector DNA in the presence of 
T4 DNA ligase (New England Biolabs) and 10 × Ligase Buffer (New England 
Biolabs). The ligation mix was then transformed into competent E. coli DH5α cells 
as mentioned in section 2.5.6 and plated onto LB agar plates containing 100 µg/ml 
of ampicillin.   
 
2.5.9.3 Colony screening by PCR 
Colony screening was performed by PCR to identify colonies that contained 
the recombinant pXJ40-FLAG-ANT2-FL plasmids with the insert cloned in the 
correct direction. Sterile tips were used to pick single colonies off the LB agar 
plates. The tips were then dipped into 0.2 ml PCR tubes containing 20 µl of the 
master mix used in PCR amplification with DyNAzyme II DNA polymerase 
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(Finnzymes) before inoculation into 5 ml of ampicillin-containing LB broth. The 
primers hANT2FL-F and hANT2FL-R were used to amplify the hANT2-FL insert 
under the following cycling conditions: (1) initial denaturation at 94 °C for 2 
minutes, (2) denaturation at 94 °C for 30 seconds, annealing at 65 °C for 30 
seconds and extension at 72 °C for 1 minute for a total of 25 cycles followed by (3) 
final extension at 72 °C for 10 minutes. The amplification products were then 
separated on a 1 % agarose gel and visualized under UV with the Molecular 
Imager Gel Doc XR system using the Quantity One 1-D Analysis Software (BioRad). 
Colonies that contain the hANT2-FL insert were then cultured overnight in 
ampicillin-containing LB broth at 37 °C with agitation at 250 rpm before plasmid 
purification as outlined in section 2.5.7.  
 
2.5.10 DNA sequencing of constructs 
100 - 300 ng of the purified pXJ40-FLAG-ANT2-FL plasmids from the 
selected clones were amplified using 0.8 M of each of the T7 Promoter (5'– 
TAATACGACTCACTAT–3 ') and hANT2FL-R primers in separate PCR tubes in the 
presence of 1 µl of Big-Dye Terminator RR Mix within a final volume of 5 µl 
containing 1 × sequencing buffer. The cycling parameters were as follows: 25 
cycles of (1) denaturation at 96 °C for 30 seconds; (2) annealing at 55 °C for 15 
seconds; and (3) extension for 4 minutes at 60 °C. To purify the extension 
products, the products were first precipitated in the presence of 75 % pure 
ethanol and 0.1 M of sodium acetate (Sigma) in a final volume of 80 µl for 15 
minutes at room temperature. After centrifuging at full speed (14,000 rpm) for 20 
minutes, the supernatant was discarded and the resultant pellet was washed with 
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75 % ethanol thrice. The pellet was then air-dried and dissolved in 10 µl of HiDi 
formamide by vortexing before analysis by the ABI PRISM 3130 Genetic Analyzer 
(Applied Biosystems) (performed by the DNA Sequencing Laboratory, Department 
of Biological Sciences, National University of Singapore). The sequences obtained 
were then analyzed against the published GenBank sequence using the DNAMAN 
sequence analysis software to check for any mutations incurred and to verify that 
the inserts were cloned in frame with the vector sequences.   
 
2.5.11 Expression check of cloned constructs 
The correctly sequenced constructs were then checked for successful 
expression in 293T cells by transient transfection of plasmid DNA as outlined in 
sections 2.3.1 followed by lysis of cells in RIPA lysis buffer and harvesting of the 
subsequent supernatant. Whole cell lysates were then separated by SDS-PAGE 
before Western blot analysis using anti-FLAG antibodies as described in section 
2.7.   
 
2.5.12 Re-transformation of plasmid DNA by KCM 
To allow for continued purification of sequenced plasmids that were 
expressing the genes encoded, plasmid DNA was re-transformed into competent E. 
coli DH5α cells by adding 0.2 l of DNA into 15 l of ice-cold KCM solution (100 
mM KCl, 30 mM CaCl2, 50 mM MgCl2). After a five-minute incubation on ice, 15 l 
of competent cells were added and incubated for a further 20 minutes on ice 
before plating onto LB plates containing 100 g/ml ampicillin. The plates were 
then incubated at 37 °C overnight. 
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Subsequently, a single colony was inoculated into 5 ml of ampicillin-
containing LB broth and allowed to grow overnight at 37 °C with agitation at 250 
rpm. A glycerol stock (50 % (v/v) culture, 50 % (v/v) glycerol) was then prepared 
and maintained at – 80 °C for future use. The remaining LB culture was used for 
further isolation of plasmid DNA.  
 
2.5.13 Generation of ANT2 domain truncation mutants 
To clone the individual domains of human ANT2 (Table 2.3) into the pXJ40-
FLAG vector, PCR was carried out using the pXJ40-FLAG-ANT2-FL plasmid DNA as 
the template and the appropriate primers (Table 2.4).  
Construct name Amino acid residues 
hANT2-N 1 - 120 
hANT2-M 120 – 205 
hANT2-C 205 - 298 




Primer name Primer sequence 
hANT2-N 
hANT2FL-F 5' – CGCGCTCGAGATGACAGATGCCGCTGTGTCC – 3’ 
hANT2N-R 5' – CGCGCCCGGGTCAACCCGATGCCAGATTCCC – 3’ 
hANT2-M 
hANT2M-F 5' – CGCGCTCGAGGGTGCCGCAGGGGCCACATCC – 3’ 
hANT2M-R 5' – CGCGCCCGGGTCAGGGATCCGGAAGCATTCC – 3’ 
hANT2-C 
hANT2C-F 5' – CGCGCTCGAGAAGAACACTCACATCGTCATCAGC – 3’ 
hANT2FL-R 5' – CGCGCCCGGGTCATGTGTACTTCTTGATTTC – 3’ 
Table 2.4 Primer sequences used for cloning of domain truncation mutants 
of human ANT2. The restriction sites used for cloning are underlined in bold.  
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The DNA fragments were amplified with DyNAzyme EXT DNA Polymerase as 
described in section 2.5.1 by temperature-gradient PCR with the following 
annealing temperatures: 50 °C, 54 °C and 60 °C. The PCR products were separated 
on a 1 % agarose gel and purified by gel extraction as outlined in sections 2.5.2 
and 2.5.3 before ligation into pGEM®-T Easy vectors and subsequent 
transformation into competent E. coli DH5α cells as described in sections 2.5.4 and 
2.5.6. Following plasmid purification (section 2.5.7), restriction digestion was 
performed as per section 2.5.9.1 using the restriction enzymes Xho I and Xma I for 
3 hours at 37 °C in the presence of buffer 4 and 1 × BSA. The inserts of interest 
were then purified after separation on 1 % agarose gel and sub-cloned into 
restriction-digested pXJ40-FLAG vectors before transformation into E. coli DH5α 
cells (section 2.5.6). Colonies were screened for recombinant FLAG-ANT2-N, 
FLAG-ANT2-M and FLAG-ANT2-C by PCR using insert-specific primers and 
subsequently sequenced and validated for expression (sections 2.5.9.3 and 
2.5.10). 
 
2.5.14 Generation of ANT2 internal deletion mutants 
To generate the various ANT2 internal deletion mutants (Table 2.5), 
secondary structure analysis was first carried out on the entire human ANT2 
protein sequence with the NPS@ (Network Protein Sequence @nalysis) consensus 
secondary structure prediction program (available at: http://www.npsa-
pbil.ibcp.fr). In addition, ClustalW2 multiple sequence alignment (available at: 
http://www.ebi.ac.uk/Tools/clustalw2/index.html) of ANT2-N, ANT2-M and 
ANT2-C protein sequences was performed and manually adjusted to generate an 
alignment that is more representative of the conservation of amino acids. The 
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boundaries for the internal deletion mutants were assigned to avoid truncating 
any recognizable secondary structural motifs such as –helices and –sheets.  
 
Construct name Amino acid residues 
hANT2-N1  1 – 15 
hANT2-N2  16 - 41 
hANT2-N3  44 – 73 
hANT2-N4  75 – 99 
hANT2-C1  218 – 243 
hANT2-C2  244 – 273 
hANT2-C3  275 – 298 
hANT2-M  121 – 205 
Table 2.5 The internal deletion mutants of human ANT2. 
 
Deletion PCR was carried out using the pXJ40-FLAG-ANT2-FL plasmid DNA 
as a template for amplifying the fragments encoding hANT2-N2, hANT2-N3, 
hANT2-N4, hANT2-C1, hANT2-C2 and hANT2-M (Table 2.5), using 
appropriate primers (Table 2.6) and PfuUltra high-fidelity DNA polymerase 
(Stratagene) that generates blunt end PCR products. Each reaction was conducted 
in 0.2 ml thin-walled PCR tubes using a thermal cycler under the following cycling 
parameters: (1) initial denaturation at 95 °C for 2 minutes, (2) denaturation at 95 
°C for 2 minutes, annealing for 30 seconds at 65 °C and extension at 72 °C for 6 
minutes for a total of 30 cycles followed by (3) final extension at 72 °C. The PCR 
products were purified using the QIAquick PCR purification kit (Qiagen) according 
to manufacturer’s instructions and eluted in a final volume of 30 l of deionized 
M.Sc Thesis  Chapter 2 Materials and Methods 
WONG Ming Zhi Denise (HT 080931 B) 
 66 
water. Single restriction digest using Eco RV (New England Biolabs) then was 
carried out in buffer 3 in the presence of 1 × BSA overnight at room temperature 
to generate blunt-ended DNA that was purified to a final volume of 25 l of 
deionized water using the QIAquick PCR purification kit. 8 l of the eluted 
products were then ligated in the presence of T4 DNA ligase and its corresponding 
1 × buffer overnight at room temperature. The ligation products were introduced 
into competent E. coli DH5α cells and colonies were screened for the presence of 
the insert by PCR using insert-specific primers (section 2.5.9.3). Plasmid DNA was 
then isolated from positive clones and sequenced before expression checks were 
conducted (sections 2.5.10 and 2.5.11).  
For cloning of hANT2N1 and hANT2C3 constructs, the pXJ40-FLAG-ANT2-
FL template was similarly used in a PCR using the DyNAzyme EXT DNA 
polymerase and appropriate primers (refer to table 2.6). After separation of the 
PCR products on 1 % agarose gel and purification by gel extraction, the inserts 
were cloned into pGEM®-T Easy vectors and transformed into E. coli DH5 cells 
(sections 2.5.4 and 2.5.6). Blue-white selection of colonies allowed for the 
identification of putative positive clones harboring the insert of interest for 
plasmid extraction. Restriction digest with Xho I and Xma I for 3 hours at 37 °C in 
the presence of buffer 4 and 1 × BSA released the insert that was then sub-cloned 
into restriction-digested pXJ40-FLAG vectors (section 2.5.9). Following 
transformation into E. coli DH5 cells (section 2.5.6), colony PCR using insert-
specific primers was carried out to identify positive clones before plasmid 
extraction for sequencing of constructs and subsequent expression check by 
transient transfection (sections 2.5.10 and 2.5.11). 
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Primer name Primer sequence 
hANT2-N1 
hANT2N1-F 5'–CGCCTCGAGGGAGTGGCCGCAGCCATCTCC – 3’ 
hANT2N1-R 5' – CGCGCCCGGGTCATGTGTACTTCTTGATTTC – 3’ 
hANT2-N2 
hANT2N2-F 5' – CGCGATATCAGCAAGCAGATCACTGCAGATAAGC – 3’ 
hANT2N2-R 5' – CGCGATATCACCTGCCAGGAAGTCCTTGGC – 3' 
hANT2-N3 
hANT2N3-F 5'–CGCGATATCAACCTGGCCAATGTCATCAGATACTTCC–3’ 
hANT2N3-R 5' – CGCGATATCCTTGCTGGCATGCTGCACC – 3' 
hANT2-N4 
hANT2N4-F 5' – CGCGATATC CTGGGTGGTGTGGACAAGAGAACC – 3’ 
hANT2N4-R 5' – CGCGATATCGTTACCGCGCCAGAAGG – 3' 
hANT2-C1 
hANT2C1-F 5' – CGCGATATCCGCAAAGGAACTGACATCATG – 3’ 
hANT2C1-R 5' – CGCGATATCTGCGATCATCCAGCTGATGACG – 3' 
hANT2-C2 
hANT2C2-F 5' – CGCGATATCGCATGGTCCAATGTTCTCAGAGGC – 3’ 
hANT2C2-R 5' – CGCGATATCCCCTGACTGCATCATCATGCG – 3' 
hANT2-C3 
hANT2C3-F 5' – CGCGCTCGAGATGACAGATGCCGCTGTGTCC – 3’ 
hANT2C3-R 5' – CGCCCCGGGTCATGCACCCTTGAAAAAAGC – 3’ 
hANT2-M 
hANT2M-F 5' – CGCGATATCAAGAACACTCACATCGTCATCAGC – 3’ 
hANT2M-R 5' – CGCGATATCACCCGATGCCAGATTCCCTGC  – 3' 
Table 2.6 Primer sequences used for the cloning of domain deletion mutants 
of human ANT2. The restriction sites used for cloning are underlined in bold.  
 
2.6 Co-immunoprecipitation studies 
2.6.1 Preparation of mammalian whole cell lysates 
293T cells were maintained as described in section 2.2.1 and seeded in 6-
well multi-dishes 24 hours prior to transfection such that they were around 70 – 
80 % confluent on the day of transfection. 1 - 2 g of plasmid DNA was transfected 
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for 24 hours using Mirus TransIT®-LT1 Transfection reagent in a 3 : 1 ratio 
(volume of transfection reagent l : g  of DNA) as outlined in section 2.3.1. To 
obtain whole cell lysates for subsequent immunoprecipitation studies, media were 
drained from each well and cells were lysed in 250 l of chilled RIPA lysis buffer 
freshly supplemented with complete protease inhibitor cocktail and 5 mM sodium 
orthovanadate. The lysates were incubated on ice for 10 minutes and vortexed 
briefly before centrifuging at 14,000 rpm at 4 °C for 20 minutes. The supernatant 
was transferred into fresh tubes for immediate immunoprecipitation.  
 
2.6.2 Co-immunoprecipitation 
Whole cell lysates obtained from transfected 293T cells were incubated with 
10 l of anti-FLAG M2 beads for 3 hours at 4 °C with constant rotation to allow 
binding of FLAG-tagged complexes to the beads. The beads were washed 4 times 
with 500 l of ice-cold RIPA lysis buffer before boiling the bound proteins in 
Laemmli buffer at 85C for 5 minutes. The proteins were then resolved on 
denaturing polyacrylamide gels for Western blot analysis.  
 
2.7 Western blot analysis 
2.7.1 SDS – Polyacrylamide gel electrophoresis (PAGE) and electrophoretic 
transfer 
SDS-containing simple gradient polyacrylamide gels were casted according 
to the following: (1) resolving gel consists of 10 – 15 % (v/v) acrylamide (40% 
acrylamide/bis solution, 29 : 1 (3.3 % cross-linker concentration) (BioRad), 0.375 
mM Tris-HCl (pH 8.8), 0.1 % (w/v) SDS, 0.0075 % (w/v) ammonium persulfate 
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(Sigma), and 0.05 % (v/v) N, N, N', N'-tetramethylethylenediamine (TEMED) 
(Sigma); (2) stacking gel consists of 5 % (v/v) acrylamide, 0.125 mM Tris-HCl (pH 
6.8), 0.1 % (w/v) SDS, 0.0075 % (w/v) ammonium persulfate and 0.08 % TEMED. 
Proteins from whole cell lysates of transfected cells and the corresponding co-
immunoprecipitates were separated in a discontinuous buffer system (25 mM 
Tris-base (1st Base), 0.19 M glycine (pH 8.3) (BioRad), 0.1 % (w/v) SDS) alongside 
the Precision Plus protein standards (All Blue) marker (BioRad) at 50 mA for 1 
hour using the Mini-PROTEAN 3 electrophoresis system (BioRad). After the 
proteins were sufficiently separated, they were electrophoretically transferred 
onto polyvinylidene fluoride Immobilon-P transfer membranes (Millipore) for 1 – 
1.5 hours at 100 V in the cold with a Mini Trans-Blot electrophoretic transfer cell 
(BioRad) in the presence of 1 × transfer buffer (33.7 mM Tris-HCl, 0.256 mM 
glycine, 20 % (v/v) methanol (Merck), 0.01 % (w/v) SDS).  
 
2.7.2 Western blot analysis of co-immunoprecipitates  
Following the transfer, the membranes were blocked for an hour at room 
temperature in blocking buffer (1 × PBST (1 × phosphate-buffered saline (PBS), 
0.1 % Tween 20 (Chemical Reagent)), 1 % BSA (Sigma)) with constant shaking. 
The membranes were then incubated with the polyclonal rabbit anti-HA (1:4000 
dilution in blocking buffer) (ZYMED, Cat # 71-5500) overnight at 4 °C with gentle 
shaking. To remove non-specifically-bound antibodies, the membranes were 
washed 3 times with 1 × PBST, with each wash lasting 5 minutes with agitation, 
before incubation with goat anti-rabbit IgG-peroxidase (1:2000 dilution in 1 × 
PBST) (Sigma Cat # A4914) at room temperature for an hour with shaking. The 
M.Sc Thesis  Chapter 2 Materials and Methods 
WONG Ming Zhi Denise (HT 080931 B) 
 70 
membranes were washed with 1 × PBST as before and visualized with the 
Supersignal West Pico chemiluminiscent substrate (Thermo Scientific) by 
exposure to either Fuji Super RX Blue medical X-Ray films (FUJIFILM Medical 
Systems, USA) or Kodak X-ray medical films (Eastman Kodak Company).  
To probe for levels of FLAG-tagged proteins, the membranes were washed 
three times with 1 × PBST to remove existing substrate before application of 
stripping buffer (25 mM glycine, 1 % SDS; adjusted to pH 2) for 4 minutes with 
shaking. After vigorous washing with 1 × PBST to remove residual buffer, the 
membrane was incubated with polyclonal rabbit anti-FLAG (1:10,000 dilution in 
blocking buffer) (Sigma, Cat # F7425) overnight at 4°C with shaking. After 
washing and incubation of secondary antibodies, the membranes were developed 
as above described.  
 
2.8 Analysis of pro-caspase levels by Western blot 
2.8.1 Preparation of whole cell lysates  
293T cells were seeded and transfected with 1 g of each construct in 6-well 
multi-dishes for 24 hours as outlined in section 2.3.1. For transfections of single 
constructs, 1 g of empty pXJ40-FLAG vector was co-transfected to maintain the 
amount of transfection reagent used across all the samples. Prior to cell lysis, 
media were drained and the cells were washed once with 1 × PBS before addition 
of 350 l 1 × sample loading buffer (67.5 mM Tris-HCl pH 6.8, 2 % (w/v) SDS, 15 
% (v/v) glycerol, 2.5 % (v/v) -mercaptoethanol, 0.005 % (w/v) bromophenol 
blue). After scraping the cells off the plate, the lysates were sonicated briefly 
under an amplitude setting of 20 % with the Sonicator XL2020 (Misonix 
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Incorporated) until lysate viscosity was sufficiently reduced. The lysates were then 
vortexed before heating at 85 C for 5 minutes.  
 
2.8.2 Western blot analysis 
The samples were loaded and separated on 10 % denaturing polyacrylamide 
gels and immobilized onto membranes as outlined in section 2.7.1. The 
membranes were then probed with the following primary antibodies diluted in 
blocking buffer overnight at 4 C : rabbit polyclonal anti-pro-caspase-3 (Cell 
Signaling Technology, Cat # 9662) (1: 1,000), rabbit polyclonal anti-pro-caspase-9 
(Cell Signaling Technology, Cat # 9502) (1: 1,000), mouse monoclonal anti-
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (Ambion, Cat # AM4300) (1: 
10,000) and mouse monoclonal anti-β-tubulin (Invitrogen Life Technologies, Cat # 
32-2600). Secondary antibodies used included goat anti-mouse IgG peroxidase 
(Sigma Cat # A4416) and goat anti-rabbit IgG peroxidase (Sigma Cat # A4914) 
(both 1: 2,000) that were incubated for an hour at room temperature. The 
proteins were detected by chemiluminiscence and developed on X-ray films as 
described previously (section 2.7.2). 
 
2.8.3 Statistical analysis 
To statistically evaluate the levels of pro-caspases in the differentially 
transfected cells, densitometry analysis of the developed X-ray films was first 
conducted using the gel analysis function embedded in the ImageJ software 
(available at http://rsb.info.nih.gov/ij; developed by Wayne Rasband, National 
Institutes of Health, Bethesda, MD). Briefly, a rectangular area was first selected 
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around a band of interest and applied to the other bands to be analyzed. After 
generating the profile plots, the size of the bands expressed as a percentage of the 
total size of all the measured bands was evaluated by the software and the values 
were tabulated in a spreadsheet. For every set of samples, the band intensities of 
pro-caspase-3 and pro-caspase-9 were normalized against the corresponding 
loading controls tubulin and GAPDH respectively before normalizing against the 
FLAG vector-transfected sample. The means of 3 sets of samples was then 
computed and the standard error was derived by dividing the standard deviation 
by the square root of the sample size. A two-tailed Student’s T-test with unequal 
variance was finally performed to assess the statistical significance (p-value) 
across pairs of samples (Microsoft Excel).   
 
2.9 Immunofluorescence studies 
2.9.1 Immunostaining 
HeLa cells were grown on uncoated glass coverslips and transfected with 0.5 
g of each construct for 24 hours as summarized above (section 2.3.2).  The media 
were then removed and substituted with pre-warmed (37 C) DMEM containing 
serum and the mitochondrial-specific dye MitoTracker® Red CMXRos (Molecular 
Probes, Cat # M7512) diluted to a final concentration of 100 nM. The cells were 
then incubated at 37 C for a further 20 minutes to allow incorporation of the dye. 
The cells were washed twice with pre-warmed 1 × PBS and twice with pre-
warmed 1 × PBSCM (1 × PBS, 1 mM CaCl2, 1 mM MgCl2) to remove excess dye 
before fixing with pre-warmed 1 × PBS (pH 7.4) containing 3.7 % 
paraformaldehyde (Sigma) at room temperature for 15 minutes. To quench the 
M.Sc Thesis  Chapter 2 Materials and Methods 
WONG Ming Zhi Denise (HT 080931 B) 
 73 
paraformaldehyde, the coverslips were washed twice with 1 × PBSCM, twice with 
1 × PBSCM containing 5 mM of ammonium chloride (Merck) and twice again with 
1 × PBSCM.  
The cells were subsequently permeabilized for 15 minutes at room 
temperature either with 1 × PBS containing 0.1 % saponin from Quillaja bark 
(Sigma) (for samples studying ANT2 mutants localization) or with 1 × PBS 
containing 0.2 % (v/v) Triton X-100 (for samples studying DLC1) before 
incubating with blocking buffer (1 × PBS, 2 % (w/v) BSA, 2 % defined fetal bovine 
serum) for 30 minutes at room temperature. The coverslips were then incubated 
face-down in 50 l of primary antibodies diluted in blocking buffer as follows: 
monoclonal mouse anti-FLAG M2, clone M2 (Sigma, Cat # F3165) (1:200), 
polyclonal rabbit anti-HA (ZYMED Cat # 71-5500) (1:100), mouse anti-Human 
DLC1 (BD Transduction Laboratories Cat # 612020) (1:200) and phalloidin, 
tetramethylrhodamine iso-thiocynate (TRITC) (Sigma, Cat # P1951) (1:200). After 
incubation for 3 – 5 hours at room temperature, the coverslips were washed face-
up for 3 times either in 1 × PBS containing 0.1 % saponin (for samples studying 
ANT2 mutants localization) or in 1 × PBS containing 0.1 % Triton X-100 (for 
samples studying DLC1) with each wash lasting 2 minutes with shaking. Next, the 
coverslips were incubated face-down in 50 l of fluorophore-conjugated 
secondary antibodies for an hour at room temperature as follows: AlexFluor488 
donkey anti-mouse IgG (Invitrogen Life Technologies, Cat # A21202), AlexFluor488 
donkey anti-rabbit IgG (Invitrogen Life Technologies, Cat # A21206), AlexFluor633 
goat anti-mouse IgG (Invitrogen Life Technologies, Cat # A21052), AlexFluor647 
donkey anti-rabbit IgG (Invitrogen Life Technologies, Cat # A31573) (all 1: 200 in 
blocking buffer). After washing as before for 5 times to remove unbound 
M.Sc Thesis  Chapter 2 Materials and Methods 
WONG Ming Zhi Denise (HT 080931 B) 
 74 
antibodies, the cells were mounted onto glass slides with FluorSave reagent 
(Calbiochem) and dried at room temperature overnight. The cells were then 
imaged under the EC Plan-Neofluar 40 ×/0.75 NA air and Plan-Apochromat          
63 ×/1.4 NA oil objective lens with the Axiovert 200M microscope attached to the 
Laser Scanning Microscopy (LSM) 510 Meta scan head (Carl Zeiss) using three 
excitation filters (argon 488 nm, helium neon 543 nm, helium neon 633). The 
captured images were merged using the LSM 510 software.   
 
2.9.2 Statistical analysis 
To assess the statistical significance of observed changes in MitoTracker® 
Red CMXRos fluorescence, 3 separate sets of samples were imaged as described 
above and scored for the absence of fluorescent signals emitted by excitation at 
543 nm in transfected cells. The mean of the 3 sets of samples was then computed 
and the standard error was derived by dividing the standard deviation by the 
square root of the sample size. A two-tailed Student’s T-test with unequal variance 
was finally performed to assess the statistical significance (p-value) across pairs of 
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3 Results  
3.1 Identification of ANT2 as a novel candidate DLC1 interacting partner  
DLC1 has been reported to perform both Rho GAP-dependent and Rho GAP-
independent cellular functions that is regulated by domains other than the Rho 
GAP domain by interaction with various protein and lipid partners. In order to 
better appreciate the mechanisms of DLC1-mediated tumorigenesis or to uncover 
novel DLC1 functions, a discovery-based proteomics pull-down approach was 
employed to identify candidate interacting protein partners of DLC1 in epithelial 
human embryonic kidney 293T cells (Figure 3.1). The 293T cell line was chosen as 
high transfection efficiencies can be achieved readily (Rio et al., 1985) such that a 
larger population of cells would express the bait DLC1 proteins to facilitate the 
capture of the endogenous pool of its interacting partner. In addition, 293T cells 
contain the Simian virus (SV)-40 Large T-antigen that would enable transfected 
plasmids containing the SV40 origin of replication to undergo episomal replication 
(Rio et al., 1985), thus further amplifying the expression of the bait protein for 
extended periods of time.  
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Figure 3.1 Proteomics pull-down to identify candidate DLC1 interacting 
partners. FLAG-tagged DLC1 bait proteins were expressed in 293T cells. Whole 
cell lysates containing the FLAG-tagged DLC1 bait proteins in a complex with its 
interacting partners were subjected to a pull-down using anti-FLAG M2 beads. 
After extensive washing to remove non-specifically bound proteins, the protein 
complexes were separated by boiling in Laemlli buffer and resolved by 1-
dimensional (1-D) SDS-PAGE. Unique bands were excised for identification by 
MALDI-TOF mass spectrometric analysis.  
 
 
To isolate partners that interact with domains other that the SAM domain as 
identified previously in our lab (Zhong et al., 2009) as well as to avoid potential 
intra-molecular auto-inhibition of the SAM domain (Kim et al., 2008) that may 
affect the binding of candidate partners to DLC1, the FLAG-tagged DLC1-PGR 
construct containing the serine-rich region and GAP domain as well as the DLC1-C 
construct consisting of the START domain were individually overexpressed as bait 
proteins in 293T cells (Figure 3.2A). Endogenous proteins in these cells that 
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associated with the DLC1 bait proteins as a complex in vivo were then enriched by 
immunoprecipitation with anti-FLAG M2 beads for three hours to isolate partners 
that interact with DLC1 in a more transient manner. An overnight pull-down was 
also performed to capture partners that formed more stable and long-lived 
associations with DLC1. The overexpression of the FLAG-tagged DLC1-PGR and 
DLC1-C bait proteins was verified in the whole cell lysates by Western blot 
analysis using anti-FLAG antibodies (Figure 3.2B). Following stringent washing to 
remove proteins that were unspecifically bound to the FLAG-tagged DLC1 bait 
proteins, the protein complexes were separated by 1-dimensional SDS-PAGE and 
stained with PageBlueTM (Figure 3.2C) to enable the detection of low levels of 
proteins (5 – 500 ng) with a sensitivity comparable to that of silver staining while 
avoiding the problems associated with over staining gel bands.  
The overexpressed DLC1-PGR and DLC1-C bait proteins appeared as thick 
protein bands at the correct molecular weight (Figure 3.2C, yellow and blue 
arrows respectively), indicating that these FLAG-tagged proteins were indeed 
bound to the anti-FLAG M2 beads in the immunoprecipitates. Consistently, a band 
between 25 kDa and 37 kDa was uniquely observed in both three hour and 
overnight pull-down complexes from DLC1-transfected cells but not in 
immunoprecipitates from vector-transfected cells (Figure 3.2C, red arrows). After 
performing a MASCOT search with the MALDI-TOF mass spectrometric raw data 
(Figure 3.3 A – C) as a query against a human database, the protein band was 
identified to be 33 kDa ANT2 with a probability score of less than 0.05. The tryptic 
peptides derived from the mass spectrometric analysis was found to cover about 
20 % of the published ANT2 amino acid sequence (Figure 3.3D), thus giving 
further confidence that the protein band excised contained ANT2.  
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Figure 3.2 Identification of candidate DLC1 interacting partners. (A) 
Schematic diagram of the domain organization of full-length DLC1 and the bait 
DLC1 proteins (DLC1-PGR and DLC1-C) used in the pull-down. The amino acid 
residue numbers indicate the domain boundaries. (B) 293T cells were transfected 
separately with either the FLAG-tagged DLC1-PGR or DLC1-C or FLAG vector 
(VEC) for 24 hours. The cells were lysed in ice-cold RIPA buffer and the whole cell 
lysates pooled were separated by SDS-PAGE and probed with anti-FLAG 
antibodies. The thick bands are indicative of the overexpressed FLAG-tagged DLC1 
bait proteins while the other bands are non-specific. WCL, whole cell lysates; WB, 
western blotting. (C) The lysates were immunoprecipitated with anti-FLAG M2 
beads for 3 hours or overnight at 4 C and proteins were separated by SDS-PAGE 
before staining with PageBlue™ solution. Overexpressed DLC1-PGR (blue arrows) 
and DLC1-C (yellow arrows) were found in the pull-down complex. A unique band 
between 25 kDa and 37 kDa (red arrows) was consistently observed in both the 
three hour and overnight pull-down using lysates from DLC1-PGR and DLC1-C-
transfected cells but not from the FLAG-vector-transfected cells. M, protein 
marker; IP, immunoprecipitate. 
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Figure 3.3 Mass spectrometric analysis of a candidate DLC1 interacting 
protein. (A) MALDI-TOF spectrum of the in-gel tryptic digest of a candidate 
protein isolated from overnight pull-down complexes from DLC1-transfected cells. 
(B) Mass assignments of the peaks identified in the mass spectrum. (C) Mass error 
of the assigned peaks. (D) The primary amino acid sequence of human ANT2 
(GenBank accession number: NP_001143). The amino acid stretches highlighted in 
red were those matched to the tryptic peptides identified by MALDI TOF mass 
spectrometry from the excised band and covers approximately 20 % of the entire 
ANT2 sequence. 
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As there are four known human isoforms of ANTs that have high amino acid 
sequence identity and somewhat overlapping expression profiles, the amino acid 
sequences of all the isoforms were compared against each other and to the tryptic 
peptides identified by mass spectrometry using the CLUSTALW2 multiple 
sequence alignment program to verify that it was truly the ANT2 isoform that was 
pulled-down by DLC1 (Figure 3.4). Two of the peptide sequences identified were 
uniquely found in the human ANT2 isoform and not in the other isoforms, 
suggesting that it was indeed this isoform that was isolated as a potential 
interacting partner of DLC1 in 293T cells.  
 
Figure 3.4 Primary amino acid sequence alignment of the four human ANT 
isoforms by ClustalW2 (available at: 
http://www.ebi.ac.uk/Tools/clustalw2/index.html). Identical residues in all the 
four isoforms are denoted by the asterisk (*) while (.) and (:) are indicative of 
conserved substitutions. The peptides that were matched to those obtained from 
mass spectrometric data are underlined in red and sequences that discriminate 
ANT2 from the other three isoforms are further highlighted in yellow. ANT1 
(GenBank accession number: NP_001142), ANT2 (GenBank accession number: 
NP_001143), ANT3 (GenBank accession number: NP_001627) and ANT4 (GenBank 
accession number: NP_112581).   
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3.2 Cloning of ANT2 constructs  
In order to validate the interaction between DLC1 and ANT2 as well as for 
further molecular analysis, the ANT2 constructs were cloned into mammalian 
expression vectors, pXJ40-FLAG and pXJ40-HA, which would enable the 
production of these proteins as a fusion with the FLAG epitope (DYKDDDDK) and 
hemagglutinin epitope (YPYDVPDYA) respectively at the N-terminal end.  
 
3.2.1 Cloning of full-length ANT2  
Primers for amplifying the human ANT2-FL cDNA from total cDNA library of 
293T cells were designed to contain the Xho I restriction site on the 5’ end of the 
amplified fragment and Xma I restriction site on the 3’ end. Evidently from Figure 
3.5A, the 894 bp ANT2-FL cDNA was successfully amplified by PCR at all the 
annealing temperatures tested, albeit more efficiently at 50 C and 56 C (lanes 2 
and 4). The ANT2-FL cDNA was then cloned into the pGEM®-T Easy vector and 
subsequently released by restriction digest (Figure 3.5B, lanes 4 and 6) with the 
restriction sites for cloning into the expression vectors.  The presence of the 
ANT2-FL cDNA insert in expression vectors was confirmed by restriction digest 
analysis (Figure 3.5C). The clones were then sequenced and verified that the 
plasmids contained no mutations and were in frame with the vector sequences.  
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Figure 3.5 Molecular cloning of human ANT2-FL cDNA into pXJ40-FLAG 
expression vectors. These gel photos were taken during the cloning of FLAG-
ANT2. HA-ANT2 was cloned in a similar manner. (A) Gradient PCR amplification 
of ANT2-FL cDNA amplified from total cDNA of 293T cells at temperatures 50 –  
65 C. The amplification products were resolved on a 1 % agarose gel containing 
SYBR®Safe and visualized under UVR. The size of ANT2-FL cDNA is indicated. M, 1 
kb DNA marker. (B) Restriction digests of the recombinant pGEM®-T Easy 
plasmids (pGEMT-ANT2#1 – 4) with Xho I and Xma I. The digested fragments from 
each recombinant plasmid were resolved on a 1 % agarose gel containing 
SYBR®Safe and visualized under UVR. Only clone #2 and #4 contained the 864 bp 
ANT2-FL cDNA insert. The 3kb fragment represents the linearized pGEM®-T Easy 
vector. M, 1 kb DNA marker.  (C) Two putative FLAG-ANT2-FL clones were 
digested with Xho I and Xma I to release the 864 bp ANT2-FL cDNA insert and 4.2 
kb linearized pXJ40-FLAG vector that was resolved on a 1 % agarose gel 
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3.2.2 Cloning of ANT2 domain truncation mutants  
Truncation mutants of human ANT2 were generated to study the functional 
domains of ANT2 and for use in binding studies to identify motifs responsible for 
mediating binding to DLC1. Human ANT2 comprises of three annotated conserved 
domains, named here as ANT2-N, ANT2-M and ANT2-C, of about 100 amino acids 
each that bear similarity to the members of the mitochondrial carrier superfamily 
of proteins (Figure 3.6A). To clone these domains into pXJ40-FLAG vectors, the 
previously cloned FLAG-ANT2-FL construct was used as a template in a gradient 
PCR to amplify these cDNA fragments (Figure 3.6B) before further cloning into 
pGEM®-T Easy vectors. Following the release of the cDNA inserts by restriction 
digest (Figure 3.6C) and subsequent cloning into pXJ40-FLAG expression vectors, 
colony screening using insert-specific primers verified the presence of the 360 bp 
ANT2-N (Figure 3.6D, left panel, lanes 3, 6, 7 and 8), 255 bp ANT2-M (Figure 3.6D, 
left panel, lanes 10 – 12, 14, and 16 – 17) and 279 bp ANT2-C (Figure 3.6D, right 
panel, lanes 2, 3 and 6 – 9). These positive clones were then validated by DNA 
sequencing to be mutation-free.  
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Figure 3.6 Molecular cloning of human ANT2 domain truncation mutants 
into pXJ40-FLAG vectors. (A) Schematic representation of human full-length 
ANT2 showing its three conserved domains as solid or shaded boxes and the 
domain truncation mutants generated in this study. The amino acid numbers 
indicate the domain boundaries. (B) Gradient PCR was performed at 50 C, 54 C 
and 60 C using pXJ40-FLAG-ANT2-FL as a template to amplify the ANT2-N (360 
bp), ANT2-M (255 bp) and ANT2-C (279 bp) cDNA. The amplification products 
were resolved on a 1 % agarose gel containing SYBR®Safe and visualized under 
UVR. M, 1 kb DNA marker. (C) Restriction digests of the recombinant pGEM®-T 
Easy plasmids with Xho I and Xma I. The digested fragments from each 
recombinant plasmid were separated on a 1 % agarose gel containing SYBR®Safe 
and visualized under UVR. The 3kb fragment represents the linearized pGEM®-T 
Easy vector while the bands between 250 bp and 500 bp are indicative of the 
ANT2 domain inserts. M, 1 kb DNA marker.  (D) PCR colony screening using 
insert-specific primers validated the presence of the ANT2-N (left panel), ANT2-M 
(left panel) and ANT2-C (right panel) after separation on a 1 % agarose gel 
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3.2.3 Cloning of ANT2 deletion mutants  
 To further characterize ANT2 and define binding motifs required for 
interaction with DLC1, FLAG-tagged internal deletion mutants of human ANT2 
were created based on information gathered from multiple sequence alignments 
and secondary structure predictions. The multiple sequence alignments generated 
by ClustalW2 were further refined and stretches of sequences that were well 
conserved in the three domains (N2, N3, N4, C1, C2 and C3) were chosen 
for deletion (Figure 3.7A). N1, a region that bears the least similarity across the 
three conserved domains was also selected for deletion. In addition, secondary 
structure prediction using the Network Protein Sequence Analysis (NPS@) 
program, that incorporates ten secondary structure prediction methods (Combet 
et al., 2000) to generate a consensus prediction, was employed to ensure that 
these deletions did not disrupt any major secondary structures such as -helices 
and -sheets (Figure 3.7B).  It should be noted that the ANT-M mutant was 
cloned after preliminary studies suggested that the ANT2-M region was a binding 
site for DLC1 and was designed for use in later functional studies.   
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Figure 3.7 Amino acid sequence analysis of human ANT2. (A) The multiple 
sequence alignment of the three conserved mitochondria carrier superfamily 
domains in ANT2 as generated by ClustalW2 (available at: 
http://www.ebi.ac.uk/Tools/clustalw2/) was refined to minimize gaps in the 
sequences. (B) The secondary structure of ANT2 as predicted by the NPS@ 
consensus secondary structure prediction web server (available at: http://npsa-
pbil.ibcp.fr/). c indicates areas predicted to fold as -sheets while h indicates 
stretches of residues predicted to fold as -helices. The regions deleted are 
highlighted as follows: N1 (yellow), N2 (green), N3 (cyan), N4 (magenta), 
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To clone the FLAG-tagged internal deletion mutants (M, N2, N3, N4, 
C1 and C2) (Figure 3.8A), primers with blunt-end Eco RV sites flanking the 
deletion sites were used to amplify the FLAG-ANT2-FL construct to generate 
mutants with the requisite sequences deleted (Figure 3.8B). Following ligation, 
PCR colony screening validated the presence of the M (lanes 1 – 3), N2 (lanes 5 
and 6), N3 (lanes 7 – 9) N4 (lanes 10 and 11), C1 (lanes 13 and 15) and C2 
inserts (lanes 16 and 18) in clones that were successfully ligated, as indicated by 
the strong bands observed (Figure 3.8C). These clones were then validated to be 
mutation-free by DNA sequencing. Separately, the N1 and C3 cDNA was cloned 
by first amplifying the inserts by PCR (Figure 3.8D) before cloning into pGEM®-T 
Easy vectors. The inserts were then released by restriction digest with Xho I and 
Xma I (Figure 3.8E) and subsequently cloned into pXJ40-FLAG vectors before 
verification of the sequences by DNA sequencing.  
M.Sc Thesis  Chapter 3 Results 
WONG Ming Zhi Denise (HT 080931 B) 
 88 
 
Figure 3.8 Molecular cloning of human ANT2 internal deletion mutants into 
pXJ40-FLAG vectors. (A) Schematic representation of ANT2-FL and the deletion 
mutants generated. The amino acid numbers indicate the domain boundaries. (B) 
PCR amplification of internally deleted ANT2 constructs using FLAG-ANT2-FL as a 
template. The amplification products were resolved on a 1 % agarose gel 
containing SYBR®Safe and visualized under UVR. M, 1 kb DNA marker. (C) PCR 
colony screening using insert-specific primers validated the presence of the M, 
N2, N3, N4, C1 and C2 inserts after separation on a 1 % agarose gel 
containing SYBR®Safe and visualization under UVR. M, 1 kb DNA marker. (D) The 
PCR amplified N1 and N3 inserts were resolved on a 1 % agarose gel containing 
SYBR®Safe and visualized under UVR. (E) Restriction digests of the recombinant 
pGEM®-T Easy plasmids with Xho I and Xma I. The digested fragments from each 
recombinant plasmid were separated on a 1 % agarose gel containing SYBR®Safe 
and visualized under UVR. The 3kb fragment is representative of the linearized 
pGEM®-T Easy vector while the approximately 900 bp bands are indicative of the 
N1 and N3 inserts. M, 1 kb DNA marker.   
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3.3 ANT2 is a bona fide DLC1 interacting partner in vivo 
To validate that ANT2 was not spuriously pulled-down by DLC1 and is a true 
interacting partner of DLC1 in vivo, FLAG-tagged ANT2-FL and HA-tagged DLC1-FL 
were co-expressed in 293T cells and co-immunoprecipitation studies were carried 
out to determine if DLC1 could be pulled-down by ANT2. Whole cell lysates were 
analyzed by Western blot to ensure that the proteins were expressed (Figure 3.9B, 
left panel). Evidently, both HA-tagged DLC1-PGR and DLC1-C were co-
immunoprecipitated with FLAG-tagged ANT2-FL (Figure 3.9B, right panel, lanes 2 
and 3). However, when FLAG-tagged ANT2-FL was not present, HA-tagged DLC1-
PGR and DLC1-C were not enriched in the co-immunoprecipitate (Figure 3.9B, 
right panel, lanes 5 and 6) even though they were well expressed (Figure 3.9B, left 
panel, lanes 5 and 6), indicating that no non-specific binding of the HA-tagged 
DLC1 proteins to the anti-FLAG M2 beads occurred. This recapitulated the 
proteomics pull-down data (section 3.1) in which endogenous ANT2-FL was 
pulled-down by FLAG-tagged DLC1-PGR and DLC1-C.  
More importantly, overexpressed HA-tagged DLC1-FL was 
immunoprecipitated only when FLAG-tagged ANT2-FL was expressed (Figure 
3.9B, right panel, lanes 1 and 4). This indicates that ANT2 interacted specifically 
with full-length DLC1 in vivo as a physiological complex and thus further 
corroborates that ANT2 is an interacting partner for DLC1. Reciprocal co-
immunoprecipitations to confirm that HA-tagged ANT2-FL could be 
immunoprecipitated with FLAG-tagged DLC1 could not be carried out, as the 
extraction of soluble HA-tagged ANT2-FL was less efficient, resulting in protein 
levels that were too weak to be detectable in whole cell lysates and 
immunoprecipitates (data not shown).  
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Figure 3.9 Full-length ANT2 interacted specifically with DLC1 in vivo. (A) 
Schematic diagram showing the domain organization of full-length DLC1 and its 
domain truncation constructs used in the co-immunoprecipitation. (B) 293T cells 
were transfected with HA-tagged DLC1 constructs in the presence/absence 
(indicated by + and – respectively) of FLAG-tagged ANT2-FL for 24 hours and the 
lysates collected were subject to immunoprecipitation with anti-FLAG M2 beads 
for 3 hours. The whole cell lysates and proteins immunoprecipitated with the M2 
beads were separated by SDS-PAGE, blotted and probed with anti-HA antibodies 
before stripping and re-probing with anti-FLAG antibodies. DLC1-FL, DLC1-PGR 
and DLC1-C were well expressed and specifically bound to ANT2-FL. These 
proteins did not display any non-specific binding to the M2 beads alone. The blot 
is representative of the results obtained from three independent repeats. WCL, 
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Next, the subcellular localization of overexpressed DLC1 and ANT2 in HeLa 
cells was studied using confocal immunofluorescence microscopy, as proteins that 
form interacting complexes are likely to be found in the same subcellular 
compartments to carry out related functions. Overexpression of DLC1 and ANT2 
was induced in HeLa cells as these cells have an extensive cytoplasmic area that 
makes them suitable for the analysis of protein localization in cytoplasmic 
structures. High levels of DLC1 overexpression that appeared as diffuse signals in 
the cytoplasm resulted in the characteristic morphological cell rounding (Figure 
3.10A and 3.10B, first panel) attributed in previous researches to the loss of actin 
cytoskeletal structures and dissolution of focal adhesions (Yuan et al., 2004; Kim 
et al., 2007; Guan et al., 2008; Liao et al., 2008). Consistent with previous literature 
(Kim et al., 2008), these DLC1-transfected cells also displayed cytoplasmic 
extensions (Figure 3.10A and 3.10B, first panel, yellow arrows). However, in cells 
that express lower levels of DLC1, DLC1 was localized to punctuated structures at 
the periphery of the cell, presumably focal adhesions, without any drastic 
morphological changes (Figure 3.10A and 3.10B, first panel, yellow arrowheads).  
ANT2, a known mitochondrial-resident protein, was largely localized to the 
mitochondria when overexpressed, as shown by the overlapped signals with the 
mitochondria-specific dye MitoTracker® Red CMXRos (hereon referred to as 
MitoTracker) (Figure 3.10C, fourth panel, bright pink signals) and did not appear 
to induce any morphological changes in transfected cells that still maintained the 
cuboidal morphology typical of HeLa cells (Figure 3.10C, last panel). In addition, 
the mitochondria of ANT2-transfected cells appeared filamentous and uniformly 
distributed in the cytoplasm (Figure 3.10C, second panel).  
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It was observed that certain DLC1 signals (green) overlapped with ANT2 
signals (pink) at distinct locations close to the cell edges in these selected cells 
(Figure 3.10A, fourth panel and inserts, white arrows). It also appeared that the 
expression of ANT2 could not revert any morphological changes in DLC1-
transfected cells (Figure 3.10A, first panel, yellow arrows) nor change the 
localization of DLC1 that was situated at the cell periphery (Figure 3.10A, first 
panel, yellow arrowheads). Although the partial co-localization could not be 
validated to have occurred at the mitochondria as the MitoTracker signals were 
not detectable at these sites, it was noted that in cells with high levels of DLC1 
expression, DLC1 signals seemingly were concentrated at areas where ANT2 was 
present (Figure 3.10A, fourth panel, white patches).  
Interestingly, the mitochondria in DLC1- and ANT2-transfected cells did not 
appear to be long and filamentous as in ANT2-transfected and untransfected cells 
but instead exhibited a segmented and swollen morphology with signals not 
uniformly present throughout the cytoplasm but were rather aggregated towards 
the shrinking cell body (Figure 3.10A, second panel, yellow arrows). This 
indicated that only a fraction of DLC1 partially co-localized with ANT2 in HeLa 
cells and preliminarily suggested that the co-expression of DLC1 and ANT2 may 
induce changes in mitochondrial morphology, thus further supporting the data 
obtained from the earlier co-immunoprecipitation analysis that ANT2 is a 
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Figure 3.10 DLC1 and ANT2 show partial co-localization in HeLa cells. (A, B 
and C) HeLa cells were transfected with either FLAG-tagged DLC1-FL, HA-tagged 
ANT2-FL or in combination as indicated for 24 hours. The cells were then fixed, 
permeabilized and protein expression was detected by staining with anti-DLC1 
(green) and anti-HA (magenta) antibodies followed by the appropriate 
fluorophore-conjugated secondary antibody. Mitochondria were visualized by 
staining with the mitochondria-specific dye MitoTracker. Representative fields of 
the cells were imaged at 63 × magnification with a confocal microscope. 
Differential interference contrast (DIC) images were simultaneously captured to 
show the morphology of the cells. Signals were merged and presented as overlaid 
staining (white or bright pink). (A) High levels of DLC1 expression induced cell 
rounding and cytoplasmic extensions (first panel, yellow arrows) while lower 
expression levels showed the localization of DLC1 to punctuated structures at the 
cell periphery (first panel, yellow arrowheads). Staining of ANT2 appeared to 
overlap with that of the MitoTracker staining patterns (second and third panel). 
Overexpressed DLC1-FL and ANT2-FL partially co-localized at distinct locations 
(fourth panel and inserts, white arrows) and mitochondria of DLC1- and ANT2-
transfected cells appeared swollen (second panel, yellow arrows). Bar, 20 m. (B) 
Similar staining patterns of DLC1 were observed in the absence of ANT2 with cell 
rounding and cytoplasmic extensions (first panel, yellow arrows) at high 
expression levels and punctuated structures at the cell periphery (first panel, 
yellow arrowheads) at low expression levels. (C) ANT2 was localized to the 
mitochondria in the absence of DLC1 as seen by the bright pink overlaid staining 
(fourth panel).  
 
 
3.4 DLC1 and ANT2 interact at distinct regions  
Having established ANT2 as a novel interacting partner of DLC1, co-
immunoprecipitation studies were next performed to identify DLC1-ANT2 binding 
sites in order to understand their mode of interaction and also to isolate such sites 
that can be deleted to completely abolish their interaction for functional analyses. 
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3.4.1 Serine-rich region and START domain of DLC1 mediates binding to 
ANT2 
Previously, the N- and C-termini of DLC1 was shown to interact with ANT2, 
suggesting that multiple sites on DLC1 may be responsible for mediating this 
interaction. To further delineate the regions on DLC1 involved in binding to ANT2, 
co-immunoprecipitation studies were employed using lysates from 293T cells 
transiently overexpressing FLAG-tagged ANT2-FL and various HA-tagged DLC1 
domain truncation mutants. Consistent with earlier data, DLC1-FL and DLC1-PGR 
were successfully immunoprecipitated by ANT2-FL (Figure 3.11, right panel, lanes 
1 and 2). Both DLC1-N and DLC1-P were also strongly bound to ANT2-FL as these 
proteins were markedly enriched in immunoprecipitates with FLAG-tagged ANT2-
FL (Figure 3.11, right panel, lanes 3 and 4). This suggests that the GAP domain of 
DLC1 was dispensable for mediating interaction to ANT2 since DLC1-N that has no 
GAP domain could bind to ANT2. In addition, as DLC1-P that has no SAM domain 
could also bind to ANT2, the SAM domain on DLC1 was also deduced to be 
dispensable for interaction with ANT2, indicating that the serine-rich region was 
the overall minimal region on the N-terminus of DLC1 exhibiting affinity for ANT2.  
This is further verified by co-immunoprecipitations showing that HA-tagged 
DLC1-SAM, DLC1-GR and DLC1-GAP could not be pulled-down by FLAG-tagged 
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Figure 3.11 The serine-rich region on DLC1 mediates interaction with ANT2. 
(A) Schematic diagram depicting the domain architecture of DLC1-FL and its N-
terminus domain truncation mutants used in the co-immunoprecipitation studies. 
(B) 293T cells were transfected with HA-tagged DLC1 constructs with or without 
(indicated by + or – respectively) FLAG-tagged ANT2-FL for 24 hours and the 
lysates collected were immunoprecipitated with anti-FLAG M2 beads for 3 hours. 
The whole cell lysates and proteins immunoprecipitated with the M2 beads were 
separated on a 10 % polyacrylamide gel, blotted and probed with anti-HA 
antibodies before stripping and re-probing with anti-FLAG antibodies. The blot on 
the right shows that all the transfected constructs was expressed after 24 hours. 
Full-length DLC1 and its N-terminus regions were specifically bound to ANT2-FL 
and were not non-specifically bound to the M2 beads. The blot is representative of 
at least three independent repeats. WCL, whole cell lysates; IP, 
immunoprecipitates; WB, Western blotting. 
 
 
Next, to map regions on the C-terminus of DLC1 that are required for binding 
to ANT2, co-immunoprecipitations were performed in a similar manner as 
described earlier. HA-tagged DLC1-C was consistently detected in the 
immunoprecipitates where FLAG-tagged ANT2-FL was expressed (Figure 3.12, 
right panel, lane 1). As HA-tagged DLC1-START but not DLC1-BGS that flanks the 
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GAP and START domain bound specifically to FLAG-tagged ANT2-FL (Figure 3.12, 
right panel, lanes 2 and 5), it appears that the START domain also represents the 




Figure 3.12 The START domain on DLC1 specifically binds to full-length 
ANT2. (A) Diagrammatic representation of the domain organization of DLC1-FL 
and its domain truncation mutants used in the co-immunoprecipitation studies. 
(B) 293T cells were either co-transfected with HA-tagged DLC1 constructs and 
FLAG-tagged ANT2-FL (indicated by +) or transfected with HA-tagged DLC1 
constructs alone for 24 hours. The cells were lysed in RIPA lysis buffer and 
incubated with anti-FLAG M2 beads for 3 hours. The whole cell lysates and 
proteins immunoprecipitated with the M2 beads were resolved on a 15 % 
reducing polyacrylamide gel, blotted and probed with anti-HA antibodies before 
stripping and probing with anti-FLAG antibodies. All the transfected constructs 
were expressed but only DLC1-C and DLC1-START were specifically 
immunoprecipitated by FLAG-tagged ANT2-FL. The blot shown is a typical blot 
acquired with at least three independent repeats. WCL, whole cell lysates; IP, 
immunoprecipitates; WB, Western blotting.  
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3.4.2 Identification of putative ANT2 binding motif on the serine-rich 
region of DLC1 
After validating that the serine-rich region contains key sites that enable 
ANT2 to bind to DLC1, various truncation mutants of this region that spans over 
500 amino acids were created and utilized in co-immunoprecipitation analyses to 
further define putative ANT2 binding motifs. As not all of the DLC1 constructs 
cloned could be expressed in the HA-tagged form, only those HA-tagged DLC1 
constructs with detectable levels of expression were used in the following 
analyses.  
Firstly, HA-tagged N-terminal serial truncation mutants of the DLC1-PGR 
construct containing the serine-rich region and GAP domain were co-
immunoprecipitated with FLAG-tagged ANT2-FL in 293T cells. It was found that 
DLC1 mutants harboring deletions of 100 amino acid stretches of the serine-rich 
region up to residues 501 (DLC1-PaGR, DLC1-PbGR and DLC1-PcGR) could still 
bind to ANT2-FL with similar affinity (Figure 3.13, right panel, lanes 1 – 3). 
However, when the region between residues 501 and 641 was further deleted in 
the DLC1-PdGR construct, the interaction with ANT2 was apparently abolished as 
the presence of the HA-tagged construct was not detected in the 
immunoprecipitate (Figure 3.13, right panel, lane 4) even though it was strongly 
expressed (Figure 3.13, left panel, lane 4). This indicates that the region between 
residues 501 – 641 constitutes a possible binding site on DLC1 for ANT2.  
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Figure 3.13 The region between residues 501 and 641 on DLC1 facilitates 
binding to ANT2. (A) Schematic diagram of the DLC1-PGR domain truncation 
mutants used in the co-immunoprecipitation studies. The amino acid residue 
numbers indicate the domain boundaries. (B) 293T cells were transfected with 
HA-tagged DLC1 constructs with or without (indicated by + and – respectively) 
FLAG-tagged ANT2-FL for 24 hours. The whole cell lysates were then 
immunoprecipitated with anti-FLAG M2 beads for 3 hours. Whole cell lysates and 
proteins immunoprecipitated with the M2 beads were separated by SDS-PAGE, 
blotted and probed with anti-HA antibodies before stripping and re-probing with 
anti-FLAG antibodies. The transfected constructs were expressed as seen from the 
left panel. DLC-PdGR did not display any binding affinity to ANT-FL. This blot is 
representative of the results obtained from three independent repeats. WCL, 
whole cell lysates; IP, immunoprecipitates; WB, Western blotting.  
 
 
Further co-immunoprecipitation analyses revealed that another site on the 
N-terminal serine-rich region of DLC1 was also involved in binding to ANT2. From 
Figure 3.14A (right panel, lanes 1, 2 and 4), HA-tagged DLC1-P1 and DLC1-SP1-1 
but not HA-tagged DLC1-P2 were found to bind to FLAG-tagged ANT2-FL that was 
captured by the M2 beads. This suggests that a region between residues 77 and 
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170 also contained binding sites for ANT2 since the SAM domain of DLC1 was 
earlier determined to be non-essential for ANT2 binding. In addition, consistent 
with earlier data, the region between residues 485 and 650 of DLC1 was necessary 
for binding to ANT2 as HA-tagged DLC1-P3 and DLC1-P23 was 
immunoprecipitated by FLAG-tagged ANT2-FL (Figure 3.14A, right panel, lane 3 
and Figure 3.14B, right panel, lane 3).  
Interestingly, while DLC1-P1-2 and DLC1-P1-3 were found not to bind to 
ANT2 (Figure 3.14B, right panel, lanes 1 and 2), DLC1-P1-23 and DLC1-P1-3P2-1 
that are longer truncations containing regions DLC1-P1-2 and DLC1-P1-3 
respectively, interacted specifically with ANT2 (Figure 3.14C, right panel, lanes 1 
and 2). This could possibly be due to cooperative folding of distant residues to 
present surfaces for binding to ANT2. As such, in the absence of such residues in 
the DLC1-P1-2 and DLC1-P1-3 mutants, binding surfaces for ANT2 could not be 
formed. It was also observed that the region containing residues 301 – 400 was 
not required for binding ANT2, as HA-tagged DLC1-NP2-1 was not 
immunoprecipitated by ANT2 (Figure 3.14C, right panel, lane 3).  
Thus, it appears that even on the serine-rich region, there exist multiple 
binding sites (a. a. 76 – 301 and a. a. 501 – 641) that mediate the interaction 
between DLC1 and ANT2 such that deletion of a single site in the full-length DLC1 
may not be sufficient to completely abolish binding to ANT2. These results 
obtained from co-immunoprecipitation studies with DLC1 mutants also suggest 
that definition of ANT2 binding motifs to a few amino acids specificity would be an 
extremely daunting task without the aid of structural data as not all the constructs 
are expressed well and known to fold correctly especially if distant residues are 
also requisite for the formation of proper binding sites.   
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Figure 3.14 Region between residues 76 – 301 also mediates DLC1 binding to 
ANT2. (A, C and E) Schematic representation of the domain architecture of DLC1-
FL and its domain truncation mutation used in the co-immunoprecipitation 
studies. The amino acid numbers indicate the domain boundaries (B, D and F) 
293T cells were transfected with HA-tagged DLC1 constructs in the 
presence/absence (indicated by + and – respectively) of FLAG-tagged ANT2-FL for 
24 hours and the lysates collected were immunoprecipitated with anti-FLAG M2 
beads for 3 hours. The whole cell lysates and proteins immunoprecipitated with 
the M2 beads were separated by SDS-PAGE, blotted and probed with anti-HA 
antibodies before stripping and re-probing with anti-FLAG antibodies. The blots 
shown are representative of results obtained with at least three independent 
repeats. (B) DLC1-P1, DLC1-P3 and DLC1-SP1-1 bound specifically to ANT2. (D) 
DLC1-P23 but not DLC1-P1-2 and DLC1-P1-3 interacted with ANT2. (F) DLC1-P1-
23 and DLC1-P1-3P2-1 displayed strong binding affinity for ANT2 while DLC1-
NP2-1 was not enriched in the immunoprecipitate containing FLAG-tagged ANT2-
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3.4.3 M domain of ANT2 mediates binding to DLC1 
Separately, to determine the regions on ANT2 that facilitate the interaction 
with DLC1, FLAG-tagged ANT2-FL and its domain truncation and internal deletion 
mutants were individually co-expressed with HA-tagged full-length DLC1 and 
their binding was analyzed by co-immunoprecipitation. As expected, full-length 
DLC1 was captured by FLAG-tagged ANT2-FL (Figure 3.15, right panel, lane 1). 
This binding was once again shown to be specific, as HA-tagged DLC1 was not 
enriched in the immunoprecipitate when FLAG-tagged ANT2 was absent (Figure 
3.15, right panel, lane 5). More importantly, out of the three homologous domains 
of ANT2, the N- and C-terminal domains did not bind to DLC1 (Figure 3.15, right 
panel, lanes 2 and 4) even though they were successfully captured by the M2 
beads, while DLC1 was successfully pulled-down by ANT2-M.  
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Figure 3.15 ANT2-M mediates binding of ANT2 to DLC1. (A) Diagrammatic 
representation of the domain architecture of ANT2-FL and its domain truncation 
mutation used in the co-immunoprecipitation studies. (B) 293T cells were co-
transfected with HA-tagged DLC1-FL constructs with FLAG-tagged ANT2 
constructs for 24 hours and the lysates collected were immunoprecipitated with 
anti-FLAG M2 beads for 3 hours. As a negative control, HA-tagged DLC1-FL was 
expressed in the absence of ANT2 proteins. The whole cell lysates and proteins 
immunoprecipitated with the M2 beads were resolved by SDS-PAGE, blotted and 
probed with anti-HA and anti-FLAG antibodies. The blots shown are 
representative of results obtained from at least three independent repeats. The 
constructs were expressed and enriched by the M2 beads in the IP. HA-tagged 
DLC1-FL was strongly pulled-down by FLAG-tagged ANT2-FL, ANT2-M and ANT2-
MC but not by ANT2-N and ANT2-C. WCL, whole cell lysates; IP, 
immunoprecipitates; WB, Western blotting.  
 
 
Additional binding studies with FLAG-tagged ANT2 deletion mutants 
revealed that deletion of any small stretches of sequences on the N- and C-
terminal domains of ANT2 did not affect the specific binding with DLC1 (Figure 
3.16, right panel, lanes 1 – 7), thus further substantiating that there are no 
additional sequences on these regions that are involved in mediating the binding 
of ANT2 to DLC1. Only deletion of the M domain on ANT2 was able to completely 
abolish any affinity with DLC1 (Figure 3.16, right panel, lane 8). This further 
validated that the M domain is the minimal region on ANT2 that was necessary 
and sufficient for interaction with DLC1.  
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Figure 3.16 Deletion of the M region of ANT2 abolishes the binding of ANT2 
to DLC1. (A) Diagram depicting the domain organization of ANT2-FL and its 
deletion mutants used in the co-immunoprecipitation studies. The amino acid 
numbers indicate the boundaries (B) 293T cells were co-transfected with HA-
tagged DLC1-FL constructs with FLAG-tagged ANT2 constructs for 24 hours and 
the lysates collected were immunoprecipitated with anti-FLAG M2 beads for 3 
hours. As a negative control, HA-tagged DLC1-FL was singly transfected. The 
whole cell lysates and proteins immunoprecipitated by the M2 beads were 
resolved by SDS-PAGE, blotted and probed with anti-HA and anti-FLAG antibodies. 
The blots shown are consistent with results obtained from at least three 
independent repeats. The expression of all the FLAG-tagged constructs was 
verified by enrichment of these proteins by the M2 beads in the 
immunoprecipitate. Deletion of stretches of conserved sequences on the N- and C-
terminal of ANT2 did not affect the ability to bind to DLC1. Only deletion of the M 
region on ANT2 could completely obliterate binding to DLC1. WCL, whole cell 
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3.5 DLC1-ANT2 co-expression did not affect levels of pro-caspase-3 or pro-
caspase-9 in 293T cells 
DLC1 and ANT2 have previously been separately implicated in caspase-
dependent apoptosis (Yuan et al., 2007; Jang et al., 2008). To investigate if the 
overexpression of both proteins co-ordinately affects apoptosis, wild-type DLC1 
and its GAP-inactive mutant (R677E) were co-expressed with ANT2 in 293T cells 
where ANT2 was initially isolated as a candidate DLC1 binding partner. The 
lysates were then analyzed by Western blot to ascertain any changes in the 
expression levels of well-characterized apoptosis markers pro-caspase-3 and pro-
caspase-9 after 24 hours.  
The single expression of wild-type DLC1 and its GAP-inactive mutant alone 
did not appear to reduce the global levels of pro-caspase-3 or pro-caspase-9, 
which are indicative of apoptosis, (Figures 3.17A and 3.18A, second panel, lanes 2 
and 6) compared to the levels in vector-transfected control cells after 24 hours 
(Figures 3.17A and 3.18A, second panel, lane 4). When normalized against the 
respective loading controls α–tubulin or GAPDH, there was no statistically 
significant change in the amounts of the two apoptotic markers among the single 
DLC1-transfected and vector-transfected control cells (Figure 3.17B and Figure 
3.18B). Similarly, the expression of ANT2 alone also did not significantly change 
the overall levels of pro-caspase-3 or pro-caspase-9 with respect to that in vector-
transfected control cells (Figures 3.17A and 3.18A, second panel, lane 3; Figures 
3.17B and Figures 3.18B). 
More critically, the co-expression of wild-type or GAP-inactive DLC1 with 
ANT2 did not affect the expression levels of pro-caspase-3 or pro-caspase-9 
(Figures 3.17A and 3.18A, second panel, lanes 1 and 5) when evaluated against the 
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levels in control cells or singly-transfected cells. Any change in the levels of the 
apoptotic markers in the DLC1-ANT2-transfected cells when assessed to that in 
the vector-transfected control cells were found not to be statistically significant 
(Figure 3.17B and Figure 3.18B). This suggests that overexpression of both GAP-
active or GAP-inactive DLC1 together with ANT2 did not mediate caspase-
dependent apoptosis in 293T cells after 24 hours.  
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Figure 3.17 Expression of DLC1 with ANT2 did not reduce pro-caspase-3 
levels in 293T cells. (A and B) 293T cells were transfected for 24 hours with the 
indicated constructs and whole cell lysates were collected after 24 hours. Proteins 
were separated by SDS-PAGE, blotted and the appropriate antibodies were used to 
probe for the levels of the proteins of interest. (A) -tubulin was used as loading 
control to show equivalent amounts of total protein analyzed across all the 
samples while -FLAG blots indicate that the transfected constructs were 
correctly expressed. Concurrent wild-type (wt) or GAP-inactive (R677E) DLC1 and 
ANT2 expression did not affect the levels of pro-caspase-3 compared to the 
control. The blots shown are representative of that obtained from three 
independent repeats. WCL, whole cell lysates; WB, Western blotting. (B) The 
percentage signal intensities from each sample on three independent blots (n = 3) 
were quantified by the Image J software and the average obtained is represented 
in the graph above along with the standard errors as relative intensities against 
the vector control. The differences in levels of pro-caspase-3 across all the 
samples were found not to be significant (p > 0.05) after performing statistical 
analysis by Student’s T-test with unequal variance for unpaired samples.   
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Figure 3.18 Expression of DLC1 with ANT2 did not affect pro-caspase-9 
levels in 293T cells. (A and B) 293T cells were transfected for 24 hours with the 
various constructs as indicated and whole cell lysates were harvested after 24 
hours. Proteins were resolved by SDS-PAGE, blotted and the appropriate 
antibodies were used to probe for the levels of the proteins indicated. (A) -
tubulin was probed as a loading control to show equivalent amounts of total 
protein analyzed across all the samples while blots were probed with -FLAG to 
show levels of transfected proteins expressed. Wild-type (wt) or GAP-inactive 
(R677E) DLC1 and ANT2 co-expression did not affect the levels of pro-caspase-3 
compared to the control. The blots shown are representative of results obtained 
from three independent repeats. WCL, whole cell lysates; WB, Western blotting. 
(B) The percentage signal intensities from each were quantified by the Image J 
software and the average of each sample from three independent blots (n = 3) 
obtained is represented in the graph above together with the standard errors as 
relative intensities against the vector control. The differences in levels of pro-
caspase-9 across all the samples were found not to be significant (p > 0.05) after 




3.6 DLC1 interacts with ANT2 to reduce mitochondrial membrane 
potential (Ψm) in HeLa cells in a GAP-independent manner 
ANT2 functions to maintain the mitochondrial membrane potential (Ψm) and 
hence regulates the exchange of metabolites between the cytosol and 
mitochondria (Vieira et al., 2000). To investigate the possible effect of DLC1 
overexpression on Ψm in a background of ANT2 overexpression, transfected HeLa 
cells were scored for a total loss of MitoTracker fluorescence as a read-out of the 
loss of Ψm. To ensure that the amount of transfection reagent used did not 
confound the results obtained by introducing cytotoxicity and corresponding loss 
of Ψm not associated with the expression of the proteins, all of the cells including 
that of the vector-transfected controls were transfected with an equal amount of 
plasmid and transfection reagent. As MitoTracker is only taken up and retained in 
live cells with a high Ψm and washed out of cells that have lost Ψm, it has been 
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shown to be a suitable fluorescent probe for monitoring changes in Ψm 
(Pendergrass et al., 2004).  
Overexpression of wild-type DLC1 alone was also able to induce loss of 
MitoTracker fluorescence in some cells (Figure 3.19A, last panel, second row 
white arrows) and the percentage of transfected cells that exhibited this loss of Ψm 
was significantly greater than in the vector-transfected control (Figure 3.19B). 
This may be attributed to the inherent Ψm-disrupting effect of overexpressed wild-
type DLC1 and possibly also as a result of the interaction of DLC1 with 
endogenous ANT2 present in cells. Similarly, overexpression of ANT2 alone was 
associated with an absence of MitoTracker fluorescence in some cells (Figure 
3.19A, last panel, fifth row white arrows) with a significantly greater number of 
cells displaying this loss of Ψm as compared to the vector-transfected control cells 
(Figure 3.19B). This could again likely be due to the effects of overexpressed ANT2 
acting alone to disrupt Ψm or acting in combination with endogenous DLC1 in the 
cells.  
Cells that co-expressed wild-type DLC1 with ANT2 were observed to exhibit 
characteristic cell rounding and also loss of MitoTracker fluorescence (Figure 
3.19A, first row, last panel white arrows). Although there were rounded cells that 
co-expressed both constructs and had normal MitoTracker staining, the co-
expression of wild-type DLC1 with ANT2 was found to significantly increase the 
percentage of transfected cells with loss of Ψm when compared to vector-
transfected cells (Figure 3.19B). It should be noted that in cells expressing wild-
type DLC1 at low levels that were insufficient to cause cell rounding, similar loss of 
MitoTracker fluorescence was also observed (Figure 3.19A, first row, last panel 
white arrowhead), suggesting that this collapse of Ψm also occurred even at low 
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levels of wild-type DLC1 expression as long as ANT2 was present. The loss of Ψm in 
double wild-type DLC1- and ANT2-transfected cells was also significant when 
compared to single wild-type DLC1-transfected and ANT2-transfected cells 
(Figure 3.19A). Together, these results suggest that the co-expression of DLC1 and 
ANT2 synergistically acts to result in the collapse of Ψm to an extent greater than 
when the proteins are individually expressed.  
It was also observed that the co-expression of the GAP-inactive DLC1 mutant 
with ANT2 could also reproduce the loss of MitoTracker staining without any 
characteristic GAP-induced cell rounding (Figure 3.19B, last panel, first row white 
arrows). The percentage of transfected cells with loss of Ψm was found to be 
significantly greater than vector-transfected cells and was comparable to the 
percentage scored when wild-type DLC1 was co-expressed with ANT2 (Figure 
3.19B). Single expression of GAP-inactive DLC1 mutant was also able to induce the 
loss of MitoTracker fluorescence in about 15 % of the transfected cells scored but 
not as effectively as when ANT2 was present (Figure 3.19B), although it was 
comparable to percentage of cells exhibiting fluorescence loss in wild-type-
transfected cells possibly due to its effects with endogenous ANT2. This suggests 
that the loss of Ψm mediated by the expression of DLC1 was independent of the 
GAP activity of DLC1 and markedly enhanced by the co-expression with ANT2.  
Aside from its application in monitoring changes in Ψm, MitoTracker can also 
be used to evaluate the morphology and integrity of the mitochondrial networks. 
Of interest, it was observed that in some DLC1-ANT2-transfected cells that had not 
completely loss MitoTracker fluorescence, the mitochondria did not appear to be 
typically filamentous (Figure 3.19A and Figure 3.19B, last panel, first row, yellow 
arrows) as in neigboring untransfected cells but were instead swollen and 
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segmented. This suggests that the mitochondrial PTPC may have been opened 
temporarily in these cells to allow the influx of water into the mitochondria that 
resulted in the profound swelling observed. It is possible that this population of 
cells represent those in which fluctuations in Ψm may lead to eventual loss of Ψm, 
with associated effects such as the irreversible opening of the mitochondrial PTPC 
and warrants further investigation.  
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Figure 3.19 Co-expression of DLC1 with ANT2 was associated with loss of 
MitoTracker fluorescence. (A, B and C) HeLa cells were transfected with the 
FLAG-tagged DLC1 and HA-tagged ANT2 constructs indicated for 24 hours. The 
cells were then fixed, permeabilized and protein expression was detected by 
staining with anti-DLC1 (green) and anti-HA (magenta) antibodies followed by the 
appropriate fluorophore-conjugated secondary antibody. The Ψm-sensitive dye 
MitoTracker was used to score for transfected cells with absence of fluorescence. 
Representative fields of the cells were imaged at 63 × magnification with a 
confocal microscope under the same intensity settings. Signals were merged to 
score for transfected cells that had lost MitoTracker fluorescence. (A and B) Co-
expression of wild-type and GAP-inactive DLC1 together with ANT2 induced the 
loss of Ψm to an extent greater than when wild-type or GAP-inactive DLC1 or ANT2 
was singly expressed. White arrows point to cells that have completely lost 
MitoTracker fluorescence while yellow arrows point to cells that display swollen 
and segmented mitochondria. Bar, 20 m. (C) At least 100 transfected cells were 
scored for MitoTracker fluorescence per transfected construct and the number of 
cells that completely lost fluorescence were expressed as a percentage of total 
transfected cells. The percentages obtained from three independent experiments 
(n = 3) were averaged and represented in the graph alongside the standard errors. 
Statistical analysis using Student’s T-test for unpaired samples with unequal 
variance was used to determine if the differences in percentage were statistically 
significant. Bars denoted with different alphabets are statistically significant (p < 
0.05) with respect to each other while bars annotated with the same alphabets are 
not statistically significant (p > 0.05).  
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3.7 Biochemical characterization of ANT2  
ANT2 contains three internal repeats of about 100 amino acids each that are 
homologous to members of the mitochondrial carrier superfamily. As there are 
few studies to date that have characterized this particular human ANT2 isoform 
biochemically in relation to its functions, the individual domains were cloned and 
examined to gain further insights into the functions of ANT2 and its interaction 
with DLC1.  
 
3.7.1 ANT2 and its domains display distinct subcellular localizations and 
effects on mitochondrial morphology and Ψm 
The localization of overexpressed full-length ANT2 and its domains were 
examined by confocal immunofluorescence microscopy in HeLa cells. By software-
assisted analysis, a significant proportion of overexpressed ANT2-FL was found to 
be perfectly co-localized with the mitochondrial-specific dye MitoTracker (Figure 
3.20, first panel, third row, yellow overlaid staining), suggesting that 
overexpressed ANT2-FL was correctly targeted to the mitochondria in HeLa cells. 
It is pertinent to note that not all of the ANT2-FL signals overlapped with the 
MitoTracker signals although these signals also mostly appeared to be 
mitochondrial-like. Also, it was observed that not all of the mitochondria stained 
by MitoTracker were targeted by ANT2-FL. This indicates that some mitochondria 
in each of the transfected cells were not distributed with overexpressed ANT2-FL.  
The mitochondrial morphology of most of the cells transfected with ANT2-FL 
appeared to adopt a filamentous form and the staining pattern of MitoTracker was 
uniformly distributed in the cells as those in neighbouring untransfected cells and 
FLAG-vector-transfected cells (Figure 3.20, first panel, insert), which indicated 
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that overexpression of ANT2-FL did not induce any mitochondrial morphological 
changes in HeLa cells. 
The N- and C-terminal domains of ANT2, when overexpressed, were found to 
also display staining that co-localized with mitochondrial signals in some cells 
(Figure 3.20, second and fourth panel, third row, yellow overlaid staining). As with 
ANT2-FL, some of the ANT2-N and ANT2-C signals were not localized to the 
MitoTracker-stained mitochondria although they appeared to adopt a similar 
mitochondria-staining pattern. The mitochondria in these cells also appeared to 
be more swollen and globular instead of filamentous as observed in neighbouring 
untransfected cells (Figure 3.20, second and fourth panel, inserts). In addition, this 
mitochondrial-like staining of ANT2-N and ANT2-C were also observed in cells 
that had no MitoTracker staining, further indicating that the mitochondrial 
membrane potential were perturbed in these cells (Figure 3.20, second and fourth 
panel, inserts white arrows). This suggests that although the high levels of 
expression of ANT2-N and ANT2-C retained the mitochondrial localization of 
these proteins in HeLa cells, they may have perturbed the Ψm and hence 
mitochondrial permeability.  
Analysis of the M domain of ANT2 alone revealed that ANT2-M was diffusely 
distributed in the cytosol and did not co-localize with MitoTracker signals when 
overexpressed in HeLa cells (Figure 3.20, third panel, third row). In addition, 
although the overexpression of ANT2-M alone appeared to be associated with 
swollen and globular mitochondria, it had no distinguishable effect on 
MitoTracker fluorescence intensity (Figure 3.20, third panel, insert), suggesting 
that overexpression of ANT2-M was not able to dramatically alter Ψm. 
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Figure 3.20 Confocal microscopic analysis of the localization of 
overexpressed ANT2 and its domain truncation mutants. Schematic 
representations of ANT2-FL and its domains studied are shown at the top of the 
panels. HeLa cells were transfected with the FLAG-tagged ANT2 constructs or 
FLAG vector as indicated for 24 hours. The cells were then fixed, permeabilized 
and protein expression was detected by staining with anti-FLAG (green) antibody 
followed by the appropriate fluorophore-conjugated secondary antibody. 
Mitochondria were visualized by staining with the mitochondria-specific dye 
MitoTracker. Representative fields of the cells were imaged under two excitation 
filters at 63 × magnification with a confocal microscope. Signals were merged to 
compare their localization and are presented as overlaid staining (yellow) (third 
row). Overexpressed full-length ANT2 were mostly localized to the mitochondria 
that displayed normal MitoTracker staining (first panel, insert) while 
overexpressed ANT2-N (second panel, insert) and ANT2-C (third panel, insert) 
exhibited mitochondrial-like staining and reduced MitoTracker fluorescence in 
transfected cells (insert, white arrows). Ectopically expressed ANT2-M was 
diffusely distributed in the cytosol and transfected cells exhibited normal 
MitoTracker staining (fourth panel, insert). Vector-transfected cells were used as a 
control to compare MitoTracker staining patterns. Bar, 20 m.  
 
 
The association of the mitochondria with the cytoskeleton has been reported 
to influence mitochondrial shape and morphology and as such the organization of 
the cytoskeletal network could critically modulate mitochondrial functions and 
permeability (Rappaport et al., 1998). Accordingly, the effects of overexpression of 
full-length ANT2 and its domains on the actin cytoskeleton were examined by 
confocal immunofluorescence microscopy. No drastic changes in cell shape or the 
organization of actin structures were visible by phalloidin staining when each of 
the constructs was individually expressed (Figure 3.21 third row), indicating that 
changes observed in mitochondria morphology and permeability due to 
overexpression of the individual ANT2-N and ANT2-C constructs were not 
associated with changes in the actin cytoskeleton. Furthermore, the results here 
suggest that the overexpression of ANT2 or its domains does not in any way affect 
cell shape.  
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Figure 3.21 Full-length ANT2 and its domain mutants did not affect the 
organization of the actin cytoskeleton. Schematic representations of ANT2-FL 
and its domains studied are shown at the top of the panels. HeLa cells were 
transfected with the FLAG-tagged ANT2 constructs indicated for 24 hours. The 
cells were then fixed, permeabilized and protein expression was detected by 
staining with anti-FLAG (green) antibody followed by the appropriate 
fluorophore-conjugated secondary antibody. Actin structures were visualized by 
staining with TRITC-conjugated phallodin (red). Representative fields of the cells 
were imaged under at 63 × magnification under a confocal microscope. Signals 
were merged to analyze the actin cytoskeleton of transfected cells. The cell shape 
and actin cytoskeletal structures were unaffected by the overexpression of ANT2-
FL or its domain mutants. Bar, 20 m.  
 
 
3.7.2 Deletion mutants of ANT2 are differentially localized and manifest 
different effects on mitochondrial morphology and Ψm 
Given that the N- and C-terminal domains of ANT2 were previously found to 
be involved in retaining the mitochondrial localization of ANT2, further deletion 
mutants of these domains were generated to define possible motifs responsible 
for determining this localization. Overexpressed ANT2-N1, ANT2-N3 and 
ANT2-N4 were localized to the mitochondria, as shown by the overlapping 
staining with MitoTracker (Figure 3.22A, first, second and third panel, third row, 
yellow overlaid staining). As with previous observations, there were some 
mitochondria within transfected cells that were not distributed with these ANT2 
deletion mutants. Also, the mitochondria of ANT2-N1 and ANT2-N3-transfected 
cells still retained the filamentous morphology with intense MitoTracker staining 
as seen in nearby untransfected cells and FLAG-vector-transfected cells (Figure 
3.22A, first and third panel, inserts). However, overexpression of ANT2-N4 was 
associated with segmented and globulous mitochondria although a loss of 
MitoTracker staining was not observed in these cells (Figure 3.22A, fourth panel, 
inserts) 
M.Sc Thesis  Chapter 3 Results 
WONG Ming Zhi Denise (HT 080931 B) 
 123 
ANT2-N2 was the only N-terminal deletion mutant that appeared to be 
distributed diffusely in the cytosol (Figure 3.22A, second panel, third row), 
suggesting that region between a. a. 16 – 42 could possibly determine the 
mitochondrial localization of ANT2 as the deletion of these residues abolished the 
ability of the protein to be maintained in the mitochondria. Additionally, 
MitoTracker staining was also obviously weaker and diffused in all the cells 
expressing ANT2-N2 (Figure 3.22A, second panel, insert white arrows), 
suggesting that deletion of these residues also affected the mitochondrial 
morphology and Ψm. As such, region between residues 16 – 42, appear to be 
important in mediating both the mitochondrial residency of ANT2 as well as its 
function in maintenance of Ψm.  
All of the C-terminal deletion mutants of ANT2 were diffusely distributed in 
the cytosol (Figure 3.22B, all panels, third row), suggesting that deletion of any of 
these conserved stretches of residues affected mitochondrial localization despite 
the presence of the region between residues 16 – 42 on the N-terminal. In 
addition, although the overexpression of ANT2-C1 and ANT2-C2 did not appear 
to induce any changes in mitochondrial morphology nor MitoTracker staining 
(Figure 3.22B, first and second panel, second row and insert), the overexpression 
of ANT2-C3 was associated with absence of MitoTracker fluorescence (Figure 
3.22B, third panel, second row and insert). This suggests that truncation of ANT2 
at a. a. 275 – 298 had detrimental effects on both mitochondrial morphology and 
Ψm.  
As the N-terminal and C-terminal domains of ANT2 were largely responsible 
for the mitochondrial residency of ANT2 while the M domain of ANT2 was 
previously found to be cytosol-distributed, deletion of this region was expected to 
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retain the mitochondrial localization of this protein. While ANT2-M signals 
appeared as punctuated structures in the cytoplasm that resembled mitochondria 
in neighboring un-transfected cells (Figure 3.22B, fourth panel), it could not be 
conclusively established if they were indeed representative of mitochondria due 
to the obvious lack of MitoTracker staining in cells expressing this construct. Thus, 
while ANT2-M retained mitochondrial-like staining, it possibly manifested Ψm-





(On next page) Figure 3.22 Confocal microscopic analysis of the localization 
of overexpressed ANT2 deletion mutants. (A and B) Schematic diagrams of the 
ANT2 deletion mutants studied are shown at the top of the panels. HeLa cells were 
transiently transfected with the FLAG-tagged ANT2 constructs indicated for 24 
hours. The cells were fixed, permeabilized and protein expression was detected by 
staining with anti-FLAG (green) antibody followed by the appropriate 
fluorophore-conjugated secondary antibody. Mitochondria were stained with 
MitoTracker. The cells were visualized under a confocal microscope with the 
appropriate laser excitation at 63 × magnification. The images were merged to 
compare the localization and displayed as overlaid staining (yellow).  Bar, 20 m. 
(A) Overexpressed ANT2-N1, ANT2-N3 and ANT2-N4 were localized to the 
mitochondria while ANT2-N2 appeared to be cytosolically distributed. Inserts 
show the mitochondrial morphology of transfected cells and the white arrows 
point to cells that have lost MitoTracker fluorescence. (B) ANT2-C1, ANT2-C2 
and ANT2-C3 when overexpressed were also found to be diffuse in the cytosol 
while overexpressed ANT2-M retains mitochondrial-like staining. Inserts show 
the mitochondrial morphology of transfected cells and the white arrows indicate 
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4 Discussion 
DLC1 is a recently identified multi-modular tumor suppressor that has 
functions which are dependent on its GAP-dependent inactivation of Rho GTPases 
as well as separate functions that appear to be mediated by its other domains such 
as the SAM and START domain. Discovery of interacting partners of DLC1 that 
either positively or negatively regulate the activity of DLC1 have provided further 
insights into the mechanisms driving the functions of DLC1 (Figure 4.1). In the 
sections below, the findings obtained in this study will be discussed to illustrate 
the evolving strategies adopted to understand the functions of DLC1 by 
identification of its novel interacting partner ANT2. The key considerations that 
emerged over the course of this study will also be highlighted.  
 
  
Figure 4.1 The interaction of DLC1 with its partners drives its functions. The 
presently known protein partners of DLC1 can be classified into two categories 
depending on their action towards DLC1: tensins and EF1A1 support the growth 
suppressive activities of DLC1, while 14-3-3 and p120RasGAP act as negative 
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4.1 Proteomics pull-down to identify novel DLC1 interacting partners 
There are several approaches that can be explored in the search for 
candidate binding partners of DLC1 including the yeast-two-hybrid method that 
identified tensin members (Yam et al., 2006; Liao et al., 2007; Qian et al., 2007) 
and p120RasGAP (Yang et al., 2009) as well as a hypothesis-driven method in 
which a putative 14-3-3 binding site was discovered on DLC1 through a 
bioinformatics search (Scholz et al., 2009). Recently, our lab has also isolated 
EF1A1 from rat liver lysates as a DLC1 interacting partner by using purified GST-
tagged DLC1-SAM as a bait protein (Zhong et al., 2009).  
Another approach was adopted in this study in which the DLC1 bait proteins 
were overexpressed in mammalian cells as FLAG-tagged proteins and allowed to 
associate with its interacting partners before these protein complexes were 
affinity-purified by anti-FLAG M2 beads. This approach is similar to the yeast-two-
hybrid method in which multiple interacting partners may be identified from a 
large protein pool but overcomes the limitation of the latter method in generating 
false positives where protein interactions occur only as a result of protein co-
expression in yeast when in fact they are not naturally occurring interactions as 
these proteins are never expressed in the same cell type at the same time. In 
addition, the use of mammalian cells as an expression host for the bait proteins 
ensures that the proteins are expressed with the proper post-translational 
modifications. This is especially important in light of the multiple potential 
phosphorylation sites DLC1 possesses in the serine-rich region (Durkin et al., 
2007b) and the recent finding that Akt-mediated phosphorylation of DLC1 
modulates its tumor suppressive abilities (Ko et al., 2010). Although 
overexpression of the bait proteins may lead to the identification of non-specific 
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interactions, the large excess of the bait proteins allows potential partners to 
preferentially bind to DLC1 even under quiescent conditions and not to its other 
protein partners, thereby facilitating the discovery of novel interacting partners.  
293T cells were used in this study as high transfection efficiencies can be 
readily attained to enable the production of high levels of the bait DLC1 proteins. 
In addition, DLC1 is expressed endogenously in 293T cells (Figure S1). This 
further enhances the quality of this screen to identify potential DLC1 interacting 
partners since both DLC1 and its partners are both expressed in the same cell type 
and can interact under physiological conditions.  
 
4.2 ANT2 is a novel DLC1 interacting partner 
In this study, human ANT2 was identified by mass spectrometry as one of 
the proteins associated with overexpressed FLAG-tagged DLC1-PGR and DLC1-C 
in protein complexes enriched by immunoprecipitation with anti-FLAG M2 beads. 
Further sequence analysis verified that ANT2 and not any of the other three 
human ANT isoforms was the candidate DLC1 interacting partner isolated from 
pull-down complexes in 293T cells and is consistent with the expression profile of 
ANT2 in tissues capable of regeneration like the kidney (Stepien et al., 1992) as 
well as in SV-40 transformed cell lines (Giraud et al., 1998). Endogenous ANT2 
was also isolated in both three hour and overnight immunoprecipitations, 
suggesting that its association with DLC1 is stable.  
The possibility of identifying spurious DLC1 interacting partners makes it 
crucial to validate the interaction between DLC1 and ANT2 by high confidence 
assays. Co-immunoprecipitation of overexpressed DLC1-PGR and DLC1-C with 
ANT2 in 293T cells, demonstrated that the bait proteins used in the proteomics 
M.Sc Thesis  Chapter 4 Discussion 
WONG Ming Zhi Denise (HT 080931 B) 
 130 
pull-down could be specifically enriched by ANT2. Furthermore, full-length DLC1 
was found to interact with ANT2 in co-immunoprecipitates from 293T cells, thus 
supporting the use of desired domains of DLC1 as bait proteins in this mammalian 
overexpression system to isolate potential DLC1 interacting partners. In addition, 
confocal microscopic immunofluorescence studies of the localization of 
overexpressed DLC1 and ANT2 in HeLa cells revealed partial co-localization of 
these two proteins at discrete sites near the cell periphery, hence further 
establishing that ANT2 interacts with DLC1 in vivo.  
  
4.2.1 Subcellular sites for the interaction between DLC1 and ANT2 
Confocal microscopic studies show that singly overexpressed DLC1 was not 
localized to the mitochondria unlike DLC2 that was targeted to the mitochondrial 
by its START domain (Ng et al., 2006). This indicates that the START domain of 
DLC1 and DLC2 may bind to different lipid ligands that determine their 
subcellular localization and may thus function differently in the two proteins. 
Moreover, the results suggest that while ANT2 interacts with the lipid-binding 
START domain of DLC1, it did not facilitate the translocation of DLC1 into the 
mitochondria, as revealed by the lack of DLC1 co-localization with the 
mitochondrial marker MitoTracker. While it cannot be ruled out that the 
interaction between DLC1 and ANT2 at the mitochondria may be a transient event 
that could not be captured robustly by a fixed time point analysis of protein 
localization by conventional microscopy methods or that loss of Ψm in these cells 
that resulted in the lack of MitoTracker staining may have precluded the co-
staining of DLC1 with the mitochondria, further investigations must be conducted 
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to confidently evaluate the exact subcellular compartment in which the 
interaction between DLC1 and ANT2 occurs.  
The lack of a clear mitochondrial localization of DLC1 in the presence of 
ANT2 corroborates with the results obtained from co-immunoprecipitation 
studies and suggests the possibility that the interaction between the two proteins 
could occur outside of the mitochondria. The finding that cytosol-resident ANT2-
M was responsible for mediating the interaction with DLC1 suggests that it is 
possible for non-mitochondrial ANT2 to interact with DLC1 as long as the M 
domain on ANT2, the binding site for DLC1, is available.  
Possible sites of DLC1-ANT2 interaction could be either in the cytosol or 
near the plasma membrane. For example, it is possible that the interaction 
between the two proteins could have occurred in the cytosol before the newly 
synthesized ANT2 is trafficked into the mitochondria. In fact, ANTs have been 
shown to interact with proteins such as those from the endoplasmic reticulum 
(Verrier et al., 2004). In addition, although the bulk of overexpressed ANT2 was 
localized to the mitochondria in accordance to its function as a mitochondrial 
ADP/ATP carrier, it appeared that when DLC1 was highly co-expressed, a small 
fraction of ANT2 was localized to the shrinking cell edges and was associated with 
DLC1 near the membranes. This is seemingly consistent with a recent finding by 
Radichev et al. (2009) that a fraction of ANT2 is localized to the plasma membrane 
of MCF7 breast carcinoma cells. Interestingly, in DLC1-overexpressing cells that 
maintained its cuboidal shape, co-localization of DLC1 with ANT2 was not 
observed, suggesting that the two proteins may be brought into proximity for 
interaction in cells where DLC1 overexpression induced cytoskeletal collapse and 
subsequent cell shrinkage. Given that disruptions in cytoskeletal networks have 
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been linked to mitochondria membrane damage and possible release of 
mitochondrial proteins (Rappaport et al., 1998), it is not inconceivable that DLC1-
mediated cell rounding could have triggered its association with ANT2 at sites 
outside of the mitochondria.   
To further substantiate these hypotheses, it is pertinent to carry out co-
immunoprecipitations with cell fractions enriched for mitochondrial and/or 
membrane proteins and compare the DLC1 immunoprecipitation profile obtained 
with that derived from co-immunoprecipitations with cell fractions enriched for 
cytosolic proteins. Ongoing work in our laboratory to determine the lipid ligands 
for the START domain in DLC1 may also reveal the possible subcellular 
compartments in which DLC1 may be associated with.  
 
4.2.2 Unique ANT2 binding regions on DLC1 suggest novel interaction 
mechanism 
As the interaction between DLC1 and ANT2 is novel with no apparent well-
characterized binding motifs known to mediate their association, co-
immunoprecipitation studies were carried out in order to characterize binding 
motifs on DLC1 that were important for binding to ANT2 in order to further 
understand their mechanism of interaction. Evidently, there are multiple ANT2 
binding sites on DLC1, including the START domain as well as regions between     
a. a. 76 – 301 and 501 – 641 on the serine-rich region (Figure 4.2). Deletion of the 
START domain in DLC1 was also found not to affect the binding of ANT2 to DLC1 
(Figure S2). Thus, in this study, a DLC1 mutant that has abrogated binding to 
ANT2 could not be generated for use in later functional analyses, as deletion of a 
M.Sc Thesis  Chapter 4 Discussion 
WONG Ming Zhi Denise (HT 080931 B) 
 133 
single site would probably not cause a complete loss of affinity between DLC1 and 
ANT2.  
The results obtained from co-immunoprecipitation studies with DLC1 
serine-rich region mutants suggest that definition of ANT2 binding motifs to a few 
amino acids specificity would be an extremely daunting task without the aid of 
structural data as not all the constructs are expressed well and known to fold 
correctly especially if distant residues are also requisite for the formation of 
proper binding sites. As the serine-rich region is thought to be a rather 
unstructured region with no known tertiary structure (Durkin et al., 2007b), 
secondary structure prediction methods may be employed in future analyses to 
facilitate the generation of DLC1 mutants. Concurrently, it may be worthwhile to 
further pursue delineating binding motifs on the START domain as structural data 
for modelling DLC1-START on existing solved START domain-containing protein 
structures are available. Ongoing mutational studies in our lab on the ligand-
binding pocket of the START domain may also yield additional insights into how 
DLC1 and ANT2 interact.  
Interestingly, the region on DLC1 that has been reported to play a regulatory 
role in DLC1 nuclear translocation and the polybasic region crucial for binding to 
PIP2-containing membranes fall within the regions crudely described in this study 
to be required for binding to ANT2 (Yuan et al., 2007; Erlmann et al., 2009). 
However, the ANT2 binding sites on DLC1 do not coincide markedly with any of 
the published sites that mediate interaction between DLC1 and its other binding 
partners (Figure 4.2). For example, the SAM and GAP domain on DLC1 that bind to 
EF1A1 and p120RasGAP respectively (Zhong et al., 2009; Yang et al., 2009), were 
dispensable for binding to ANT2. In addition, the consensus sites for interaction 
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between DLC1 and tensin1, tensin2 or cten to mediate their localization to focal 
adhesions did not overlap with binding sites for ANT2 (Qian et al., 2007; Chan et 
al., 2009; Liao et al., 2007). The nuclear localization sequence on DLC1 that is 
masked by interaction with 14-3-3 was also outside of the regions required for 
binding of ANT2 to DLC1. This suggests that ANT2 possibly interacts with DLC1 in 
a mechanistically different way and implies a potential novel function underlying 
their interaction. As such, the functional significance of the interaction between 




Figure 4.2 ANT2 interacts with DLC1 at unique binding sites. The red boxes 
with the amino acid boundaries indicated highlight the regions on DLC1 required 
for interaction with ANT2. The sites mapped for binding with known interacting 
partners EF1A1, tensin family members, 14-3-3 and p120RasGAP are indicated by 
the blue arrows while regulatory sites that mediate the localization of DLC1 to the 
nucleus or membrane are indicated by the green arrows.  
 
 
4.2.3 DLC1 and ANT2 co-expression does not induce the activation of the 
intrinsic apoptotic pathway in 293T cells 
During DLC1-mediated apoptosis, the inactive pro-caspase-3 is cleaved into 
active cysteine proteases that direct various cellular effects such as DNA 
fragmentation, membrane blebbings and cell shrinkage that are key hallmarks of 
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apoptotic cell death (Zhou et al., 2004; Syed et al., 2005; Yuan et al., 2007; Guan et 
al., 2008). The findings that implicate ANT2 in apoptosis (Le Bras et al., 2006; Jang 
et al., 2008) prompted the investigation to evaluate if ANT2 has a role in 
coordinating the apoptotic response in cells when DLC1 is expressed. While stable 
cell lines that overexpress DLC1 may be used to evaluate the levels of established 
apoptotic markers such as caspase-3 (Guan et al., 2008), 293T cells were used 
here as the high transfection efficiencies readily achieved in this cell line allows 
for high expression of the these proteins transiently while avoiding adaptive 
responses to apoptosis in stably-overexpressing cell lines. 
Apoptosis can occur in cells via the extrinsic pathway that requires the 
activation of pro-apoptotic cell surface receptors in response to external death 
insults or via the intrinsic pathway that senses internal cell death signals and 
results in the release of pro-apoptotic factors from the mitochondria to activate 
caspases (Elmore, 2007; Bayer and Oberbauer, 2003). As the activation of the 
intrinsic apoptotic pathway is dependent on the permeability of the mitochondrial 
membrane that is regulated by ANT2, the levels of the key caspases of this 
pathway, upstream caspase-9 and downstream caspase-3, were analysed as 
markers of apoptotic induction by this pathway. While the classical apoptosis 
markers are the cleaved and activated forms of the caspases, the antibodies used 
for Western blot analysis were unable to detect the active 17-kDa subunit of 
cleaved caspase-9 or caspase-3. As such, the activation of caspase-9 and caspase-3 
were evaluated by the disappearance of the 47 kDa and 35 kDa forms respectively. 
The evaluation of levels of pro-caspase-9 and pro-caspase-3 as an indirect read-
out of the levels of activated caspase forms and hence caspase activity has been 
exploited in other apoptosis studies (Deshpande et al., 2000; Jin et al., 2006) as it 
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has been documented that levels of pro-caspase-9 and pro-caspase-3 have been 
found to correlate with their cleaved forms (Srinivasula et al., 1998) and other 
apoptotic markers such as Poly(ADP-ribose) polymerase (Jin et al., 2006).  
Overexpression of ANT2 in this study did not activate the caspase-dependent 
intrinsic apoptotic pathway in 293T cells and is consistent with other studies that 
show ANT2 is not a pro-apoptotic isoform (Bauer et al., 1999; Zamora et al., 2004). 
Surprisingly, overexpression of DLC1 alone did not cause a marked decrease in the 
levels of pro-caspase-9 or pro-caspase-3 unlike in previous reports (Zhou et al., 
2004; Syed et al., 2005; Yuan et al., 2007; Guan et al., 2008). This could be due to 
several reasons such as differences in cell lines used for analysis of apoptosis. 
293T cells are particularly sensitive to environmental cues, thus high levels of 
DLC1 expression may already be sufficient to cause damage such that they bypass 
the apoptotic cell death machinery without activation of the caspase cascade 
(Albayrak and Grimm, 2003). It is also possible that the 24-hour time-point used 
in this study was not sufficient to cause caspase-dependent apoptosis that was 
reported in cells that stably overexpress DLC1 (Guan et al., 2008) or after 40 
hours post-transfection (Yuan et al., 2007). In addition, the observation that DLC1-
transfected 293T cells that displayed morphological cell rounding could still 
survive after subjecting them to trypsinization before re-seeding them on new 
plates (own observations) and the ability to generate DLC1-overexpressing stable 
cell lines (Guan et al., 2008) seems to suggest that DLC1 is not a potent inducer of 
apoptosis and may require other death stimuli for complete execution of 
apoptosis. This is corroborated with the finding by Yuan et al. (2007) that there 
were populations of DLC1-expressing cells that did not become apoptotic, as they 
did not undergo protein nuclear translocation.  
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More importantly, the results obtained in this study suggest that the co-
expression of DLC1 with ANT2 was not sufficient to mount a caspase-dependent 
intrinsic apoptotic response in 293T cells.  It is possible that the co-expression of 
DLC1 and ANT2 in cells may require the integration of additional death stimuli 
before apoptosis is induced. Hence, this warrants further investigation to 
determine if the co-expression of DLC1 and ANT2 in cells that are treated with 
certain apoptosis inducers may sensitize these cells to apoptosis or if other forms 
of programmed cell death such as detachment of anchorage-dependent cells in 
anoikis or even necrosis are enhanced when the two proteins are co-expressed.  
 
4.2.4 A novel GAP-independent function of DLC1 involving ANT2  
ANT family members play a regulatory role in the formation of the 
mitochondrial PTPC that controls the permeability of inner and outer 
mitochondrial membranes for metabolites such as ADP and ATP (Vieira et al., 
2000). Fluctuations in the opening of this non-specific pore is correlated with 
changes in Ψm and irreversible opening of this pore has been shown to result in 
the collapse of Ψm as metabolites are allowed to move freely across the permeable 
mitochondria thus destroying the electrochemical gradient established across 
mitochondrial membranes (Crompton, 1999).  
To explore the potential effects of DLC1 co-expression with ANT2 on Ψm, 
MitoTracker® Red CMXRos was employed in this study to monitor changes in Ψm 
and to assess the overall health of the mitochondrial networks. Unlike 
conventional rhodamine-based fluorescent stains for labeling mitochondria, the 
MitoTracker probes are a series of cationic lipophilic dyes that passively diffuse 
across the plasma membrane and are preferentially accumulated in the negatively 
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charged matrix of active mitochondria in live cells (Pendergrass et al., 2004). The 
distribution of these dyes across the inner mitochondrial membrane is described 
by the Nernst equation (Ehrenberg et al., 1988; Poot et al., 1996; Macho et al., 
1996) in which mitochondrial fluorescence is reduced upon the dissipation of Ψm, 
therefore making them suitable reporters of changes in Ψm. MitoTracker® Red 
CMXRos, in particular, is a widely used aldehyde-fixable fluorochrome that is 
sensitive to changes in Ψm (Macho et al. 1996) and has been widely used to 
evaluate Ψm in cells that have been fixed and permeabilized for detection of target 
proteins by imaging under fluorescent microscopes (Bauer et al., 1999; Isenberg 
and Klaunig, 2000). In addition, MitoTracker® Red CMXRos also contains a thiol-
reactive moiety that can covalently bind to thiols present on proteins in the 
mitochondrial matrix, thus allowing them to be retained well after fixation and 
permeabilization (Poot et al., 1996; Macho et al., 1996).  
At the concentration of MitoTracker used in the assay here (100 nM), the 
contribution of the thiol-binding properties of MitoTracker towards MitoTracker 
fluorescence is small compared to the Ψm-dependent retention of MitoTracker 
(Marchetti et al., 1997). Consequently, the significant increase in the percentage of 
cells that display complete loss of MitoTracker fluorescence when DLC1 and ANT2 
were co-expressed versus when they were individually expressed indicate that 
the two proteins may function together to initiate the dissipation of Ψm. This 
possible novel function of DLC1 that involves ANT2 was also shown in this study 
to be independent of the GAP activity of DLC1 as the co-expression of ANT2 with a 
DLC1 mutant, in which GAP activity was abolished by substitution of the catalytic 
arginine residue, was also able to reproduce the loss of Ψm. It would have been of 
value to introduce the ANT2-ΔM mutant that does not bind DLC1, into DLC1-
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expressing cells to see if the loss of Ψm can be rescued in order to show that DLC1-
mediated loss of Ψm was mediated by its interaction with ANT2. However, this was 
not possible as the ANT2-ΔM mutant alone was found to drastically affect Ψm, thus 
rendering it unsuitable for further analyses. Thus, it may be pertinent to generate 
mutants of ANT2 with deletions of smaller regions on the M domain that does not 
bind to DLC1 and imposes minimal effects on the Ψm.  
 
4.3 ANT2 domain function relationships 
Separately, characterization of human ANT2 also provided new insights into 
the functions of this isoform in relation to its structure and localization. Human 
ANT2 is completely identical to bovine ANT1 except at 33 amino acid positions 
across its three known domains (Figure S3), suggesting that its protein structure 
organization is highly similar to that of bovine ANT1 that has been recently solved. 
It was shown in this study that the N- and C-termini of ANT2 that 
corresponds to the first and last two transmembrane helices were sufficient for 
the mitochondrial retention of ANT2. However, preliminary data indicate that 
overexpression of just the N- or C-termini domains alone can disrupt Ψm. Further 
analysis of the localization of various ANT2 mutants, it was discovered that the 
region between residues 16 – 42, that is part of the first transmembrane helix, was 
important for determining the mitochondrial localization of ANT2 and may serve 
as an internal mitochondrial targeting sequence to maintain its mitochondrial 
localization. In addition, deletion of any of the last two C-terminal transmembrane 
helices or its adjoining loop region resulted in a loss of ANT2 mitochondrial 
localization and suggests that this region must also be present in order to retain 
its proper localization to the mitochondria. Preliminary data also indicate that the 
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regions between residues 16 – 42 and 274 – 298, which corresponds to the first 
and last transmembrane helices respectively, are necessary for maintenance of Ψm 
as indicated by the loss of MitoTracker fluorescence. The overlap of the regions 
that promote the mitochondrial localization of ANT2 with regions that are 
important for preservation of the Ψm suggests that the localization of ANT2 is 
tightly linked to its function. The data and ANT2 mutants generated in this study 
will open avenues for future exploration of the mechanisms of ANT2 functions. 
 
4.4 Implications of the study – a working hypothesis  
In this study, ANT2 was identified as a novel interacting partner that was 
implicated in a novel GAP-independent function of DLC1 to disrupt Ψm. The 
potential underlying implications of the loss of Ψm and the final cellular effects 
that ultimately follow this dissipation of Ψm when both proteins are expressed are 
addressed below.  
It is entirely possible that the co-expression of DLC1 with ANT2 does not 
immediately result in apoptotic cell death when no additional death insults are 
present. The results obtained under the conditions employed in this study support 
this suggestion that the collapse of Ψm was not associated with caspase-dependent 
intrinsic apoptosis after 24 hours. Studies suggest that Ψm disruptions do not 
necessarily lead to the irreversible opening of the mitochondrial PTPC and 
subsequent release and activation of apoptogenic factors (Minamikawa et al., 
1999; Crompton, 1999). Mitochondrial swelling manifested as a result of 
permeabilization of the mitochondrial inner membrane that allows ions to 
equilibrate across the membrane and subsequent movement of water into the 
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mitochondrial matrix can also occur transiently and reversibly without triggering 
cell death (Minamikawa et al., 1999).  
However, as the maintenance of Ψm and mitochondrial integrity is tightly 
linked to the machinery responsible for energy production in the mitochondria, it 
is possible that the cooperative effect of DLC1 and ANT2 in inducing the loss in Ψm 
observed in this study may have been sufficient to affect cellular bioenergetics 
such that energy production that is necessary for cellular activities such as protein 
synthesis, cell proliferation and even programmed cell death cannot be efficiently 
carried out. In turn, the energy status of the cell may have effects on the overall 
mitochondrial health including mitochondrial biogenesis, permeability transition 
and mitochondrial-mediated calcium homeostasis in a continual feedback cycle 
(Hapala, 1989; Hock and Kralli, 2009). Moreover, it was shown that in energy-
depleted cells, the ADP/ATP translocase was less efficiently targeted to the proper 
intramitochondrial compartment, thus reinforcing the energy-depleted state of 
the cell (Hapala, 1989). In addition, fluctuations in Ψm may also induce cellular 
oxidative stress via the release of reactive oxygen species that may cause further 
imbalances in energy production (Lyamzaev et al., 2004).  
It has also been reported that although Ψm as measured by a fluorescent 
potential-sensitive dye is decreased in early apoptotic cells, the apoptotic process 
could not be completed (Kashiwaya et al., 2009). This may be due to the selection 
of cell death pathways depending on the energy status of the cell (Hand and 
Menze, 2008). Energy-dependent types of cell death have been reported in breast 
carcinoma MCF7 cells in which apoptosis is completely executed only when 
sufficient oxygen and energy supplies are available (Lemasters et al., 1999; 
Formigli et al., 2002). As the ATP energy stores are depleted, cells are forced to 
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switch to a different type of cell death termed as aponecrosis, in which cells 
display features of necrotic cell death such as cytoplasmic swelling as a result of 
the incomplete implementation of the apoptotic machinery (Formigli et al., 2000). 
Finally, the cells undergo caspase-independent necrosis when ATP is no longer 
available under extreme hypoxia (Formigli et al., 2000; Formigli et al., 2002; 
Lyamzaev et al., 2004). Thus, it is plausible that DLC1 and ANT2 cooperate to 
disrupt Ψm that may result in energy metabolic defects that dictate the pathways 
for cell death. Cancer cells that are heavily reliant on glycolysis to generate energy 
for cellular activities depend on the unique kinetics of the ANT2 isoform to meet 
the high energy demands of the cell (Giraud et al., 1998). By interaction with ANT2 
to mediate the collapse of Ψm, DLC1 may function to suppress the cancer-
promoting properties of ANT2, thereby exerting its function as a tumor 
suppressor. It is thus hypothesized that the combinatorial effects of all these 
insults conferred by DLC1 and ANT2 that cripple mitochondrial health and energy 
metabolism may be assimilated to sensitize the cells to die especially in the 
presence of additional death stimuli (Figure 4.3).  
If indeed DLC1 engages ANT2 to induce a loss of Ψm that allows the cell to 
elicit a more integrated action in response to external death stimuli, what may be 
the mechanism that drives this process? It has been shown that cytoskeletal 
disruptions may induce mitochondrial membrane damage where apoptotic bodies 
are formed as a result of the reorganization of intracellular membranes that is 
modulated by actin polymerization (Yamazaki et al., 2000).  A separate study also 
revealed the role of Cdc42 activity and actin polymerization in the transmission of 
a novel signal that drives necrosis in lymphocytes (Chaigne-Delalande et al., 
2008). It is tempting to propose that DLC1-GAP-mediated actin cytoskeletal 
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disruptions may be linked to the destruction of mitochondrial membranes such 
that ANT2 is released from the mitochondria and/or translocated to the plasma 
membrane, where it can no longer function efficiently, thus resulting in the loss of 
Ψm. This phenomenon of translocation of mitochondrial proteins is well 
documented for ATP synthase (Moser et al., 1999; Quillen et al., 2006; Lu et al., 
2009; Xing et al., 2010) and from the observations in this study that a small 
fraction of ANT2 is localized near the plasma membrane in shrinking cells 
expressing DLC1, preliminarily lends support to this hypothesis. However, the loss 
of Ψm was found to occur independently of Rho GAP activity and in cells that do 
not display morphological cell shrinking. This suggests that the START domain 
and serine-rich region, sites found to bind to ANT2, may regulate its novel 
function. Future work should thus focus on unraveling this novel mechanism of 
DLC1-mediated tumor suppression through its effects on the functions of ANT2 
and in turn the energy metabolism of the cell.  
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Figure 4.3 Proposed model of the functional significance of DLC1-ANT2 
interaction. DLC1 cooperates with ANT2 to induce a loss in Ψm that may be 
associated with fluctuations in the opening of the mitochondrial PTPC that may 
then affect mitochondrial biogenesis or homeostasis. In addition, the consequent 
release of reactive oxygen species and improper targeting of mitochondrial 
proteins required for the maintenance of Ψm may also feedback to further perturb 
Ψm and induce irreversible and permanent opening of the mitochondrial PTPC, 
such that the cell completely loses viability and succumbs to cell death in the 
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5 Conclusions and future perspectives 
The identification of interacting partners for the novel Rho GAP DLC1 has led 
to a better understanding of how DLC1 functions, both in normal physiology and 
in pathology. In a discovery-based proteomics pull-down approach used in this 
study, ANT2 was identified as a novel partner of the tumor suppressor DLC1 in 
293T cells that likely interacts outside of the mitochondria. The interaction was 
mapped to the DLC1-START domain, N- and C-terminal ends of the serine-rich 
region on DLC1 with the M domain of ANT2. A novel GAP-independent function of 
DLC1 to induce a loss of Ψm when co-expressed with ANT2 was uncovered and 
raised the possibility that there exists a novel mechanism by which DLC1 affects 
mitochondria activity and cellular metabolism and overall health and functions of 
the cell. Still, there remain several issues that must be addressed in future studies 
in order to better understand what drives the interaction between DLC1 and 
ANT2 as well as the final physiological outcome of their interaction and 
mechanisms underlying their cooperative functions. The various approaches that 
can be explored are further explained below. 
  
5.1 Future work 
5.1.1 Study of the interaction mechanism between DLC1 and ANT2 
Firstly, it may be of use to investigate if endogenous DLC1 and ANT2 exist as 
a complex in cells under physiological conditions by performing endogenous pull-
down assays using mitochondrial and cytosolic fractions. This overcomes 
limitations of co-immunoprecipitation approaches that rely on the use of 
recombinant protein overexpression that examines protein interactions in 
isolation without taking into account other competing protein interactions that 
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occur within cells. The endogenous pull-down assay would not only further 
validate their interaction but may also substantiate the observations in this study 
that the interaction possibly occurs largely outside of the mitochondria. In 
conjunction with this, the use of the DuoLink® proximity ligation assay™ 
technology that allows for the analysis of protein-protein interactions in situ in 
fixed cells under endogenous conditions may be considered as a complementary 
strategy. The system exploits the usage of probes consisting of an antibody of 
choice that is targeted to the endogenous protein of interest and attached to a 
synthetic oligonucleotide. The specific signal generated can be amplified when the 
probes are in close proximity and can thus report exact spatial locations in which 
the interactions occur up to a single molecular level. Although the results obtained 
from this study suggests that DLC1 interaction with ANT2 may not mitochondrial-
based, the use of this tool may enable the more confident identification of the 
subcellular compartment in which the interaction occurs.  
Also, the identification of ANT2 in a complex with DLC1 in the proteomics 
pull-down approach used here does not preclude that a third interacting partner 
may mediate the interaction between the two proteins. As such, binding studies 
may be conducted to establish if the interaction between DLC1 and ANT2 occurs 
directly using an in vitro translation system. This would again provide insights 
into the mechanism of their interaction and how ANT2 is involved in the DLC1-
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5.1.2 Validation that DLC1-mediated loss of Ψm is associated with ANT2-
mediated mitochondrial permeability transition 
As discussed previously, there is controversy surrounding the use of Ψm as a 
reporter of downstream cellular events such as mitochondrial PTPC opening and 
cell death. Hence, future studies must be structured to focus on the significance of 
the loss of Ψm when DLC1 and ANT2 are expressed. An obvious starting point 
would be to examine if DLC1 and ANT2 can induce the irreversible and permanent 
opening of the PTPC by in vitro fluorescent-based swelling assays to measure 
mitochondrial permeability transition in isolated mitochondria such as those 
described by Blattner et al. (2001). Alternatively, the commercial cell-based assays 
that measure the loss of calcein fluorescence in the mitochondria by flow 
cytometry as a reporter of pore opening may be performed in transfected cells. 
Cyclosporin A, a well-established blocker of mitochondrial permeability transition 
(Broekemeier and Pfeiffer, 1995), may also be used to investigate if it can rescue 
the loss of calcein fluorescence postulated to occur as a result of the cooperative 
action of DLC1 and ANT2. This may further support the hypothesis that these two 
proteins function together to affect the opening of the mitochondrial PTPC. In 
addition, time-course analysis over a 48 to 72 hour period of the loss of Ψm and 
induction of mitochondrial PTPC using the overexpression of fluorescent protein-
tagged DLC1 and ANT2 to facilitate live-cell imaging can be concurrently executed. 
Such studies would not only allow the monitoring of fluctuations in Ψm due to 
actions of DLC1 and ANT2 but also reveal the dynamics of mitochondrial PTPC 
opening. Moreover, this would aid in the selection of appropriate fixed time points 
for analysis of downstream cellular effects after induction of the transition pore. 
To further understand the mechanism driving pore opening, global levels of 
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reactive oxygen species such as peroxides and superoxide anion radicals should 
be quantitatively analyzed as accumulated exposure to such scavenging radicals 
have been well documented to increase the oxidative stress burdens in 
mitochondria that can feedback to induce opening of transition pores and collapse 
of Ψm that can lead to potentially significant mitochondria and cellular injury 
(Zorov et al., 2000; Zorov et al., 2006).  
 
5.1.3 Study of the possible cellular effects following DLC1-ANT2-mediated 
loss of Ψm and underlying mechanisms 
Next, it would be of great interest to investigate what cellular effects are 
associated with DLC1 and ANT2 cooperative action in mediating the loss of Ψm 
and affecting the opening of the PTPC. Correspondingly, it would first be necessary 
to show that DLC1 and ANT2 function to mediate some form of cell death by co-
staining MitoTracker-stained transfected cells with propidium iodide to identify 
dead cells. This would allow the determination of the proportion of cells that 
eventually undergo some form of cell death as a result of the loss of Ψm and 
mitochondrial PTPC opening. Once it is established that DLC1 functions together 
with ANT2 to induce cell death, the mechanisms of cell death may be further 
explored.  
The loss of Ψm and opening of PTPC is also tightly associated with the 
functioning of the electron transport chain that is tied to cellular energy 
production. It is known that ATP levels in the cell is a differentiating factor in 
determining the modes of cell death and as such, it may be worthwhile to study 
the ratio of ADP and ATP in DLC1 and ANT2-transfected cells using commercially 
available luminescent assays. This would provide information on the cellular 
M.Sc Thesis  Chapter 5 Future perspectives 
WONG Ming Zhi Denise (HT 080931 B) 
 149 
energy status and clues into the possible modes of cell death triggered by the 
presence of DLC1 with ANT2.  
Following this, various forms of cell death such as apoptosis, aponecrosis 
and necrosis may be studied at the appropriate time points as selected earlier to 
verify if the interaction between DLC1 and ANT2 does lead to eventual cell death. 
Although this study did not implicate the involvement of caspase-dependent 
apoptosis at 24 hours post-transfection, DLC1 and ANT2 may function to sensitize 
cells to various death insults. As such, it may be prudent to investigate the 
possibility of DLC1-ANT2-mediated apoptosis at suitable time points in the 
presence of respiratory inhibitors or uncouplers that may more effectively cripple 
the bioenergetic machinery of the cell. In parallel, cells expressing DLC1 with 
ANT2 can be subject to treatment with TNF-α or other death-inducing ligands to 
analyse if the two proteins afford cells greater responsiveness to extrinsic 
apoptosis that is triggered by such external death signals that may also be 
secreted by neighboring cells that have sustained some form of cellular injury. 
Effects of DLC1 and ANT2 on the bioenergetics of the cell may also affect 
cellular processes other than induction of cell death. For example, it is known that 
the cell cycle is dependent and driven by the levels of cellular ATP and as such 
there exist various energy checkpoints within the cell cycle (Sweet and Singh, 
1999). If the loss of Ψm observed when DLC1 and ANT2 are co-expressed perturbs 
the levels of ATP within the cell, it is entirely possible that cell proliferation may 
be affected. In addition, cellular ATP levels are also closely linked to actin 
polymerization with depletion of ATP in cells shown to be detrimental for the 
formation of actin stress fibers (Atkinson et al., 2004). Actin polymerization assays 
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may be performed to assess the contribution of ANT2 to DLC1-mediated 
dissolution of actin stress fibers.  
Further deletional and mutational binding studies should be carried out with 
the aid of structural prediction or modeling data to generate DLC1 and ANT2 
mutants that have lost mutual binding capabilities for analysis in functional 
studies such as assessment of Ψm, cell death and cell proliferation assays. It may 
also be useful to generate stable DLC1 and/or ANT2 knockdown lines or use 
shRNAs transiently targeted against these two proteins in such functional studies 
to further validate their involvement in mediating various cellular effects.   
Finally, it is pertinent to understand the mechanisms that underlie the 
cellular functions performed by DLC1 in relation to ANT2. This is a major 
undertaking that can be completed only when the cellular effects mediated by the 
interaction between the two proteins are better understood. Preliminary findings 
in this study suggest that a fraction of ANT2 is localized near the cell periphery in 
DLC1-transfected cells and it was proposed that DLC1-mediated actin cytoskeletal 
remodeling may be associated with damage of mitochondrial membranes such 
that ANT2 is released from the mitochondria and/or translocated to the plasma 
membrane, resulting in the loss of mitochondrial Ψm. Therefore, it must be further 
established if the ANT2 is truly plasma membrane-localized as reported (Radichev 
et al., 2009) or is resident in the mitochondria that is in close proximity to the 
shrinking plasma membrane. Total internal reflection fluorescence microscopy 
may be employed to study the localization of proteins at structures that are close 
to the basal plasma membrane. Also, it may be worthwhile to pursue the analysis 
of the dynamics and spatial organization of DLC1 and ANT2 interaction perhaps 
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by measurement of intermolecular fluorescence resonance energy transfer using 
multi-photon fluorescence lifetime imaging microscopy in live cells.  
 
5.2 Conclusions 
The discovery of a novel interacting partner of DLC1 that has a role in the 
bioenergetics of the cell suggests a possible link between the actin cytoskeleton 
and energy metabolism. This study represents an ongoing effort to understand the 
function and molecular mechanisms governing the activity of the tumor 
suppressor DLC1 that may have potential applications in the design of therapeutic 
cancer treatments.  Given the plasticity of mitochondrial networks in response to 
various metabolic parameters, energy metabolic therapy is fast emerging as a 
promising new anti-cancer strategy where tumor cell death is induced by the 
alteration of the concentration of metabolites such as ATP via manipulating 
mitochondrial permeability transitions. It is envisioned that this study may 
contribute to the development of combinatorial approaches in which such 
therapies may be incorporated as a strategy to complement existing anti-tumor 
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Figure S1 DLC1 is expressed in 293T cells. Cells that were transfected with 
FLAG-tagged DLC1 for 24 hours and untransfected cells (UT) were lysed in RIPA 
lysis buffer and proteins from the whole cell lysates were resolved by SDS-PAGE, 
blotted and probed with anti-DLC1 antibody. Overexpressed FLAG-tagged DLC1 
ran at a slightly higher molecular weight compared to the endogenous DLC1 that 












Figure S2 Deletion of START domain in DLC1 did not abolish binding to 
ANT2. 293T cells were transfected with HA-tagged DLC1-ΔSTART in the 
presence/absence (indicated by + and – respectively) of FLAG-tagged ANT2-FL 
for 24 hours and the lysates collected were subject to immunoprecipitation with 
anti-FLAG M2 beads for 3 hours. The whole cell lysates and proteins 
immunoprecipitated with the M2 beads were separated by SDS-PAGE, blotted 
and probed with anti-HA before stripping and re-probing with anti-FLAG 
antibodies. DLC1-ΔSTART still displayed binding affinity to FLAG-ANT2-FL. The 
blot is representative of the results obtained from three independent repeats. 
WCL, whole cell lysate; IP, immunoprecipitate; WB, Western blotting.  
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Figure S3 Alignment of bovine ANT2 against human ANT2. The two amino 
acid sequences were aligned using the CLC Sequence Viewer programme (CLC 
Bio) to evaluate sequence identity.  Only 33 amino acid residues were different 
across the two proteins. Bovine ANT1 (bANT1) (GenBank accession number: 
NP_777083.1); Human ANT2 (hANT2) (GenBank accession number: NP_001143).  
